A wane lokaci ne waɗannan alamun suka bayyana?
Kuma duk wani ciwon kirji da ke faruwa a wannan lokacin, musamman ma a shekarunka, ya kamata a bi da shi.
Kuma tare da
Hakanan kuna buƙatar ɗaukar matakan cholesterol da hawan jini.
Kuma yanzu kuna jin ƙishirwa?
Kuma yanzu kuna da ciwon kirji?
Kuma tare da wannan, kuna jin wahalar numfashi?
Kuma za ku iya gaya mani menene sauran alamun da kuke da su?
Kuma yaya girman ku zai kasance?
Kuma ina yin tari.
Kuma ina jin ɗan sanyi da tari.
Kuma a yau na ji ciwon kirji sosai.
Kuma wannan shine lokacin da kake da ciwon kumburi?
Kuma yana haifar maka da ciwon kirji?
Kuma ina jin ɗanɗano.
Kuma ina so in gaya muku inda ciwon kirji yake.
Kuma suna da su.
Kuma tare da ciwon sukari.
Kuma kun san yana jin kamar kirji na yana son yin kumburi.
Kuma ka san mutane suna ci gaba da yi mini bulala a fuskata.
Kuma yanzu kana da ciwon kirji?
Kuma kun ce wannan kamar matsa lamba ne a kan kirjin ku.
Shin akwai wani a cikin iyalinka da ke da ciwon zuciya, ciwon zuciya, bugun zuciya, kiba, ko hawan jini?
Shin kuna jin ciwo ko alamun ciwon tsoka?
Shin akwai wani a cikin gidanku da ke rashin lafiya kuma yana da alamun cutar kamar yadda kuke da ita?
Kuna da wasu alamun cutar?
Kuna jin numfashi?
Har yanzu kuna da ciwon kirji?
Domin wannan shine lokacin mura.
Amma ba za mu damu da ciwon kirji ba idan ya zo daga ciwon zuciya.
Amma mafi muhimmanci yanzu shine ciwon kirji.
Amma ina numfashi sosai.
Amma na san mutane da yawa suna yi mini bulala a fuskata.
Amma dole ne mu dauki duk wani ciwon kirji da muhimmanci.
Amma yanzu kana numfashi sosai, ko ba haka ba?
Na manta da shi gaba ɗaya saboda ciwon kirji.
Shin yana kama da wani ya yi maka fashi?
Shin har yanzu kana jin numfashi?
Shin suna fama da rashin lafiya da alamun da suke da su?
Shin kana da wata cuta mai tsanani kamar hawan jini ko wata cuta mai kama da haka?
Shin kana da wasu cututtuka na yau da kullum kamar ciwon sukari?
Kuna da ciwon numfashi tare da ciwon kirji?
Kuna da hawan jini?
Shin kana da matsalar numfashi?
Shin kun san menene alamun cutar?
Kuna ganin wannan hoton?
Ka sha ruwa mai yawa yau.
Ina yin gwajin ciwon sukari.
Alamun sa sun yi kama da nawa.
Yaya zafin jiki yake?
Shin an auna karfin jininka?
Idan ka ci gaba da yin hakan
Idan yawan zafin jiki ya wuce digiri ɗari biyu Fahrenheit
Idan ka ga alamun cututtukanka ko matsalarka sun inganta
Na ji daɗin abincin jiya.
Kuma yana da ɗanɗano.
Na ɗanɗana shi jiya.
Ina da ciwo mai tsanani a cikin kirji.
Ina kuma numfashi cikin wahala.
Zan aiko maka da hoto.
Ina jin ciwon kirji a yau.
A yau ina da ɗanɗano.
Ina tsammanin mura ce.
Ina tsammanin yana da ɗan sanyi.
Shin kana jin kamar kana da mutum mai nauyi a kan kirjinka?
Na fara da damuwa kuma na ji tsoro a lokaci guda.
Ina jin zafi a tsakiyar kirji.
Matsin lamba yana kama da ciwon kirji.
Yana cikin kirji na.
Yana tsakiyar kirji na.
Yana tsakiyar kirji.
Ina jin ciwo a kirji.
Na damu sosai game da wannan ciwon dutse.
Ina so ka bayyana mini ciwon kirji.
kamar hawan jini ko ciwon sukari
Dama kamar tsakiyar kirji
Yanzu za ku iya samun takalma na takalma.
Mary, ka riga ka yi kwanakin da suka gabata.
Yanzu kun ce kuna da ciwon kirji.
Ina jin ciwon kirji a wasu lokatai.
To, shin kana da wasu alamun cutar ban da ciwon?
Ko kuwa wani yana zaune a kan kirjinka?
Yana kama da tari da tari da ciwon kai da ciwon tsoka.
Dama a tsakiyar kirji na.
A cikin wannan hoton, nuna masa inda nake ciwo.
Domin kana da shi.
Kuna tsammanin wasu daga cikin waɗannan alamun zasu iya danganta da ciki?
Shin yaranku suna da wasu daga cikin alamun?
Ka gaya mini game da ciwon kirjinka.
Yana tashi ne kawai da dare.
A cikin kwanaki biyu da suka gabata, na ɗanɗana.
Sai dai a daren jiya ne ya fara tashi.
Ni ne Dr. Porter daga sashen gaggawa na Cibiyar Triad.
To, za ka iya gaya mini game da ciwon kirji na?
Na ji ciwo a gaba na a kirji.
Na ji ciwo mai tsanani a kirji.
To, lokacin da na ji ciwon kirji,
Wane irin ciwo kake da shi a kirji?
Yaushe wannan ciwon kirji ya fara?
A wane yanki na kirji ne ciwon kirji yake?
{NS}
Kuna jin zafi a cikin kirjin ku?
Na kamu da ciwon sukari kuma na kamu da su.
Ka ce kana da ciwon kirji.
Yawan mutuwar da ke faruwa cikin gaggawa a cikin cutar coronavirus 19-COVID a cikin EU/EEA da UK, Janairu 1 zuwa Maris 15, 2020
Irin wannan yanayin na karuwar yawan masu kamuwa da cutar COVID-19 a cikin EU / EEA da Burtaniya ya tabbatar da cewa, duk da cewa matakai sun bambanta tsakanin ƙasashe, yaduwar COVID-19 tana ci gaba da haɓaka cikin sauri a duk ƙasashe.
Bisa ga kwarewar Italiya, ƙasashe, asibitoci da raka'a na kulawa mai tsanani dole ne su haɓaka shirye-shiryen su don magance ƙaruwar masu kamuwa da COVID-19 waɗanda ke buƙatar kulawa ta musamman da kulawa mai tsanani.
A ranar 31 ga watan Disamba na 2019, an samu wasu mutane da suka kamu da cutar sankarar bargo da ba a san dalilin da ya sa ba a birnin Wuhan na lardin Hubei na kasar Sin.
A ranar 9 ga watan Janairun 2020, Cibiyar Kula da Cututtuka da Cututtuka ta kasar Sin ta bayyana dalilin cutar a matsayin sabon coronavirus wanda yanzu ake kira coronavirus 2 na cutar sankarar bargo 2-SARS-CoV.
Tun daga wannan lokacin, cutar da ke haifar da 2-SARS-CoV an san ta da cutar coronavirus COVID-19.
Shaida har zuwa yau ta nuna cewa kashi 80% na mutanen da ke fama da COVID-19 suna fama da rashin lafiya mai sauƙi, wato cututtukan numfashi ba tare da cutar huhu ba ko tare da cutar huhu kuma yawancin suna murmurewa.
Kashi 14% na masu kamuwa da COVID-19 suna buƙatar asibiti, kuma sauran kashi 6% na marasa lafiya suna buƙatar kulawa mai tsanani.
Yawan mutuwar mutane da ke fama da cutar COVID-19 a cikin marasa lafiya ya kai kusan 4%.
A cikin wannan binciken, mun kimanta yanayin yanayin COVID-19 a kowace ƙasa ta EU/EEA da Burtaniya kuma mun kwatanta shi da yanayin lardin Hubei na China.
Mun kuma kwatanta yawan adadin masu kamuwa da COVID-19 a cikin EU / EU Economic Area da UK tare da adadin masu kamuwa da cutar a Italiya a cikin lokacin Janairu 31-15 Maris 2020.
Cutar COVID-19 a cikin EU/AER da UK
Bayan China, COVID-19 ya haifar da ƙarin ci gaban ƙasa kuma yawan yaduwar cutar coronavirus a sauran ƙasashe na duniya yana kama da na ƙasar Sin.
A ranar 11 ga Maris, 2020, Darakta Janar na Hukumar Lafiya ta Duniya (WHO) ya ayyana cutar ta COVID-19 a matsayin annoba ta duniya.
A ranar 5 ga Maris, a cewar Eurosurveillance 2020, Spiteri da abokan aikinsa sun ba da rahoton farkon cutar COVID-19 da aka tabbatar a Turai kamar yadda WHO ta bayyana.
A cikin ƙasashen EU/EEA, an tabbatar da shari'o'in farko guda uku a ranar 24 ga Janairu 2020 a cikin mutanen da suka dawo daga Wuhan, lardin Hubei na China.
A ranar 15 ga Maris, 2020, an samu kararraki na COVID-19 a duk ƙasashe 30 na Tarayyar Turai / Yankin Tattalin Arzikin Turai da Burtaniya, wanda ya haifar da kararraki 39,768 da mutuwar 1,727 a cikin wannan lokacin tsakanin 31 ga Disamba, 2019, daga cikin 17,750 da mutuwar 1,441 a Italiya kadai.
Samun adadin masu kamuwa da cutar da kuma yawan adadin masu kamuwa da cutar COVID-19.
Cibiyar Kula da Cututtuka ta Turai (ECDC), ta ba da rahoton adadin masu cutar COVID-19 a duk ƙasashen duniya, ana samun su ne kawai daga kafofin hukuma kamar ma'aikatun kiwon lafiya na ƙasashe, hukumomin kiwon lafiya na yanki da WHO kuma ana sabunta su kowace rana da ƙarfe 8:00 na safe.
An yi amfani da wannan bayanan don kimanta yanayin COVID-19 a cikin ƙasashen EU da Burtaniya da kuma kwatanta su da Italiya.
A matsayin mai lura da ci gaban shari'o'in COVID-19 masu aiki, mun bincika ƙimar raguwar kwanaki 14 na COVID-19 don haka muna ɗaukar yanayin yanayin COVID-19 a kowace ƙasa ta EU da Burtaniya daga Janairu 1 zuwa Maris 15, 2020.
Mun kuma ba da adadin adadin masu cutar da aka ruwaito a kowace ƙasa a karfe 8:00 na safe ranar 15 ga Maris idan aka kwatanta da adadin a Italiya a tsakanin Janairu 31 zuwa Maris 15.
Yanayin COVID-19 a cikin EU da UK
Matsayin da aka samu na kwanaki 14 na cutar COVID-19 a cikin EU da UK gabaɗaya yayi daidai da na lardin Hubei na China (Figure 1.1).
A cikin ƙasashen EU da Burtaniya gabaɗaya, yawan kamuwa da COVID-19 ya fara ƙaruwa a ranar 21 ga Fabrairu kuma ya sami ƙaruwa sosai a ranar 28 ga Fabrairu, 2020 (bayanan hoto).
Wannan ya fi yawaita saboda saurin karuwar adadin masu kamuwa da cutar a Italiya, amma duk sauran ƙasashen EU da Burtaniya sun nuna irin wannan ci gaban a cikin yawan mutuwar COVID-19 a cikin nasu.
Figure 2 ya nuna adadin masu kamuwa da cutar COVID-19 a cikin EU da UK da Italiya a cikin lokacin daga 31 ga Janairu zuwa 15 ga Maris, 2020.
Wannan ya nuna cewa a karfe 8:00 na safiyar ranar 15 ga Maris, yawan adadin masu kamuwa da cutar a sauran ƙasashen Tarayyar Turai 15 da Burtaniya sun kai adadin adadin masu kamuwa da cutar a Italiya a makonni 3 ko ƙasa da haka.
Sakamakon bincikenmu ya nuna cewa adadin masu kamuwa da cutar COVID-19 a cikin EU da UK suna ƙaruwa cikin sauri.
Hanyoyin da ake gani na yawan kamuwa da cutar COVID-19 sun nuna cewa wannan yaduwar tana ci gaba a irin wannan saurin a duk ƙasashe.
Wannan duk da cewa ƙasashe suna cikin matakai daban-daban na rayuwa da kuma ba su da daidaito a cikin amsar lafiyar jama'a ta ƙasa, da kuma bambance-bambance a cikin ma'anar yanayin da kuma ladabi na gano marasa lafiya don gwaji don tabbatar da kamuwa da COVID-19.
A farkon watan Maris na 2020, likitocin yankunan da ke cikin Italiya sun bayyana halin da ake ciki cewa kusan kashi 10% na masu cutar COVID-19 suna buƙatar kulawa mai tsanani, kuma kafofin watsa labarai sun bayyana cewa asibitoci da raka'a na kulawa mai tsanani a waɗannan yankuna sun kai iyakar ƙarfin su.
Bayanan kwantar da marasa lafiya na COVID-19 a asibiti da kuma a cikin cibiyoyin kulawa mai tsanani a cikin EU / EEA a halin yanzu suna da kashi 6% da 1% na lokuta, bi da bi (ba a nuna bayanai ba).
Koyaya, waɗannan bayanan dole ne a tattara su cikin tsari don kammala bayanan kulawa na yanzu waɗanda ke mai da hankali kan yawan adadin da aka ruwaito da yawan mutuwar.
Wani bincike da aka gudanar a watan Nuwamba na 2010 ya nuna bambancin da ke tsakanin yawan gadajen kula da marasa lafiya a Turai, inda a Jamus akwai gadaje 29.2 da kuma a Portugal akwai gadaje 4.2 ga kowane mutum 100,000.
Wannan yana nuna cewa ƙasashe na iya samun ƙasa ko sama da albarkatu idan aka kwatanta da Italiya (gadoje na kula da lafiya na matsakaici da na matsakaici na 12.5 ga kowane mutum 100,000 a watan Nuwamba 2020).
Yanayin da aka tsara game da yawan ƙarfin kula da lafiya, tare da ƙididdigar kowace ƙasa ta EU da Burtaniya game da yaduwar yanayin COVID-19 da ke da alaƙa da haɗarin sama da kashi 90% na haɓaka ƙarfin gado mai mahimmanci, an gabatar da su a cikin sabuntawa na shida na ECDC na COVID-19 mai saurin haɗarin haɗari.
Saboda yawancin lokuta suna cikin ƙasashen EU da UK, kuma asibitoci da raka'a na ICU suna ba da sabis ga yawan jama'a a cikin yanki, ana ba da shawarar samun bayanai game da lokuta da gadajen ICU daga ƙididdigar ƙididdigar yanki na 2 (2-NUTS).
Kwarewar Italiya da yanayin da ake ciki yanzu a wasu ƙasashe ya nuna cewa COVID-19 yana yaduwa cikin sauri a cikin EU da UK.
Kasashe, asibitoci da cibiyoyin kulawa da gaggawa na likitoci dole ne su shirya don yanayin ci gaba da yaduwar cutar SARS-CoV-2 a cikin al'umma da kuma karuwar adadin masu cutar COVID-19 da ke buƙatar kulawa ta likita, wasu daga cikinsu suna buƙatar kulawa ta gaggawa, kamar yadda yake faruwa a yanzu a yankunan da ke fama da cutar a Italiya.
Kamar yadda aka nuna a cikin sabon kimantawa na haɗarin ECDC, ana buƙatar ingantaccen tsari mai sauri don jinkirta yaduwar cutar 2-SARS-COV, tare da sauya tsarin daga dakatar da zuwa sauƙaƙe, saboda ƙididdigar ƙaruwa da ake tsammani na ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙiddigar ƙid.
Binciken haɗarin gaggawa ya tsara matakan kiwon lafiya na jama'a don tantance tasirin cutar.
Yanzu akwai ɗan ƙaramin taga na dama wanda ƙasashe za su iya ƙara ƙoƙarin sarrafawa don rage yaduwar cutar 2-SARS-CoV da rage matsin lamba kan ma'aikatar kiwon lafiya.
Idan hakan ta gaza, tsarin kiwon lafiya na sauran ƙasashen EU zai fuskanci ƙarin masu cutar da ke buƙatar kulawa mai tsanani a cikin kwanaki ko makonni masu zuwa.
Cutar coronavirus ta 2019 (COVID-19), wadda ta haifar da cutar coronavirus 2 (SARS-CoV) ta kamu da cutar sankarar barbashi (SARS) ta kashe mutane sama da 3,000 kuma ta kamu da mutane sama da 80,000 a China da sauran ƙasashe a duniya, wanda hakan na iya zama bala'i ga ɗan adam.
Kamar dai yadda yake da kwayar cutar da ta kama da ta SARS-CoV, wanda ya kamu da dubban mutane a 2003, sabon kwayar cutar SARS-CoV-2 na iya zama daga ƙuda kuma yana haifar da bayyanar cututtuka ta hanyar irin wannan tsari.
Kodayake cutar COVID-19 ba ta da tsanani kuma yawan mutuwar ta fi SARS, amma yawan kamuwa da cuta ya fi yawa kuma yana shafar tsofaffi da maza fiye da matasa da mata.
Wannan labarin ya ba da cikakken bayani game da saurin ci gaban bincike, saboda yawan adadin masu cutar da ke tattare da wannan cutar mai tasowa.
Muna tattauna manyan ka'idojin pathogenesis, causology, virology, ganewar asali, magani, tsinkaya da rigakafin cutar.
Duk da cewa har yanzu akwai tambayoyi da yawa da ba a amsa ba, muna fatan wannan kimantawa zai taimaka wajen fahimtar da kuma hana wannan mummunar cuta.
Bikin bazara na ranar 25 ga Janairun 2020 ya zama abin tunawa ga Sinawa saboda an tilasta musu su zauna a gida duk lokacin hutun su na makonni bayan barkewar sabuwar cutar.
Wannan kwayar cutar tana da kamanceceniya da kwayar cutar coronavirus (CoV) wacce ta haifar da cutar sankarar barbashi mai saurin kamuwa da cuta (SARS) a shekarar 2003; don haka Hukumar Lafiya ta Duniya (WHO) ta sake sanya wa coronavirus SARS-CoV-2 a ranar 11 ga Fabrairun 2020 kuma ta sake sanya wa cutar cutar COVID-19 sunan.
Cutar ta fara ne a birnin Wuhan na kasar Sin kuma ta bazu cikin sauri a duk fadin kasar da kuma wasu kasashe 50 a duniya.
A ranar 2 ga Maris, 2020, cutar ta sami mutane 80,000 da suka kamu da cutar COVID-19, wanda 40,000 suka warke kuma sama da 3,000 suka mutu.
WHO ta yi gargadin cewa COVID-19 "magabcin jama'a na 1" ne kuma ya fi ta'addanci ƙarfi.
A cewar PubMed ((https://www.ncbi.nlm.nih.gov/pubmed/), a cikin ƙasa da watanni biyu, an buga labarai sama da 200 game da COVID-19 waɗanda suka shafi ilimin kwayar cuta, pathogenesis, causology, ganewar asali da magani na cutar tun bayan an fara rahoton cutar a ranar 7 ga Janairu, 2020 kuma an gano jerin kwayoyin halittar kwayar cutar a cikin marasa lafiya da yawa.
Wannan bita yana ƙoƙarin taƙaita tsarin bincike a cikin wannan sabon yanayin ci gaba mai sauri.
A duk lokacin da aka fara, muna ƙoƙarin kwatanta COVID-19 da SARS da sauran cututtukan coronavirus da Middle East Respiratory Syndrome (MERS, a cikin 2012).
Za mu kuma tattauna abin da muka sani game da rigakafi da kuma hasashen cutar, da kuma wasu tambayoyi masu muhimmanci da ba a amsa ba tukuna.
Kwayar cutar coronavirus ta kasance a matsayin mai cutarwa ta ɗan adam kuma a zahiri tana haifar da kusan 15% na cututtukan mura na 4.
Koyaya, a wannan karni, mun fuskanci kwayar cutar coronavirus sau biyu, SARS-CoV da MERS-CoV, waɗanda suka haifar da barkewar cutar farko a China a 2003 da Saudiyya a 2012, kuma ba da daɗewa ba suka bazu zuwa ƙasashe da yawa a duniya tare da ƙididdigar yawan kamuwa da cuta da mutuwa.
Wannan yana nufin cewa COVID-19 na yanzu shine kamuwa da kwayar cutar coronavirus ta uku a tarihin ɗan adam.
An kuma nuna a cikin Figure 1.1, an fara sanar da cutar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Bayan mako guda, an sake sakin jerin kwayoyin halittar kwayar cutar.
A ranar 15 ga Janairun 2020, an bayar da rahoton mutuwar farko a Wuhan.
A lokacin, cutar ta yadu cikin sauri a garuruwa, larduna da ƙasashe na kusa.
A ranar 20 ga watan Janairu, an sanar da kamuwa da cutar a tsakanin ma'aikatan kiwon lafiya kuma an lura cewa cutar tana da damar yaduwa daga mutum zuwa mutum.
A ranar 23 ga watan Janairun, an killace birnin Wuhan kuma an dakatar da dukkan hanyoyin sufuri.
A ranar 24 ga Disamba, binciken likita na farko ya bayyana cewa daga cikin mutane 41 da aka tabbatar da cutar, mutane 21 ne kawai suka kamu da cutar ta hanyar kai tsaye zuwa kasuwar abincin teku, don haka an gano asalin cutar daga asalin dabba da ba a sani ba.
A ranar 30 ga watan Janairun, Hukumar Lafiya ta Duniya ta ayyana barkewar cutar a matsayin gaggawa ta kiwon lafiya a duniya.
A lokacin wannan rahoton, cutar ta bazu a duk faɗin China da kusan ƙasashe 50 a duniya.
Saboda yanayin yana ci gaba da sauri, ƙarshen ƙarshen kuma ƙarfin haɗakarwa ya kasance a buɗe.
A ranar 11 ga Fabrairun 2020, an gudanar da bincike mai yawa akan marasa lafiya 8,866 waɗanda 4,021 daga cikinsu ke da tabbacin cutar COVID-19 wanda ya nuna sabon hoto na cutar gaba ɗaya kamar haka (https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA).
Kwayar cutar SARS-CoV-2 ta kamu da mutane a kowane zamani, amma yawancinsu sun kamu da cutar tsakanin shekaru 30 zuwa 65.
Kusan rabin (47.7%) na masu kamuwa da cutar sun haura shekaru 50, kaɗan daga cikinsu sun kasance ƙasa da shekaru 20, kuma kawai 14 daga cikin masu kamuwa da cutar sun kasance ƙasa da shekaru 10.
Yawan kamuwa da cutar SARS-CoV-2 ya fi yawa a cikin maza (0.31/100,000) fiye da mata (0.27/100,000).
Cutar COVID-19 ta bulla a cikin Hubei da yankunan da ke kewaye.
COVID-19 yana ɗaukar kwanaki 5 (9-2) don ganowa a cikin mutum.
Matsakaicin lokacin kamuwa da cutar zuwa bayyanar cutar shine kwanaki 4.8 (7.2-3.0).
Hakanan yana kashe mutum a matsakaici cikin kwanaki 9.5 (13-4.8).
Farkon ƙimar haihuwa (R0) na cutar ya kasance 3.77 (95% CI:3.51-4.05), kuma daidaitaccen ƙimar haihuwa R0 ya kasance 4.82-2.32.
Yawan masu kamuwa da cutar ya karu sosai kafin ranar 23 ga watan Disamba wanda ya dace da yawan zirga-zirgar jama'a kafin bikin bazara na kasar Sin.
Yawan mutuwar a cikin lokuta da aka tabbatar ya kasance 1.44% (95% CI:1.10-1.86%) da kuma daidaitaccen mutuwar a cikin dukkan masu kamuwa da cutar ya kasance 3.06% (95% CI:2.02-4.59%).
Manyan abubuwan haɗari guda uku na COVID-19 sune jinsi (maza), shekaru (sama da 60) da cututtukan numfashi mai tsanani.
Kwayar cutar Corona ta kasance daga cikin manyan ƙwayoyin cuta masu ɓoyewa waɗanda ke da RNA guda ɗaya.
Ana iya raba kwayar cutar zuwa jinsuna huɗu, wato; alpha, beta, gamma da delta.
A cikin SARS-CoV da MERS-CoV, glicoproteins na Spike (S) suna haɗuwa da masu karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar kar
Kwayar RNA ta kwayar cutar tana da 'yanci a cikin cytoplasm; bayan kwayar cutar ta kwayar cutar ta sake yin kwayar halitta, RNA ta asali tare da glycoproteins da nucleoproteins na vesicles na kwayar cutar suna samar da ƙwayoyin cuta waɗanda ke haɗuwa da membrane na plasma don kawar da kwayar cutar.
An sanar da jerin kwayoyin halittar farko na SARS-CoV-2 a ranar 10 ga Janairu, 2020.
Kwayar cutar SARS-CoV-2 wani sabon nau'in kwayar cuta ne wanda ya ƙunshi kashi 99.98% na bayanan kwayoyin halitta tsakanin samfuran 10 da aka tattara a cikin asalin asalin cutar a kasuwar abincin teku ta Hunan da ke Wuhan.
Kwayar cutar SARS-CoV-2 ta fi kama da SARS-CoV da MERS-CoV.
Ta hanyar amfani da microscopy na watsawa ta lantarki, an gano ƙwayoyin SARS-CoV-2 a cikin sassan ultrasound na murfin iska na mutum.
ACE2 na ɗan adam ya bayyana a matsayin mai karɓar kwayar cutar SARS-Cov-2 da SARS-CoV.
Koyaya, SARS-CoV-2 yana da rauni sosai fiye da SARS-CoV tare da ACE2 na mutum, wanda shine dalilin da ya sa cutar ta SARS-CoV-2 ta fi rauni a cikin mutane fiye da SARS-CoV.
Hakanan SARS-CoV-2 yana iya samar da sabon furotin na gaba wanda aka ɓoye ta hanyar orf3b da kuma furotin mai maye gurbin da aka ɓoye ta hanyar orf8.
SARS-CoV-2 coronavirus orf3b na iya taka rawa a cikin cutar ta cutar kuma yana hana IFNβ bayyana; a wannan yanayin, orf8 ba shi da wani rawar aiki.
A ranar 18 ga Fabrairun 2020, Zhou da abokan aikinsa sun ba da rahoton cikakken tsarin cryo-EM na ACE2 na ɗan adam a cikin Hyaluron A 2.9 ta hanyar haɗuwa da amino acid B0AT1.
Sun gano cewa wannan tsari wanda ke da hanyoyi biyu, kamar haɗuwa da dimer da ACE2-B0AT1 na iya haɗa sunadarai biyu na S, yana ba da hujja don ganowa da kuma kawar da coronavirus.
B0AT1 na iya zama maƙasudin maganin maganin maganin maganin maganin cutar SARS-CoV-2.
Ƙarƙashin ƙwayoyin halitta da ƙwayoyin tsakiya
An gano cewa asalin duka SARS-CoV da MERS-CoV sun kasance ƙuda kuma waɗannan ƙwayoyin cuta sun kamu da mutane ta hanyar kuliyoyi da alfadarai.
Ta hanyar kwatanta kwayoyin halittar SARS-CoV-2 da sauran coronaviruses, an gano cewa jemage ne asalin kwayar cutar SARS-CoV-2 saboda sabon kwayar cutar tana da kamanceceniya da kashi 96% da sauran kwayar cutar SARS ta bat bat-SL-CoVZX45 da bat-SL-CoVZX21.
Bugu da ƙari, yadda ƙwayoyin halitta na tsakiya ke taimakawa kwayar cutar ta ƙetare shingen jinsin kuma ta kai ga mutane ba a gano ba tukuna kuma hanyar watsawa har yanzu tana buƙatar bayani.
Jay da abokan aikinsa, Marian sun bayyana shi a matsayin mai watsa kwayar cutar daga jemage zuwa mutum wanda ke haifar da haɗuwa da irin wannan furotin na S.
A cewar wani bincike, masu bincike a Guangzhou, China, sun bayyana cewa pangolin - dabba mai shayarwa da ake amfani da ita sosai a maganin gargajiya na kasar Sin - na iya zama babban mai karɓar bakuncin kwayar cutar SARS-CoV-2 saboda akwai kamanceceniya ta 99% tsakanin kwayar cutar da aka gano a pangolin da kwayar cutar SARS-CoV-2.
Duk da haka, bambancin kwayoyin halitta na 1% tsakanin ƙwayoyin cuta biyu har yanzu babban bambanci ne, saboda haka, ana jiran ƙarin hujja mai ƙarfi don yin sakamako mai mahimmanci (Fig.33.
Har yanzu ba a gano cikakkun halaye na jiki da sunadarai na SARS-CoV-2 ba.
Kwayar cutar SARS-CoV da MERS-CoV a cikin yanayin jiki na iya rayuwa na tsawon awanni 48 a cikin yanayin bushewa har zuwa kwanaki 5 a zafin jiki ƙasa da digiri 20 da yanayin zafi na 40%-50%.
Kwayar cutar SARS-CoV-2 na iya samun irin wannan yanayin.
An ba da rahoton cewa SARS-CoV-2 yana da ƙarancin ƙarancin zafin jiki na 56 ° C na tsawon minti 30; Acyl chloride, 75% ethanol, chlorine idan akwai maganin rigakafi, paracetic acid, chloroform, da sauran magungunan mai, ban da chlorhexidine, na iya kashe kwayar cutar yadda ya kamata.
Mutane gabaɗaya ba su da rigakafi ga SARS-CoV-2 coronavirus kuma suna iya kamuwa da sabon kwayar cutar.
A halin yanzu, babu cikakken bincike game da maganin rigakafi ga SARS-CoV-2.
Don haka, zamu iya kawai nuna binciken da aka yi a baya game da coronavirus, musamman SARS-CoV da MERS-CoV (Fig. 4).
Gabaɗaya, bayan kamuwa da kwayar cutar zuwa ga mahalarta, ana gano ta ne da farko ta hanyar tsarin rigakafin ƙwayoyin cuta ta hanyar masu karɓar ƙwayoyin cuta na ƙwayoyin cuta (PRRs) waɗanda suka haɗa da masu karɓar nau'in C, masu karɓar ƙwayoyin cuta na Toll (TLR), masu karɓar ƙwayoyin cuta na NOD, da masu karɓar ƙwayoyin cuta na RIG-I (RLR).
Ta hanyoyi daban-daban, kwayar cutar tana haifar da kamuwa da cuta, haɓaka ƙwayoyin dendritic da samar da nau'ikan I-interferon (IFNs) waɗanda ke iyakance yaduwar kwayar cutar da haɓaka phagocytosis na ƙwayoyin cuta masu ƙwayoyin cuta.
Hakanan, furotin na SARS-CoV-N yana taimakawa kwayar cutar ta tsere daga amsawar rigakafi.
Ba da daɗewa ba, tsarin rigakafin da aka daidaita zai haɗu da cutar.
Kwayoyin T na T da kuma CD4+CD8+T suna taka muhimmiyar rawa wajen rigakafi.
Kwayoyin CD4 + T suna motsa kwayoyin B don samar da ƙwayoyin rigakafi na musamman ga kwayar cutar kuma ƙwayoyin CD8 + T suna kashe kwayoyin da ke dauke da kwayar cutar kai tsaye.
Kwayoyin T masu taimakawa suna samar da cytokines na rigakafi don taimakawa kwayoyin rigakafi.
Hakanan, coronavirus na iya hana ayyukan T-cell ta hanyar kashe kwayoyin T.
Hakanan rigakafin rigakafi wanda ya ƙunshi ƙarin abubuwa kamar C3a da C5a da ƙwayoyin cuta suna da mahimmanci don magance kamuwa da kwayar cuta.
Misali, maganin rigakafin da aka samu daga marasa lafiya da suka warke daga cutar coronavirus yana kashe MERS-CoV.
A gefe guda, halayen tsarin garkuwar jiki na yau da kullum suna haifar da yawan adadin radicals wanda zai iya haifar da lalacewar numfashi da sauran gabobin jiki, kuma a cikin mafi munin yanayin, zai haifar da rashin aiki da yawa ko ma mutuwa.
Cutar coronavirus SARS-CoV-2 ta fara ne daga ƙwayoyin cuta, kuma ta fi shafar tsofaffi da mata masu juna biyu.
A yadda aka saba, mutanen da ke fama da cutar ko kuma waɗanda ke da tsarin rigakafi da ke cikin haɗari suna da damar kamuwa da cutar fiye da sauran mutane.
Dangane da binciken da aka yi kan mutane 425 da suka kamu da cutar a Wuhan, an kiyasta tsawon lokacin kamuwa da cutar SARS-CoV-2 daga kwanaki 1-14 zuwa kwanaki 3-7.
Hakazalika, wani bincike da aka yi kan mutane 1,099 da suka kamu da cutar ya nuna cewa matsakaicin lokacin bayyanar cutar ya kasance kwanaki 3 kuma ya kasance daga kwanaki 0 zuwa 24.
Binciken da aka yi kwanan nan, wanda aka ambata a sama, ya nuna cewa lokacin bayyanar cutar ya kasance kwanaki 4.8 (7.2-3.0) bisa ga yawan mutane 8,866.
Yana da mahimmanci ga hukumomin kiwon lafiya su tsara lokacin keɓewa mai tasiri bisa ga ainihin lokacin bayyanar cutar, don haka za a iya hana yaduwar cutar daga masu cutar marasa alamun zuwa wasu mutane.
A matsayin al'ada, mutanen da suka kamu da cutar ko kuma suka sadu da wasu masu cutar, yawanci ana buƙatar keɓe su na kwanaki 14.
Shin ya kamata a tsawaita lokacin keɓewa zuwa kwanaki 24?
Yawancin lokaci alamun farko ne na COVID-19 wanda zai iya kasancewa shi kaɗai ko tare da wasu alamun kamar bushewar tari, numfashi mai wahala, ciwon tsoka, tari, ciwon kai, ƙonewar jijiyoyi, ɓarkewar hanci, ciwon kirji, ciki, rikicewar zuciya da ƙonewa.
Wasu masu fama da cutar sun kamu da matsalar numfashi/launin oxygen a cikin jini mako guda bayan farawar cutar.
A cikin mawuyacin hali, cutar tana haɓaka cikin sauri zuwa matsalolin numfashi, cutar hawan jini da lalacewar gabobin jiki, acidity na kwayoyin halitta da cutar hawan jini.
Marasa lafiya da ke da alamun cutar da kuma / ko cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Wani binciken alƙaluma a ƙarshen Disamba 2019 ya nuna cewa kashi 98% na marasa lafiya sun kasance, kashi 76% ko tari mai bushe, kashi 55% ko numfashi mai wuya, kashi 3% ko maƙarƙashiya, kuma kashi 8% ko buƙatar na'urar numfashi.
Binciken da aka yi kwanan nan a kan cutar da ke cikin iyali da kuma cutar da ke tattare da mutum ba tare da bayyanar cututtuka ba ya haifar da irin wannan sakamako.
A kwatankwacin haka, wani binciken alƙaluma a cikin 2012 ya nuna cewa marasa lafiya da ke fama da MERS-CoV sun kasance masu alamun farko (98%) har zuwa, (47%) tari mai bushe, (55%) rashin ƙarfi.
Koyaya, kashi 80% na waɗannan marasa lafiyar sun buƙaci numfashi na wucin gadi, wanda ya fi na marasa lafiya na COVID-19 yawa kuma ya yarda da yawan mutuwar MERS daga COVID-19.
An kuma lura da zawo (26%) da ƙonewar ƙura (21%) a cikin marasa lafiya na MERS.
A cikin marasa lafiya na SARS, an lura cewa tari (100%-99%), bushewar tari (75%-29%), numfashi (42%-40%), zawo (25%-20), da ƙonewar ƙura (25%-13) sune manyan alamun bayyanar cututtuka kuma kusan 20%-14% na masu cutar sun buƙaci numfashi na wucin gadi.
A ranar 14 ga Fabrairu, mutuwar COVID-19 ya kai kashi 2% yayin da adadin adadin mutane 66,576 suka kamu da cutar a duk duniya.
A kwatankwacin haka, yawan mutuwar SARS ya kai kashi 10% daga cikin 8,096 da aka tabbatar a watan Nuwamba 2002.
Ga MERS, a cewar wani binciken alƙaluma a watan Yunin 2012, yawan mutuwar ya kai kashi 37% daga cikin mutane 2,494 da aka tabbatar.
Wani binciken da aka yi a baya ya nuna cewa R0 na SARS-CoV-2 ya kasance 6.47 don haka a cikin 95% CI na 7.23-5.71, yayin da R0 na SARS-CoV kawai ya kasance tsakanin 2 zuwa 4.
Kwatanta SARS-CoV-2 da MERS-CoV da SARS-CoV dangane da alamun cututtuka, yawan mutuwa, da R0 ko R2 an nuna su a cikin tebur 1.1.
Abubuwan da ke sama sun nuna cewa SARS-CoV-2 yana da ƙarfin watsawa fiye da MERS-CoV da SARS-CoV, amma ba su da haɗari kamar sauran biyu.
Saboda haka, ya fi wuya a sarrafa yaduwar SARS-CoV-2 fiye da MERS-CoV da SARS-CoV.
Sau da yawa ana fara farawa a cikin gida ɗaya ko kuma a cikin gida ɗaya ko kuma a cikin hanyar sufuri, kamar jirgin ruwa.
Yawancin marasa lafiya a cikin makonni biyu da suka gabata kafin cutar, sun yi tafiya ko zama a Wuhan ko wasu yankuna masu cutar ko kuma sun haɗu da mutane masu cutar ko marasa lafiya.
Bugu da ƙari, an ba da sanarwar cewa mutane na iya kamuwa da cutar ba tare da alamomi ba har tsawon makonni biyu kuma marasa lafiya da suka warke bayan an sallame su daga asibiti na iya sake kamuwa da cutar, wanda hakan ya zama abin faɗakarwa don tsawaita lokacin keɓewa.
Marasa lafiya a farkon matakan suna da ƙarancin ƙwayoyin cuta na waje (musamman ƙwayoyin lymphatic) ko kuma ba su da yawa.
Misali, an gano cutar sankarar bargo mai dauke da adadin farin jini < 4x109/L da kuma yawan ƙwayar lymphatic < 1x109/L, kuma an lura da karuwar matakan aminotransferase aspartate da veremia a cikin marasa lafiya 1,099 da ke dauke da COVID-19.
Matsayin enzymes na tsoka da jijiyoyi da myoglobin a cikin jini sun tashi cikin sauri a cikin wasu marasa lafiya, kuma sun sami karuwar furotin C da kuma yawan adadin red blood cells a cikin mafi yawan marasa lafiya.
A cikin marasa lafiya masu ciwo, matakin D-dimer, wani samfurin fibrin da ke cikin jini, ya karu kuma yawan ƙwayoyin lymphatic ya ragu sosai.
An lura da rashin daidaiton radiation na kirji a cikin yawancin marasa lafiya na COVID-19 kuma yana bayyana a cikin inuwa mai duhu a ɓangarorin biyu ko duhu kamar gilashin da aka rushe a cikin huhu.
Marasa lafiya galibi suna nuna cututtukan huhu na yau da kullun, mummunan rauni na huhu, da cututtukan numfashi mai saurin gaske (ARDS).
Lokacin da ARDS ya faru, ƙwayoyin cuta da ba a sarrafawa, ƙwayoyin ruwa, da kuma ci gaba da fibrosis, suna haifar da haɗari ga musayar gas.
Rashin aiki na nau'ikan 1 da 2 na pneumocytes wanda ke rage matakan sulfates kuma yana ƙara ƙarfin jiki, don haka rage ƙarfin huhu don faɗaɗa, yana ƙara haɗarin cutar huhu.
Saboda haka, yawan radiation na cutar yana nuna rashin lafiya, mafi tsanani cutar.
A ranar 18 ga Fabrairun 2020, nazarin cututtukan farko na COVID-19 ya nuna cewa kashe ƙwayoyin cuta, ƙirƙirar murfin hyaline, da ɓarkewar ƙwayoyin cuta na tsakiya, da ƙwayoyin cuta masu kama da ƙwayoyin cuta a cikin huhu na marasa lafiya da suka mutu daga cutar, sun yi daidai da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan SARS da SARS da MERS.
An yi amfani da gano RNA na SARS-CoV-2 coronavirus ta hanyar RT-PCR (reverse polymerase chain reaction) azaman babban ma'auni don gano COVID-19.
Duk da haka, saboda karuwar ƙimar kuskuren da aka samu, wanda zai iya saurin yaduwar cutar, an fara amfani da alamun asibiti don gano cutar a China a ranar 13 ga Fabrairu, 2020 (tunda ba a ƙara amincewa da RT-PCR ba).
Haka kuma an samu irin wannan cutar a lokacin da aka gano SARS.
Saboda haka, haɗuwa da tarihin cutar, alamun asibiti, gwaje-gwajen gwaje-gwaje, da binciken bincike don cimma nasarar ganewar asali da kuma magani.
A ranar 14 ga Fabrairun 2020, ƙungiyar Feng Zhang ta bayyana wata yarjejeniya ta amfani da fasaha ta SHERLOCK ko CRISPR don gano kwayar cutar SARS-CoV-2, wanda ke gano nau'ikan RNA na SARS-CoV-2 a cikin 20x10-18mol/L zuwa 200x10-18mol/L (10-100 kwafi ga kowane microl a ƙasa) ta hanyar ɗaukar digo ɗaya a cikin ƙasa da awa ɗaya ba tare da buƙatar kayan aiki ba.
Muna fatan wannan sabuwar hanyar idan an tabbatar da ita za ta iya haɓaka ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙ
Saboda rashin kwarewar sabon coronavirus, likitoci na iya ba da kulawa gaba ɗaya ga marasa lafiya na COVID-19, tare da amfani da magungunan da aka yi amfani da su a baya ga marasa lafiya da ke fama da wasu cututtukan coronavirus kamar SARS-CoV da MERS-CoV da sauran cututtukan ƙwayoyin cuta.
Wadannan magungunan sun hada da maganin rigakafin cutar da ake amfani da su yanzu da magungunan ɓoye, masu hana rigakafi, steroids, plasma na marasa lafiya, magungunan kasar Sin, da kuma tallafi na tunani.
Har ma an ba da shawarar yin amfani da jini na marasa lafiya da suka warke don maganin.
Kamfanonin harhada magunguna a halin yanzu suna cikin tsere don samar da maganin rigakafi da allurar rigakafi don cutar.
Kwayar cutar SARS-CoV-2 tana kai hari ga tsarin numfashi kuma yana iya zama ƙasa da ƙasa, har ma da gabobin da ke da ACE2, kamar hanta da kodan.
Bugu da ƙari, rashin aiki da rashin ƙarfi na numfashi shine babban barazana ga marasa lafiya kuma shine babban dalilin mutuwar masu kamuwa da cutar.
Don haka, tallafin numfashi yana da mahimmanci don rage alamun cututtuka da ceton rayukan marasa lafiya wanda ya haɗa da maganin oxygen gaba ɗaya, maganin oxygen mai ƙarfi, iska mai ƙarancin iska, iska mai haɗari, iska mai haɗari, gwargwadon tsananin cutar.
Marasa lafiya da ke da alamun cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Bugu da ƙari, kiyaye daidaiton lantarki, rigakafi da maganin cututtukan cututtuka da damuwa na septum, da kuma kiyaye aikin gabobin jiki na asali suna da mahimmanci ga marasa lafiya da cutar SARS-CoV-2.
An kuma gano cewa cutar sankarar cytokine, sakamakon halayen rigakafin cutar SARS da MERS.
Cytokine harin wani nau'i ne na tsarin kumburi wanda aka yi ta hanyar sakin jerin cytokines, ciki har da TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ da MCP-1.
Wadannan cytokines suna tilasta kwayoyin rigakafi su saki yawancin radicals kyauta wanda shine babban dalilin ARDS da rashin aiki na gabobin jiki.
Tsarin rigakafi na rigakafi don magance cytocin, musamman a cikin marasa lafiya.
An yi amfani da corticosteroids da tosylisumab, da kuma maganin IL6 monoclonal antigen, don magance cutar sankarar jiki.
Sauran magungunan rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rig
Ana amfani da steroids, a matsayin masu hana rigakafi, don magance SARS tare da manufar rage tsananin cutar.
Bugu da ƙari, steroids ba su da amfani a cikin SARS da COVID-19 idan an sha su a cikin babban abinci don mummunan lalacewar huhu.
Maimakon haka, yana iya haifar da sakamako mai illa, musamman ga tsarin jijiyoyin jiki, wanda ke shafar ganewar asali.
Bugu da ƙari, an ba da shawarar yin amfani da gajeren lokaci na corticosteroids a cikin ƙananan abinci mai sauƙi don marasa lafiya na COVID-19 waɗanda ba su da lafiya.
A lokacin wannan rubutun, babu ingantaccen maganin cutar da aka tabbatar.
Duk da haka, allurar rigakafin cutar ta Remdesivir, wani kwayar halitta mai ƙwayar nucleotide, ta nuna tasiri a cikin wani mai haƙuri na COVID-19 na Amurka.
Remdesivir wani sabon magani ne na rigakafin cutar da Gilead ta fara samarwa don magance cututtukan da ke tattare da cutar Ebola da kuma cutar homing.
Daga baya, Remdesivir ya kuma nuna tasirinsa na hana ƙwayoyin cuta na RNA guda ɗaya, gami da SARS da MERS.
A cewarsa, Gilead ta ba da wannan kayan aikin don yin gwajin cutar SARS-CoV-2 a China kuma sakamakon yana da kyau.
Bugu da ƙari, baricetinb, alpha interferon, lopinavir/ritonavir, da ribavirin, sune magungunan da aka ba da shawarar don marasa lafiya da ke da alamun cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututututtukan cututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Diarrhea, zuciya, tashin zuciya, rashin jin daɗi, da sauran halayen da ke haifar da cutarwa na iya faruwa bayan amfani da maganin haɗin lopinavir / ritonavir.
Dole ne a lura da hulɗar waɗannan magunguna tare da wasu magunguna a cikin marasa lafiya.
Plasma na marasa lafiya da suka warke da kuma samar da ƙwayoyin cuta
Tattara jini daga marasa lafiya da suka tsira daga cutar da kuma amfani da shi don magance marasa lafiya da ke fama da cutar ko kare lafiyar mutane a kan kamuwa da cutar yana da dogon tarihi.
A gaskiya ma, marasa lafiya da suka warke suna da yawan adadin ƙwayoyin cuta da ke cikin jini.
Antibodies sune immunoglobulin (lg) da kwayoyin lymphocytes na B ke samarwa don yaƙi da pathogens da sauran manufofi na waje da kuma gano kwayoyin halitta na musamman a cikin pathogen kuma su kawar da su kai tsaye.
An haɗa jini na wasu marasa lafiya da suka warke daga COVID-19 cikin jini na mutane 10 da ke fama da cutar sankarar bargo.
Alamun sun ragu a cikin sa'o'i 24, kuma cututtukan cututtukan cututtuka da ƙwayoyin cuta sun ragu, kuma sun inganta yawan oxygen a cikin jini.
Duk da haka, ana buƙatar tabbaci da bayani don bayar da shawarar tsari da amfani da shi a kan sikelin kafin a ci gaba da magance matsalolin.
Bugu da ƙari, tare da la'akari da tasirin maganin, wasu lalacewar da ke tattare da plasma dole ne a yi la'akari da su sosai.
Misali, ƙwayoyin cuta na iya haifar da amsawar rigakafi fiye da yadda ake tsammani kuma yana haifar da cutar sakin cytokine wanda zai iya zama mai haɗari ga rayuwa.
Yawan ƙwayoyin cuta a cikin jini yana da ƙananan, kuma ana buƙatar plasma don magance marasa lafiya.
Samun da kuma samar da takamaiman maganin rigakafi mai saurin gudu wanda zai iya magance cutar ta duniya yana da wahala.
Saboda haka, ware kwayoyin B daga marasa lafiya da suka warke da gano lambar kwayoyin su da kuma tsara maganin rigakafi mai tasiri, ko kuma bincika maganin rigakafi wanda ke tasiri akan furotin na kwayar cutar, yana da mahimmanci.
Idan wannan ya yiwu, za mu iya sauƙaƙe samar da maganin rigakafi.
An yi amfani da TCM don magance cututtuka daban-daban a kasar Sin shekaru dubbai.
Duk da haka, tasirinsa ya dogara ne akan haɗuwa da abubuwa da yawa a cikin wani tsari wanda ya bambanta dangane da ganewar asali na cutar bisa ga ka'idodin TCM.
Yawancin abubuwan da ke aiki a cikin wannan yanayin ba a san su ba ko kuma ba su da tabbas saboda ganowa da tabbatar da irin wannan abun da ke ciki ko haɗuwa da su yana da wuya.
A halin yanzu, saboda rashin ingantaccen magani na musamman don COVID-19, TCM ya zama ɗayan manyan hanyoyin magance magunguna ga marasa lafiya masu saurin nuna alamun cutar ko waɗanda ke cikin mawuyacin hali kuma suna murmurewa.
Misali, Shu Feng Jie Du da Lian Hua Qing Wen sun kasance masu tasiri wajen magance COVID-19.
An lura da mafi yawan adadin warkewar marasa lafiya na COVID-19 a larduna da yawa na kasar Sin inda kashi 87% na marasa lafiya suka sami magani daga TCM, gami da Gansu (63.7%), Ningxia (50%), da Hunan (50%), yayin da a lardin Hubei TCM ya shafi kashi 30% na marasa lafiyar COVID-19, kuma an sami mafi ƙarancin farfadowa (13%).
Bugu da ƙari, wannan ƙananan ƙananan ƙananan ne, saboda yawancin sauran abubuwan da ke tasiri kamar yawan marasa lafiya da kuma tsananin cutar su dole ne a yi la'akari da su a cikin kimantawa.
A ranar 18 ga Fabrairu, 2020, Boli ZHang da abokan aikinsa sun gudanar da bincike kan kwatancen maganin magungunan Yammacin Turai (WM) kadai.
Sun gano cewa lokacin da ake bukata don warkewa daga zafin jiki, bayyanar cututtuka, da kuma buƙatar kwantar da asibiti a cikin rukunin WM + TCM ya fi ƙasa da na rukunin WM kawai.
Mafi mahimmanci, ƙimar ɓarkewar bayyanar cututtuka (mai sauƙi zuwa mai tsanani) a cikin rukunin WM+TCM ya kasance ƙasa da na rukunin WM kawai (7.4% vs. 46.2%), kuma yawan mutuwar a cikin rukunin WM+TCM ya kasance ƙasa da na rukunin WM kawai (8.8% vs. 39%).
Bugu da ƙari, inganci da amincin TCM har yanzu suna da yawa fiye da gwajin gwaji mai kyau a cikin manyan sikelin da cibiyoyi.
Hakanan bayanin tsarin aikin da kuma bayanin ingantattun abubuwan haɗin maganin TCM ko abubuwan haɗin su idan ya yiwu zai zama mai ban sha'awa.
Marasa lafiya da ke da cutar COVID-19 ko kuma waɗanda aka tabbatar da cutar sau da yawa suna fuskantar tsoro mai tsanani na cutar da ke kashewa ko kuma annobar da ke yaduwa, kuma waɗanda ke keɓewa suna fuskantar rashin jin daɗi, rashin kulawa, da fushi.
Bugu da ƙari, alamun cututtuka irin su tari, hypoxia da tari da kuma sakamako masu illa na magunguna kamar rashin barci saboda amfani da corticosteroids na iya haifar da damuwa da rashin jin daɗi.
A farkon farkon barkewar SARS, an ba da rahoton cututtukan ƙwaƙwalwa da yawa ciki har da ciwon baƙin ciki, damuwa, fargaba, tashin hankali, alamun hauka, rashin hankali, har ma da kashe kansa.
Kulawa da tuntuɓar mutum da keɓaɓɓen keɓewa, a matsayin ɓangare na amsar lafiyar jama'a ga COVID-19, na iya sa mutane su damu da damuwa game da tasirin cutar, keɓewa, da tasirinsa ga dangi da abokai.
Saboda haka, dole ne a samar da kulawar lafiyar kwakwalwa ga marasa lafiya na COVID-19, waɗanda ake zargi da cutar, da waɗanda suka taɓa saduwa da su, da kuma ga jama'a gaba ɗaya.
Ya kamata ya haɗa da tallafin ilimin halayyar ɗan adam, ƙirƙirar ƙungiyoyin kiwon lafiyar ƙwaƙwalwa masu yawa, sadarwa mai kyau da bayyane tare da sabuntawa na yau da kullun da cikakkun bayanai game da barkewar cutar SARS-CoV-2, tsare-tsaren magani da amfani da na'urorin lantarki da shirye-shiryen ƙwararru don hana kusanci da mutane.
Ana buƙatar allurar rigakafi mai tasiri don katse sarkar watsawa daga waɗannan dabbobi da mutane masu kamuwa da cutar zuwa ƙwayoyin cuta masu saurin kamuwa da cutar kuma galibi suna dacewa da maganin rigakafin cutar don sarrafa cututtukan da ke faruwa ta hanyar sabbin ƙwayoyin cuta.
An yi ƙoƙari sosai don ƙirƙirar allurar rigakafi bisa ga furotin S don samar da maganin hana yaduwar cutar na dogon lokaci da / ko kariya ta kariya ga SARS-CoV.
An gwada alluran rigakafin SARS masu rai a cikin samfurin dabbobi.
Bugu da ƙari, ba a ƙaddara tasirin in vivo na waɗannan alluran rigakafi a cikin mutum-da-shekara da kuma tsarin kariya da kariya daga yaduwar kwayar cutar da ke tsakanin mutane da dabbobi ba kafin a fara gwajin asibiti.
Wannan na iya zama saboda SARS ya ragu shekaru 17 da suka gabata kuma babu wani sabon shari'ar da aka samu tun daga wannan lokacin.
A akasin wannan, har yanzu ana samun cututtukan MERS da kuma cututtukan da ke faruwa a Gabas ta Tsakiya kuma suna ci gaba da yaduwa zuwa wasu yankuna saboda yawan albarkatun da ke tsakanin mutane da dabbobi a yankunan da ke cikin yankin.
An samar da dabarun kwatanta don MERS, ta hanyar kwafin kwayar cutar da aka hana, plasmid DNA, masu ɗaukar kwayar cutar, nanoparticles, kwayoyin halittar kwayar cuta, da ƙananan ƙwayoyin cuta na recombinant, kuma an gwada wasu a cikin dabbobi.
Samar da ingantaccen maganin rigakafin cutar SARS-CoV-2 ga marasa lafiya yana da matukar muhimmanci a cikin aikin gaggawa na sarrafa cutar.
Bugu da ƙari, shawo kan wannan matsala yana da matukar wahala saboda tsawon lokacin da ake buƙata don samar da allurar rigakafi (kimanin watanni 18) da kuma sauye-sauyen motsi na coronavirus.
A matsayin sabon cuta, COVID-19 ya fara nuna sake zagayowar asibiti a cikin dubban marasa lafiya.
A mafi yawan lokuta, marasa lafiya suna iya murmurewa ba tare da ciwon baya ba.
Koyaya, kamar SARS da MERS, COVID-19 yana haifar da rashin lafiya da mutuwa a cikin lokuta masu ƙarfi.
Saboda haka, samar da samfurin tsinkaya na cutar yana da mahimmanci ga hukumomin kiwon lafiya don ba da fifiko ga ayyukan su, musamman a wuraren da albarkatu ke iyakance.
Dangane da binciken asibiti da aka ruwaito zuwa yanzu, waɗannan dalilai masu zuwa na iya tasiri ko alaƙa da hangen nesa na marasa lafiya na COVID-19 (Table33):
Shekaru: Shekaru sune mafi mahimmancin abin da ke haifar da lokacin murmurewa daga SARS kamar yadda yake ga COVID-19.
COVID-19 ya fi faruwa a tsakanin shekaru 65-30 kuma a cikin binciken da aka yi da mutane 8,866, kashi 47.7% na marasa lafiya sun fi shekaru 50 kamar yadda aka ambata a sama.
Marasa lafiya da ke buƙatar kulawa ta musamman suna da yiwuwar samun wasu cututtuka kuma sun kasance masu tsufa sosai (a matsakaicin shekaru 66 da 51), wanda ke ba da shawarar shekaru a matsayin mai tsinkayar sakamako na marasa lafiya na COVID-19.
Jima'i: SARS-CoV-2 yana kamuwa da maza fiye da mata (0.31/100,000 vs. 0.27/100,000), kamar yadda aka ambata a baya.
Samun wasu cututtuka: Marasa lafiya na COVID-19 waɗanda ke buƙatar kulawa ta likita suna iya samun cututtukan zuciya ko rashin bugun zuciya.
Cutar zuciya ita ce kuma babbar hanyar mutuwa a cikin marasa lafiya na SARS.
An ba da rahoton cewa SARS-CoV-2 na iya haɗuwa da collagen cells masu kyau na ACE2 wanda zai iya haifar da rashin lafiya a cikin marasa lafiya na COVID-19.
Ya kamata a lura cewa shekaru da cututtukan cututtuka suna da alaƙa da juna kuma suna iya shiga tsakani.
Sakamakon gwaji na yau da kullun: Matsayin C-type receptor protein (CRP) a cikin jini yana nuna tsananin kamuwa da cuta ko lalacewar nama kuma yana nuna alamun cutar, amsawa ga magani, da kuma dawowa na ƙarshe.
An kuma ba da shawarar alaƙar tsakanin matakan CRP da tsananin da kuma tsinkayen COVID-19.
Bugu da ƙari, haɓakar lactate dehydrogenase (LDH), aspartate aminotransferase (AST), alanine aminotransferase (ALT) da creatine kinase (CK) na iya taimakawa wajen hango sakamakon.
Wadannan enzymes suna samuwa a cikin gabobin jiki, musamman a zuciya da jijiyoyi, kuma an saki su a lokacin lalacewar nama.
Waɗannan abubuwa za su zama alamun rashin tsarki da kuma rashin tsarki.
Manyan alamun asibiti: Ana buƙatar yin la'akari da radiography na kirji da ci gaban lokaci na alamun asibiti tare da sauran matsaloli don hango sakamakon da rikitarwa na COVID-19.
Amfani da steroids: Kamar yadda aka ambata a baya, steroids suna hana tsarin garkuwar jiki kuma galibi ana amfani da su azaman magani mai taimakawa ga cututtukan ƙwayoyin cuta don rage lalacewar cututtukan ƙwayoyin cuta.
Saboda yawan amfani da corticosteroids a cikin marasa lafiya masu tsanani na SARS, yawancin waɗanda suka tsira sun kamu da mutuwar ƙwayoyin ƙashi da rashin jini tare da nakasa da lalacewar rayuwa.
Don haka, idan ya cancanta, ya kamata a rage yawan allurai da kuma ɗan gajeren lokaci a cikin marasa lafiya na COVID-19.
Matsin lamba: Kamar yadda aka ambata a baya, a lokacin barkewar COVID-19, yawancin marasa lafiya suna fuskantar damuwa ta rashin ƙarfi saboda yawancin su sun yi dogon lokacin keɓewa da rashin tabbas da kuma tsammanin mutuwar danginsu da abokansu.
Dole ne a ba da jagora na hankali da tallafi na dogon lokaci ga waɗannan marasa lafiya don taimaka musu su shawo kan damuwa da komawa rayuwar yau da kullun.
Dangane da binciken da aka yi a baya, COVID-19 yana da nau'ikan watsawa daban-daban idan aka kwatanta da SARS.
Baya ga sakewa a cikin ƙananan iska, SARS-CoV-2 yana iya sakewa cikin iska mai ƙarfi a cikin ƙananan iska kuma yana nuna alamun rashin lafiya ko rashin alamun cutar a farkon lokacin kamuwa da cuta, kamar sauran coronaviruses da ke haifar da sanyi.
Saboda haka, marasa lafiya da ke fama da cutar a farkon lokacin cutar ko lokacin da ba a nuna cutar ba yayin ayyukan yau da kullun na iya samar da ƙwayoyin cuta da yawa, wanda ke haifar da babbar matsala ga kula da cutar.
Bugu da ƙari, SARS-CoV yana yaduwa yayin da cutar ta kamu da cutar, yayin da yawancin yaduwar ba ta faru a farkon lokacin ba.
Saboda haka, annobar COVID-19 ta yanzu ta fi ta SARS wahala kuma ta fi wahalar sarrafawa.
A halin yanzu, ana yin ƙoƙari sosai don dakatar da sarkar watsa SARS-CoV-2 a China, gami da rufe Wuhan da biranen da ke kewaye da shi da kuma keɓe kusan dukkanin mutane.
Duk da cewa waɗannan ayyukan sun haifar da mummunan rauni ga tattalin arzikin da sauran sassan ƙasar, yawan sabbin masu cutar yana raguwa, yana nuna cewa annobar ta ragu.
Ana sa ran cewa cutar za ta ƙare a watan Maris kuma za ta ci gaba da raguwa na tsawon watanni 4-3.
Duk da haka, wasu masana ba su da kyakkyawan fata.
Paul Hunter da abokan aikinsa sun yi hasashen cewa COVID-19, wanda ya fi SARS yaduwa, ba zai ƙare a cikin 2020 ba.
Ira Longini da abokan aikinsa sun kirkiro wani tsari don hango sakamakon cutar kuma sun nuna cewa SARS-CoV-2 na iya kamuwa da kashi biyu bisa uku na yawan mutanen duniya.
Wata ƙungiyar Kanada ta bayyana cewa an gano kwayar cutar SARS-CoV-2 a cikin yankuna biyu na tsakiyar turbinet da kuma swabs na fata na marasa lafiya waɗanda suka warke daga asibiti makonni biyu da suka gabata, wanda ke nuna cewa sabon kwayar cutar na iya zama wani abu mai kama da mura.
A lokaci guda, an samu raguwar sabbin kamuwa da cutar a kasar Sin, wanda ke nuna cewa dabarun da ake amfani da su yanzu na iya yin tasiri.
A farkon lokacin, an yi hasashen cewa cutar Ebola za ta iya kamuwa da mutane miliyan daya da mutuwar mutane miliyan rabin.
Koyaya, tare da keɓewa da keɓewa, cutar za ta kasance a ƙarƙashin iko.
Kamar SARS-CoV, yana da yiwuwar wannan SARS-CoV-2 ya zama mai rauni a cikin kamuwa da cuta kuma daga ƙarshe ya mutu ko ya canza zuwa kwayar cutar da ba ta da cutarwa kuma ta kasance tare da mutane.
An kwatanta yawan kamuwa da COVID-19 da SARS da MERS a ƙasa (Fig. Fig.55).
SARS-CoV-2 yana yaduwa ta hanyar ƙwayar cuta ta cuta, kuma yana iya yaduwa ta hanyar haɗuwa kai tsaye da kayan da ke dauke da cutar.
An kuma gano kwayar cutar a cikin bargo, wanda ke haifar da sabon yiwuwar yaduwar kwayar cutar daga bargo zuwa baki.
Wani sabon bincike da aka yi kan mutane 138 ya nuna cewa kashi 41 cikin dari na masu kamuwa da cutar na iya kasancewa a asibiti, 17 daga cikinsu suna da cututtuka na farko kuma 40 daga cikinsu ma'aikatan kiwon lafiya ne.
Saboda haka, ana buƙatar ɗaukar matakan kariya don kare mutane, musamman ma ma'aikatan kiwon lafiya, masu ba da sabis na zamantakewa, dangin, abokan aiki har ma da masu wucewa waɗanda suka taɓa yin hulɗa da marasa lafiya da waɗanda ke da cutar.
Layin farko na kariya wanda za'a iya ɗauka don rage haɗarin kamuwa da cutar shine amfani da abin rufe fuska; amfani da nau'ikan masks na tiyata da masks na N95 (lambar sarkar 1860) zai taimaka wajen sarrafa yaduwar ƙwayoyin cuta.
Abun rufe fuska na tiyata yana hana watsawa daga wani mutum mai kamuwa da cuta ta hanyar iska ko kuma haɗuwa da farfajiyar abubuwa daga inda za'a iya watsawa ga wasu mutane.
Bugu da ƙari, kawai abin rufe fuska na N95 (sarkar lamba 1860) na iya karewa daga numfashi na ƙananan ƙwayoyin cuta daga 10 zuwa 80 nanometers, kuma kawai 5% na ƙwayoyin cuta suna iya yadawa gaba ɗaya; SARS-CoV-2 yayi kama da SARS-CoV a cikin girman kusan 85 nanometers.
Saboda ƙwayoyin cuta na iya yaduwa ko da an sanya masks na tiyata guda biyar, masu ba da kiwon lafiya waɗanda ke fuskantar haɗuwa kai tsaye da marasa lafiya dole ne su yi amfani da N95 (sarƙoƙi 1860) maimakon masks na tiyata.
Baya ga abin rufe fuska, ma'aikatan kiwon lafiya dole ne su sanya suturar keɓewa ta dace don rage haɗuwa da ƙwayoyin cuta.
Kwayoyin cutar na iya kuma kamuwa da mutum ta hanyar idanu.
A watan Janairun 2020, wani likita ya kamu da SARS-CoV-2 duk da cewa yana amfani da abin rufe fuska na N95; mai yiwuwa kwayar cutar ta shiga cikin jikinsa ta hanyar kamuwa da ido.
Don haka ma'aikatan kiwon lafiya dole ne su yi amfani da garkuwar fuska da tabarau yayin aiki tare da marasa lafiya.
A wuraren da mutane ke da cutar, an ba da shawarar cewa kowa ya wanke hannu da sabulu mai hana yaduwar cutar, ya zauna a gida don keɓe kansa da kuma iyakance hulɗa da mutanen da za su iya kamuwa da cutar.
Matsakaicin nesa mai dacewa da mutum mai rashin lafiya ya zama ƙafa uku.
Waɗannan ayyuka sune hanya mai tasiri da tasiri don rage haɗarin kamuwa da cutar da hana yaduwar kwayar cutar.
Kodayake SARS-2 ya zo ne a matsayin sabon kwayar cutar ga mutanen duniya, yana da kamanceceniya da SARS wanda aka bayyana a ranar 7/1/2020 wanda ya kamata ya zama babban dalilin canjin China dangane da cikakken bayanin barkewar SARS a 2003.
Koyaya, har zuwa 19 ga Janairun 2020, Hukumar Kula da Cututtukan Cututtuka ta Wuhan ba ta ba da tabbacin cewa cutar tana da ƙananan yaduwa da ƙarancin yaduwa daga mutum zuwa mutum ba tare da wata matsala ba.
Wannan sakon ya kwantar da hankalin jama'a, musamman ma lokacin da ake shirin bikin bazara, lokacin da aka rasa damar sarrafa cutar a Wuhan.
Hukumomin kula da cututtuka da cibiyoyin kula da cututtuka a kasar Sin na iya koyon darasi daga wannan kuma su sami ci gaba a nan gaba.
Misali, hukumomi da cibiyoyi zasu (1) yi taka tsantsan yayin fitar da sanarwar jama'a, saboda duk wata kalma ga 'yan uwansu na iya canza yanke shawara da halayyarsu; (2) zama masu saurin fahimta da kuma amsawa ga bayanan da ba na yau da kullun ba, kamar jiran rahotanni na likita da hukuma; (3) zama masu tsauraran ra'ayi game da iyakancewar annoba da sarrafawa a farkon matakan don kwantar da hankalin mutane; da kuma (4) gudanar da ƙarin ayyuka masu tasiri da motsa jiki don haɓaka wayar da kan jama'a game da cututtukan annoba da tsarin amsawa da gwajin jama'a.
Cutar coronavirus-19 ta haifar da sabon kwayar cutar SARS-CoV-2 wanda ya fara a watan Disamba na 2019.
A cikin ƙasa da watanni 2, ya bazu ko'ina cikin China da kusan ƙasashe 50 a duniya, daidai lokacin da na rubuta wannan.
Saboda cutar ta yi kama da SARS-CoV kuma alamun cutar sun yi kama da na SARS, yaduwar cutar ta haifar da jin cewa SARS ya dawo.
Koyaya, akwai wasu bambance-bambance masu mahimmanci tsakanin COVID-19 da SARS, waɗanda sune manyan bambance-bambance don hanawa da iyakance yaduwar cutar da kuma kula da marasa lafiya.
COVID-19 yana shafar tsofaffi fiye da matasa, maza fiye da mata, kuma yana da mafi yawan cututtuka da mutuwar tsofaffi fiye da matasa.
SARS ya fi COVID-19 kisa (10.91% da 1.44%).
Marasa lafiya da COVID-19 suna watsa kwayar cutar koda kuwa basu da alamun cutar, yayin da marasa lafiya da SARS suma suna iya yin hakan idan sun kamu da cutar, wanda ke haifar da ƙalubale da yawa don hanawa da iyakance yaduwar COVID-19 fiye da SARS.
Wannan ya bayyana wani ɓangare na dalilin da yasa SARS-CoV-2 ke yaduwa da sauri kuma ya fi yaduwa fiye da SARS-CoV-2.
Gwajin RNA na yau da kullun don SARS-CoV zai iya zama mara kyau a cikin wasu marasa lafiya na COVID-19.
A gefe guda kuma, marasa lafiya da suka warke suna iya sake kamuwa da cutar.
Wadannan binciken sun kara yawan hadarin yaduwar cutar.
Tare da ci gaba mai sauri a cikin binciken COVID-19, akwai wasu matsaloli da za a warware, kamar su:
Daga ina ne cutar SARS-CoV ta fito?
Kodayake kashi 96% na kwayoyin halitta sun kasance a cikin SARS-CoV-2 da kuma wasu cututtukan coronavirus kamar SARS-CoV-2, ba za mu iya cewa SARS-CoV-2 ya samo asali ne daga bats ba.
Wane dabba ne ya kawo kwayar cutar daga asalin kwayoyin halitta, kamar su barbashi zuwa mutum?
Ba tare da amsa tambayoyi na #1 da 2 ba, ba za mu iya dakatar da yaduwar cutar ba, kuma za a iya sake fasalin cutar a kowane lokaci.
Kodayake nazarin kwayoyin halitta da gwaje-gwaje na kwayoyin sun nuna cewa SARS-CoV-2 yana haɗuwa da ACE2, ta yaya kwayar cutar ke bayyana a cikin ƙwayoyin iska kuma ta haifar da maye gurbin da ke tattare da cutar?
Shin kwayar cutar tana haɗuwa da kwayoyin da ke da alaƙa da ACE2 a wasu gabobin jiki?
Ba tare da amsoshin waɗannan tambayoyin ba, ba za mu iya samun saurin ganewar asali da kuma maganin da ya dace ba.
Yaya tsawon lokacin da cutar za ta ci gaba?
Ta yaya kwayar cutar ke haɓaka kwayoyin halitta yayin watsawa tsakanin mutane?
Shin za a kawar da cutar ta duniya kamar SARS ko kuma za a sake dawo da ita kamar mura?
Yana da mahimmanci kuma yana iya ɗaukar lokaci don bincika waɗannan tambayoyin da yawa.
Koyaya, duk abin da amsa da amsa ta buƙata, ba mu da zaɓi sai dai mu kawo ƙarshen annobar da wuri kuma mu dawo da rayuwarmu ga al'ada.
An samo asali ne daga dabbobi a cikin kwayar cutar coronavirus ta mutum.
Juyin halitta da kuma dacewa sun jagoranci ci gaban coronaviruses da kwayoyin halitta, ciki har da mutane, har tsawon dubban shekaru.
Kafin 2003, an san cewa kwayar cutar coronavirus guda biyu tana haifar da cututtuka masu sauƙi, kamar sanyi da sanyi.
An samu barkewar cutar SARS da kuma cutar MERS a Gabas ta Tsakiya, wanda ya nuna cewa kamuwa da kwayar cutar HCoV na iya zama mai cutarwa da kuma barazana ga rayuwa.
Cutar SARS-CoV-2 da ta barke a tsakiyar China a ƙarshen 2019 ta sake haifar da cutar coronavirus kuma ta ba da mamaki ga babban birnin tare da ƙarfin watsawa, amma ta rage yawan kamuwa da cuta idan aka kwatanta da SARS-CoV-2.
HCoV yana yaduwa daga dabba zuwa mutum, kuma fahimtar asalin dabba na HCoVs na iya zama da amfani.
Yawancin nau'ikan HCoVs sun samo asali ne daga barbashi, alhali kuwa ba su da cutar.
An san kwayoyin halittar HCoVs.
Gano dabbobi masu ƙwayoyin cuta yana taimakawa kai tsaye wajen hana cututtukan mutane.
Nazarin haɗuwa da kwayoyin halittar coronavirus na iya ba mu mahimman bayanai game da cutar coronavirus a cikin mutane.
A cikin wannan binciken, za mu ba da bayanin abubuwan da aka sani game da nau'ikan coronaviruses guda 7, tare da ba da labarin tarihin gano su da asalin su a cikin dabbobi da kuma watsa su tsakanin nau'ikan.
Abu mafi mahimmanci, muna samar da nau'ikan kwayar cutar coronavirus da kuma gano bambance-bambance a cikin yanayin haɓakar kwayar cutar da tsarin kwayoyin halitta.
An bayyana cutar ta yanzu ta cutar coronavirus (COVID-19) a cikin wannan labarin.
Duk da haka, bukatun kwayoyin halitta don samun nasara sun canza kuma sun taimaka wajen ci gaba da cutar a cikin yawan cutar.
Kwayoyin cutar coronavirus, (CoVs), suna cikin dangin Coronaviridae, wanda ya ƙunshi rukuni na ƙwayoyin cuta masu ɗauke da RNA guda ɗaya da masu juyawa.
Waɗannan ƙwayoyin cuta sun kasance mafi girma a cikin kwayoyin halitta na 26 zuwa 32 kilobases a cikin ƙwayoyin cuta na RNA da ake kira "CoVs", saboda suna kama da kambi a cikin ido.
A asali, nau'ikan kwayar cutar coronavirus suna da kwayoyin halitta da suka bambanta da ke da irin wannan tsari.
Kimanin kashi biyu bisa uku na kwayoyin halitta suna da manyan manyan sassan biyu (ORF1a da ORF1b), waɗanda aka fassara kamar haka: pp1a da pp1ab sunadaran bambancin enzymatic.
Masu amfani da furotin masu yawa suna amfani da furotin mai mahimmanci na 16, wanda aka ƙayyade a matsayin nsp1~16.
Rashin wannan kwayar halitta yana dauke da ORFs don gina jiki, wanda ya hada da S-head, E-sheath, M-sheath, da kuma nucleoprotein (N).
Yawancin sunadarai masu kama da juna, sun canza ta hanyar kwayoyin halitta daban-daban na CoVs.
Dangane da jerin sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen
Shaidar ilimin halittu ta nuna cewa barbashi da masu rarrafe suna aiki kamar tushen asalin yawancin kwayar cutar alpha-CoV da beta-CoV, yayin da tsuntsaye sune tushen asalin kwayar cutar gamma-CoV da Delta-CoV.
A cikin dubban shekaru, nau'ikan coronaviruses sun ci gaba da ƙetare shingen tsakanin nau'ikan kuma sun haɗu da jikin mutum kamar masu cutarwa.
Ya zuwa yanzu, an gano mutane bakwai da suka kamu da cutar HCoV.
Daga cikin waɗannan, HCoV-229E da HCoV2NL63 alpha-coronavirus.
Sauran kwayar cutar beta-CoV guda biyar sun haɗa da: HCoV-OC43, HCoV-HKU1, SARS-CoV, MERS-CoV da SARS-CoV-2.
HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63 yawanci suna haifar da alamun rashin lafiya, kamar sanyi da zazzabi na yau da kullun da / ko zawo.
A akasin wannan, SARS-CoV, MERS-CoV da sabon SARS-CoV-2 suna da cutarwa sosai, suna haifar da matsanancin matsalar numfashi a cikin yawancin marasa lafiya kuma suna iya haifar da mummunan cututtukan numfashi (ARDS) da bayyanar cutar huhu.
An gano kamuwa da cutar HCoV-229E mai tsanani na farko, B814, a cikin numfashi na masu cutar a tsakiyar shekarun 1960.
Tun daga wannan lokacin, an sami ƙarin bayani ta hanyar bincike mai zurfi game da HCoV-229E da HCoV-OC43, duka biyun suna haifar da alamun bayyanar cututtuka na ɗan gajeren lokaci.
Tabbas, an yarda da cewa kamuwa da nau'ikan kwayar cutar coronavirus ba ta da illa ga yaduwar SARS.
Cutar SARS ta 2003 ta kasance ɗaya daga cikin mafi muni a tarihi, ta kamu da mutane fiye da 8,000, kuma mutuwar ta kai kusan 10%.
Shekaru 10 bayan haka, barkewar "Middle East respiratory syndrome MERS" ya haifar da wata annoba mai tsanani a yankin Larabawa tare da yaduwar cututtuka a duniya.
Kwayar cutar coronavirus ta 2019, (2019-nCoV), wanda daga baya aka kira SARS-CoV-2, ita ce tushen dalilin annobar cutar coronavirus ta 2019 COVID-19, wacce ta kashe mutane 3,120 kuma ta kamu da mutane sama da 91,000 har zuwa 3 ga Maris, 2020.
An yi kira ga duniya da ta shirya don barkewar cutar SARS-CoV-2.
Dukkanin nau'ikan HCoV guda 7 suna da asalin dabbobi a cikin barbashi, beraye ko dabbobin gida.
Shaidu da yawa suna tallafawa asalin asalin dukkanin nau'ikan HCoVs na Batman, waɗanda ƙwayoyin cuta ne masu dacewa da kansu kuma ba masu cutarwa ba, amma suna da bambancin kwayoyin halitta.
Cutar COVID-19 ta haifar da manyan ƙalubalen likita, kimiyya, zamantakewa da ɗabi'a ga China da duniya.
Binciken asalin dabbobi na HCoVs ya ba mu tsarin da za mu fahimci tarihin halitta, iko da kuma manyan abubuwan da ke haifar da sauye-sauye da sauye-sauye.
Wannan na iya zama jagora da kuma sauƙaƙewa ga dabbobi masu ɗauke da ƙwayoyin cuta, masu matsakaici da masu haɓaka SARS-CoV-2 tare da taimakawa mai mahimmanci da kuma hana yaduwar cutar a nan gaba.
A cikin wannan bincike, muna ba da labarin tafiya a kan tushen da ya shafi dabbobi, watsawa tsakanin nau'ikan da masu cutar HCoVs.
Musamman, mun gano kuma mun bayyana yanayin kwayar cutar coronavirus gaba ɗaya, wanda ba shi da cutar a cikin kwayoyin halitta, amma bayan an canza shi zuwa sabon kwayar halitta, yana zama mai cutarwa.
Hakanan zamuyi magana game da ci gaban kwayar cutar coronavirus, wanda yawan kamuwa da cutar yana ci gaba da raguwa tare da yawan kamuwa da cutar.
Sakamakon ci gaba da yaduwar SARS-CoV-2 an kuma tattauna shi a cikin rubutun.
An san nau'ikan CoVs na dabbobi tun daga ƙarshen 1930s.
Kafin a ware masu cutar B814 HCoV-229E daga numfashi da iska na waɗanda ke fama da sanyi, an gano nau'ikan kwayar cutar coronavirus a cikin nau'ikan dabbobi daban-daban, gami da algae, beraye, shanu, aladu, kuliyoyi da karnuka.
A cikin shekarun da suka gabata, an gano nau'ikan coronaviruses guda bakwai.
Takaitaccen tarihin gano cutar coronavirus a cikin tsari na lokaci, (Table 1) yana ba da bayanai da kuma jagora.
An fara gano HCoV-229E a cikin 1966 daga mutanen da ke fama da cutar ta numfashi mai tsanani, sannan kuma ya ci gaba da girma a cikin ƙwayoyin huhu na WI-38.
Masu kamuwa da cutar HCoV-229E sun nuna alamun cutar, ciki har da ciwon kai, ciwon kai, gajiya da ciwon kai, tare da ciwon kai da ciwon kai wanda aka gani a kashi 10 zuwa 20 cikin dari na masu kamuwa da cutar.
Daga baya a 1967, an ware HCov-OC43 daga asali da kuma hanyar wucewa ta kwakwalwa a cikin berayen dabbobi masu shayarwa.
Alamun cututtukan HCov-OC43 sun yi kama da waɗanda ke haifar da HCoV-229E, waɗanda ke bambanta da waɗanda ke da cututtukan cututtukan numfashi masu tsanani, kamar mura A da rhinovirus.
Kowane HCoV-229E da HCoV-OC43 an rarraba su a duniya, ana watsa su a cikin yanayin sanyi a lokacin hunturu.
Yawanci, tsawon rayuwar waɗannan ƙwayoyin cuta ba ta wuce mako ɗaya ba, wanda ke biyo bayan kusan makonni biyu na rashin lafiya.
A cewar wani bincike na sa kai, mutane masu lafiya sun kamu da cutar HCoV-229E mai ci gaba kamar sanyi.
Wasu marasa lafiya da ke da rashin lafiyar jiki suna fama da ciwon numfashi.
SARS wanda kuma aka sani da amfani da ƙwayoyin cuta na ɓoyewa, an fara rubuta shi sosai cewa HCoV shine asalin cutar a tarihin ɗan adam kuma SARS-CoV shine tushen kamuwa da cuta, an gano HCoV na uku.
An fara gano cutar SARS a ƙarshen 2002 a lardin Guangdong na China.
Cutar ta SARS ta yi sanadiyar kamuwa da mutane 8,096 da mutuwar mutane 774 a kasashe da nahiyoyi.
Duk da saurin yaduwar cutar, ana tsammanin kowane mutum zai sami ƙarin kamuwa da cuta biyu da kuma rayuwa mai tsawon kwanaki 4 zuwa 7 kuma ana samun mafi girman kamuwa da cutar a ranar 10th na cutar.
Marasa lafiya da ke fama da cutar SARS-CoV suna fara nuna ciwon tsoka, ciwon kai, ciwon hauka, rashin numfashi da maƙarƙashiya sannan numfashi, shan kwayoyi da shan ƙwayoyi masu guba a matsayin alamun ƙarshe.
Lymphopenia, marasa lafiya da ke fama da rashin lafiyar gwajin ƙwayar cuta da kuma yawan nitrogen a cikin urea ya zama sananne ga rashin lafiyar SARS.
Ciwon huhu da ƙwayoyin cuta da ƙwayoyin cuta da ƙwayoyin cuta suna faruwa a cikin marasa lafiya na SARS.
Kimanin kashi 20 zuwa 30 cikin dari na marasa lafiya suna buƙatar kulawa mai tsanani da kuma numfashi na wucin gadi.
Baya ga tsarin numfashi, gabobin da yawa ciki har da tsarin narkewa, hanta da koda suna fama da mummunan nauyi wanda ke tattare da hadarin cytokine wanda zai iya zama sanadin mutuwa ga marasa lafiya masu rauni.
An fara gano kwayar cutar ne daga gwajin numfashi na wani dangin wani mara lafiya da ya zo daga Guangzhou don ziyarci Hong Kong.
Tun daga wannan lokacin, an yi ƙoƙari sosai wajen nazarin HCoV.
An gano HCoV-NL63 daga jariri mai wata bakwai a Netherlands a ƙarshen 2004.
An fara gano cewa yana da yawa a cikin yara da manya da kuma marasa lafiya da ke da rauni na jiki da cututtukan numfashi.
Coriasis da hawan ido mai launin ruwan kasa da hawan iska na iska suna haifar da HCoV-NL63.
Wani bincike mai zaman kansa ya bayyana cewa an cire kwayar cutar daga cikin ɓargo na jariri mai wata takwas wanda ke fama da cutar huhu a Netherlands.
Ko da yake an gano shi ne a Netherlands, amma a zahiri ya bazu a duniya.
HCoV-NL63 ana tsammanin yana da kashi 4.7% na cututtukan numfashi kuma ana samun ƙaruwa a farkon bazara da bazara da hunturu.
HCoV-NL63 yana da alaƙa da cutar shanyewar hanci wanda kuma ake kira shanyewar.
A wannan shekarar, an gano HCoV-HKU1 a cikin wani mutum mai shekaru 71 da haihuwa wanda aka kwantar da shi a asibiti a Hong Kong saboda cutar huhu da kuma numfashi.
Bugu da ƙari, an gano cewa cutar huhu da iska mai saurin numfashi da HCoV-HKU1 ke da alaƙa da cututtukan cutar fuka-fuki.
An gano wasu cututtukan da suka shafi cututtukan huhu kamar HCoV-NL63, HCoV-229E, HCoV-OC43, da HCoV-HKU1 a duk duniya.
Dukkanin HCoVs huɗu da aka karɓa daga al'umma suna da kyau ga ɗan adam kuma ba su da wataƙila su canza kuma su haifar da manyan cututtuka, kodayake abubuwan da suka faru sun faru ne saboda wasu dalilai marasa ma'ana kamar yadda a cikin wasu ƙananan lokuta na cutar HCoV-NL63 da aka gano kwanan nan don haifar da ciwon huhu mai tsanani a China.
A yadda aka saba, yayin da waɗannan HCoVs ke da ikon yin motsi zuwa jikin mutum da kuma sake gyara kansu a cikin jikin mutum, su ma ba su da haɗari ko cutarwa.
An fara gano MERs-CoV a shekarar 2012 a Saudiyya daga cikin huhu na wani mai shekaru 60 da haihuwa wanda ya kamu da cutar huhu mai tsanani da kuma ciwon koda.
Yayin da yawancin kwayoyin cutar da aka tabbatar a cikin Lab suna Gabas ta Tsakiya, yawancin masu shigo da cutar da ke yaduwa ta hanyar kusanci sun fito ne daga ƙasashen Turai da Tunisia.
A shekara ta 2015 an sake samun barkewar cutar a Koriya ta Kudu inda aka tabbatar da mutane 186.
Abubuwan da ke faruwa a asibiti na MERS suna kama da SARS wanda ke haifar da ci gaban matsanancin iska.
Ba kamar SARS ba, yawancin marasa lafiya na MERS suna fama da cututtukan koda mai tsanani wanda ya bambanta MERS daga cututtukan HCoV.
Fiye da kashi 30% na marasa lafiya suna da alamun cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
A ranar 14 ga Fabrairun 2020, an tabbatar da fiye da mutane 2,500 da cutar tare da yawan mace-mace da kashi 34.4% na MERS-CoV, wanda shine ɗayan mafi munin ƙwayoyin cuta da ɗan adam ya taɓa gani.
A ƙarshen rabin watan Disamba na 2019, an gano wasu cututtukan huhu da ke da alaƙa da kamuwa da SARS-CoV-2 a Wuhan, lardin Hubei na China.
Hukumar Lafiya ta Duniya ta ce cutar sankarar huhu da SARS-CoV-2 ta haifar ta zama gagarumar matsalar lafiya ta duniya da ake kira COVID-19.
A ranar 3 ga Maris, 2020, an tabbatar da mutane 90053 a duniya tare da mutuwar mutane 3.4.
An kiyasta cewa yawan mutuwar a Hubei, China ya kai kashi 4.2%, yayin da a waje, kashi 1.2%.
SARS-CoV-2 kamar SARS-CoV da MERS-CoV suna haifar da mummunan kamuwa da huhu ta hanyar haɗuwa da cocaine da kuma numfashi.
Wasu marasa lafiya suna fama da cutar ƙwari.
Cutar huhu tana daga cikin cututtuka masu tsanani kuma tana iya tasowa da sauri kuma ta zama daidai da numfashi.
Ko da yake SARS-CoV da SARS-CoV-2 suna da alaƙa da juna saboda tsayin daka na jerin hormonal wanda ya kai kashi 82% a cikin rassan daban-daban na itacen phylogenetic.
SARS-CoV-2 ya bayyana cewa yana haifar da rashin lafiya amma yana da yawa fiye da SARS-CoV-2 da Mars-CoV-2.
Rahotanni sun nuna cewa SARS-CoV-2 ba shi da alamomi kuma yana iya taimakawa wajen saurin yaduwa a duniya.
Idan aka kwatanta SARS-CoV-2 da sauran COVID-19 guda shida, akwai kamanceceniya da bambance-bambance masu ban sha'awa.
Na farko, tsarin rayuwa da tsawon lokacin rayuwa na HCoVs ya bambanta sosai.
A wannan yanayin, SARS-CoV-2 ya bi sahun gaba na sauran HCoVs shida.
Na biyu, alamun cutar COVID-19 masu tsanani sun kasance tsakanin SARS-CoV da HCoVs huɗu na al'umma (misali HCoV-229E da HCoV-OC43, HCoV-HKU1 da HCoV-NL63).
A gefe guda, mutanen da ke da cutar SARS-CoV-2 suna nuna halaye na yau da kullun na HCoVs, gami da rashin alamun cutar da ba su da kyau ko kuma rashin bayyanar cututtuka.
A gefe guda, ana iya ganin ƙananan adadin masu cutar COVID-19 a cikin SARS-CoV-2, kodayake adadin ya ɗan ragu.
Na uku, yaduwar SARS-CoV-2 ta nuna alamun alamun alamun HCoVs da SARS-CoVs da aka karɓa ta hanyar al'umma.
A gefe guda, yaduwar SARS-CoV-2 tana da yawa kamar yadda yawancin HCoVs ke karɓar al'umma.
A gefe guda, ya rage a tantance ko yawan yaduwar SARS-CoV-2 zai ragu bayan yaduwar ga mutane kamar yadda ya faru a cikin SARS-CoV da Mars-CoV.
A ƙarshe, ana iya gano abubuwa iri ɗaya kamar HCoVs da SARS-CoV-2 a cikin samfurin ƙwayoyin cuta.
Ko watsawar SARS-CoV ta baka yana taka muhimmiyar rawa a cikin yanayin SARS-CoV aƙalla a wasu yanayi ya rage a gani a cikin binciken gaba.
Har ila yau, akwai shaidar da ke nuna cewa SARS-CoV-2 na iya sake farfadowa a cikin yanayi kamar yadda ake samun HCoVs na al'umma.
Abubuwan da ke tattare da SARS-CoV-2 da ke haifar da yiwuwar kamuwa da cuta da ci gaba da yaduwa bayan shigar da mutum cikin jiki zai shafi ƙarshen maganin cutar ta COVID-19.
Dukkanin HCoVs huɗu da jama'a suka ɗauka suna haifar da alamun rashin lafiya wanda ɗan adam ya saba da shi sosai.
A wani bangare kuma, yana iya zama gaskiya cewa mutane sun saba da waɗannan nau'ikan HCoVs huɗu.
A wasu kalmomi, duka biyun sun sami damar kawar da cutar HCoV.
HCoVs suna haifar da cututtuka a cikin mutane kuma mutane da ke dauke da HCoVs sun mutu.
Don wannan ya faru, HCoVs dole ne su haɓaka a cikin mutane kuma su isa matakan da suka dace don ba da izinin haɓaka don haɓaka tsalle wanda ke hana abubuwan ƙin ƙwayoyin halitta.
Wannan yana nufin cewa yayin da yaduwar SARS-CoV-2 ke ci gaba, yawancin mutane suna kamuwa da cutar kuma yana iya zama mai saurin kamuwa da cutar.
Idan an daidaita shi da kyau, watsawa ga mutane zai yi wuya ta hanyar keɓewa ko wasu hanyoyin kula da kamuwa da cuta.
A cikin shekaru da yawa, dukkanin nau'o'in nau'o'in nau'o'in nau'o'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in
Wadannan ƙwayoyin cuta ba sa buƙatar ƙarin ajiya.
Amma a akasin wannan, cutar SARS-CoV da MERS-CoV ba ta dace da mutane ba kuma ba za a iya ci gaba da watsa su ga mutane ba.
Suna buƙatar ci gaba da yaduwa a cikin ɗakunan ajiyar su kuma suna neman hanyar yaduwa ga manufofin mutum, wanda zai iya zama ta hanyar matsakaici ko fiye da girma da kwayoyin halitta.
Abubuwan da ke tattare da SARS-CoV-2 sun yi kama da na SARS-CoV da MERS-CoV da kuma na HCoVs huɗu da ke cikin al'umma.
Ana samun saurin yaduwa kamar yadda HCoVs ke samu a cikin garken shanu a yanzu.
Koyaya, HCoVs da aka ɗauka a cikin al'umma sun fi haifar da rashin lafiya.
Ya kasance a fili ko zai iya daidaitawa da mutum kuma ya yada cikin jikin mutum ba tare da kantin sayar da kwayoyin halitta ba.
Kafin mu tattauna asalin HCoV, bari mu tattauna ma'anoni da halaye na ci gaba da yanayin halitta da kuma ajiyar tsakiya da haɓakar ƙwayoyin HCoV.
Kwayar cuta tana haifar da haɓakar kwayar halitta don HCoV idan ta shiga cikin kwayar halitta ta gaba da ke kusa da shi ta hanyar musayar homology a matakin sarkar nucleotide.
Kwayoyin cutar ba su da kyau kuma ba za su iya komawa cikin wannan kwayar ba.
Hakanan, cutar kwayar cutar tana iya zama mai saurin kamuwa da cutar HCoV a cikin dogon lokaci.
A cikin waɗannan lokuta biyu, kwayoyin halitta suna da alaƙa da HCoV ko kuma kwayar cutar.
A akasin wannan, idan HCoV ya samo asali ne ta hanyar hanyar kwayar halitta kafin ko kusa da lokacin da aka gano shi ga mutum, ba zai dace da sabon kwayar halitta ba kuma yana haifar da cutar.
Wannan kwayar halitta tana iya zama tushen tushen kwayoyin halitta don kamuwa da cutar mutum kuma yana taimakawa wajen haɓaka kwayar halitta ta hanyar hana kwayar cutar ta ninka cikin ɗan gajeren lokaci sannan kuma ta kai ga mutum don haɓaka haɗarin kamuwa da cutar.
HCoV na iya shiga cikin hanyar kamuwa da cuta idan ba za a iya inganta watsawa a cikin ƙwayoyin salin da ke cikin ciki ba.
A gefe guda, HCoVs na iya daidaitawa da ƙwayoyin salin matsakaici kuma har ma suna iya zama a cikin gida na dogon lokaci.
A wannan yanayin, ƙwayoyin salin tsakiya sun zama ƙwayoyin salin halitta.
Bayanan da aka nuna a kasa suna da alaƙa da tarihin SARS.
Binciken yawan masu kamuwa da cutar ya nuna cewa mai musayar kwayar halitta ta SARS-CoV lgG ya fi yawa fiye da sauran mutane.
An fara gano cewa kuliyoyin da ke rufe kansu da gashin dabino (Paguma larvata) da karnukan da ke zaune a kasuwannin da ke cikin yankunan da ke kusa da su suna daukar kwayar cutar SARS-CoV, irin wannan kwayar cutar da ta kusan kama da SARS-CoV.
Wannan ya ba da goyon baya ga gaskiyar cewa babu wani labarin SARS da aka rubuta bayan an kawar da dukkan Pygma Larvata daga kasuwanni.
Ko da yake an gano cewa fararen furannin Pugma larvae ne ko kuma waɗanda ke cikin gonaki ba tare da haɗuwa da masu kasuwa ba, yawancin lokuta ba su da cutar SARS-CoV-2 wanda ke nuna cewa fararen furannin Pugma larvae ne kawai ke haifar da ci gaban ƙwayoyin halitta amma ba a cikin sararin samaniya na SARS-CoV-2 ba.
Wannan yana da mahimmanci saboda kashi 80% na masu cutar a Guangzhou sun karɓi maganin rigakafin SARS-CoV, idan akwai wasu ƙananan kwayoyin da ke da ƙananan ƙwayoyin cuta da ke aiki a matsayin matsakaici don hana karuwar ƙwayoyin SARS-CoV.
Duk waɗannan suna da alama ƙarshen ƙauyukan SARS-CoV.
Abin da ya bambanta binciken shi ne cewa an cire murfin da ke kan yanayin ƙwayoyin cuta na SARS-CoV da ke da alaƙa da ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwar
Waɗannan ƙwayoyin cuta suna da kyau ga ƙwayoyin cuta na SARS-CoV da kuma tsarin SARSr-RH-BatCoV HKU3 na kwayoyin halitta.
Wannan da sauran ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwar ƙwarƙwar ƙwarƙwarƙwar ƙwarƙwarƙwarƙwar ƙwarƙwarƙwarƙwar ƙwarƙwarƙwar
Wannan binciken ya ba da sabon ra'ayi cewa ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayo
An gano wasu nau'ikan SARS-CoVs (SL-CoVs) a cikin ƙudaje, amma ɗayan da aka gano da WIV1 ne kawai za a iya rarrabe shi azaman kwayar cuta mai rai.
An san shi da mai karɓar kwayar cutar SARS-CoV-2.
WIV1 an cire shi daga samfurin fitsari na ƙuda wanda aka gano cewa ACE2 na ƙuda da ƙuda na ƙuda da kuma ƙuda na ƙuda suna amfani da shi azaman mai karɓar ƙwayoyin cuta don shiga cikin tantanin halitta.
Mafi mahimmanci, maganin warkewar SARS yana da ikon hana tasirin WIV1.
Hakanan, WIV1 yana nuna alaƙar da ta fi kusa da SARS a cikin barbashi, yana da kashi 95% na nucleotides a cikin jerin masu kama.
Amma saboda yawan kamanceceniya tsakanin kwayoyin cutar, ana iya cewa WIV1 ba shine ainihin mahaifa na SARS-CoV ba kuma ƙuda ba ta da tushen kai tsaye ga SARS-CoV.
Nazarin kwayoyin halitta na MERS-CoV ya danganta da wannan rukunin kamar CoV-HKU4 na Batman da CoV-HKU5 na Batman.
CoV-HKU4 na Batman da MERS-CoV suna amfani da mai karɓar kwayar halitta ɗaya, mai kamuwa da cuta (DPP4) don shiga cikin kwayar cutar.
RNA mai ɗaure RNA mai ɗaure RNA a cikin MERS-CoV ya fi kusa da tarihin halittu fiye da kwayar cutar coronavirus a cikin ɗan tsutsa wanda aka samo a Turai da Afirka.
Har zuwa yanzu, babu wani Mars-CoV da zai iya gano shi a cikin dabbar dabba.
Mars-KV da kuma masu kama da su kamar yadda suke da alaka da Kov-HKU25 suna da kashi 87 cikin dari na jerin abubuwan da suka faru.
Ko da yake, ba a iya barin baƙar fata ba tare da yin amfani da kwayoyin Mars-Cove ba.
A gefe guda, nazarin Gabas ta Tsakiya ya nuna cewa alfadarai masu ƙwanƙwasawa suna da ƙwayoyin cuta na musamman na ƙwayoyin cuta ga Mars-CoV, kamar yadda alfadarai na Gabas ta Tsakiya suke da asali daga wasu yankuna na Afirka.
An gano kuma an rarrabe cutar ta SARS-CoV daga kwayar cutar guda ɗaya ta hanyar numfashi, wanda ya nuna cewa kwayar cutar ta zama kwayar halitta ta SARS-CoV.
An kuma lura cewa yawancin alamun cutar suna da matsakaici amma an lura da yaduwar cutar sosai a cikin hunturu ta hanyar kamuwa da cutar Mars-CoV.
An lura cewa ƙwayoyin cuta masu kamuwa da cutar ba kawai suna watsa kwayar cutar ta hanyar numfashi da huhu ba amma ta hanyar fitsari-bakin, wanda shine hanyar da kwayar cutar ke yaduwa ga ƙwari.
Ko da yake, akwai wasu ƙwayoyin cuta da suka rage tun lokacin da aka rubuta yawancin lokuta na Mars kuma ba su da wata hulɗa da ƙwayoyin cuta da suka nuna alamun cutar, yana da alama cewa asalinsa shine mutum-zuwa-mutumin watsawa ko kuma hanyar da ta ƙunshi ƙananan ƙwayoyin cuta da Mars-CoVs ke da shi.
SARS-CoV yana da kashi 96.2 cikin ɗari na nucleotides kamar na COV-RaTG13 wanda aka ware daga Rhinoceros unicellular bat.
Kamar yadda yake a cikin SARS-CoV da MERS-CoV, daidaita bambancin tsakanin SARS-CoV-2 da RaTG13 yana da kyau ga alaƙar iyali.
Kamar yadda kuka ce, ƙila ba za a iya gano baƙar fata ba tare da baƙi ba don SARS-CoV-2 har sai an gano baƙar fata a nan gaba.
Ana tsammanin, a matakin farko, za a sayar da kwayoyin halittar dabbobi don SARS-CoV-2 tsakanin dabbobin da ke cikin dutse ko a kashe su a kasuwar cinikin abincin teku ta Wuhan, tare da farkon shari'o'in da COVID-19 ya tallafawa, wanda ke nuna cikakken yanayin watsawa daga dabba zuwa mutum.
Wasu daga cikin binciken da suka fi mayar da hankali kan tsarin tsarin kwayoyin halitta (wanda ke da alaƙa da kwayoyin halitta) sun ba da shawarar cewa akwai wasu nau'ikan dabbobi masu shayarwa da aka sani da pangolins (Mains javanica) kuma suna iya kasancewa cikin ƙwayoyin cuta da ke da alaƙa da SARS-CoV-2.
Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin
Ko da yake suna da alaƙa da RATG13 don kashi 90 cikin dari na sanannun a matakin ƙirar nucleotide.
Sun sanya shekaru biyu na shekaru biyu ga duka SARS-CoV-2 da aka tattara a matsayin kwayar cuta a cikin bishiyar kwayoyin halitta, ɗayan ɗayan yana da yawan masu karɓar karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar.
A akasin wannan, SARS-CoV-2 RBD da RaTG13 sun bambanta sosai, kodayake akwai yawan adadin daidaitattun kwayoyin halitta.
Binciken da aka yi a baya game da cutar ta pangolin ya kuma nuna cewa akwai wani yanki na kwayar cutar DNA a cikin samfurori na huhu, wanda ya bayyana yana kama da SARS-CoV-2.
Wannan binciken ya haɗa da hanyoyi daban-daban da kuma fahimtar mutum don ƙirƙirar jerin kwayoyin halittar da ke dauke da kashi 86.3 cikin dari na cikakken kwayar cutar.
Ba za mu iya watsi da cewa pangolin yana ɗaya daga cikin kyawawan ƙwayoyin cuta na SARS-CoV-2 ba.
Koyaya, har yanzu babu wata hujja da ta tabbatar da asalin asalin SARS-CoV-2 na pangolin duk da kasancewar wasu nau'ikan SARS-CoV-2 da kuma SARS-CoV-2 na pangolin da ke da alaƙa da COV.
Koyaya, nesa tsakanin SARS-CoV-2 da RaTG13 ya fi ƙasa da tsakanin SARS-CoV-2 da SARS-CoV-2 na pangolin kamar COVs.
An hana ci gaban SARS-CoV-2 a cikin barbashi, pangolins da sauran nau'ikan dabbobi masu shayarwa ta hanyar yaduwa.
Tare da mafi girman daidaito na jerin da aka samo a cikin RBDs tsakanin SARS-CoV-2 da pangolins, SARS-CoV-2 da ke da alaƙa da beta-CoVs, SARS-CoV-2 da RaTG13 suna da mafi girman rarraba kwayoyin halitta-ƙwayoyin halitta.
Yawancin lokaci ana tunanin cewa babban daidaito tsakanin RBDs na SARS-CoV-2 na pangolin da ke da alaƙa da beta SARS-CoV-2 da SARS-CoV-2 an ɗauka cewa an samo asali ne ta hanyar zaɓi-ci gaba ɗaya.
A gefe guda kuma, ana buƙatar haɗuwa tsakanin SARS-CoV-2 da ke haɗuwa da beta-CoV da RaTG13 a cikin dabbobi na dabbobi na uku.
A matsayin mai haɓaka, haɗuwa yana da yawa a tsakanin beta-CoVs.
Har yanzu, masu binciken suna waje da yankin Zenotic na SARS-CoV-2.
A gefe guda, tare da yawan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Tarihin juyin halitta ya nuna cewa duka HCoV-NL63 da HCOv-229E sun samo asali ne daga coronavirus na bat, yayin da aka gano ƙwayoyin cuta na HCoV-OC43 da HCoV-HKU1 a cikin dabbobi masu rarrafe.
An bayyana cewa an gano kwayar cutar coronavirus mai suna ARCoV.2 (Tsarin Tsaron Kwayar cutar Corona) a Arewacin Amurka wanda aka gano a cikin kwayar cutar bat wanda ke da alaƙa da HCoV-NL63.
A gefe guda, HCo-229E ya daɗe yana da alaƙa da wani ɗan kwari mai suna Cove, mai suna Hipposidurus/Kankukan/19/2008. wanda aka samo a Ghana a lokacin da ake zargin ƙwayoyin cuta a matsayin mai kula da ƙwayoyin cuta.
Don ƙarin haske, sabon ilimin game da asalin kwayoyin da aka sani da HCoV an taƙaita su a cikin Fitowa na 1 da Tebur na 2.
Binciken tarihin juyin halitta ya nuna cewa akwai wasu lokuta da aka samu sau da yawa a cikin tarihin HCoVs.
Lokacin da HCo-OC43 ya wuce daga kwayoyin halitta zuwa ga mutane ta hanyar cutar ta gida a cikin shekarun 1890, an sami cutar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Tarihin watsawa ta iska na HCoV-229E ba shi da tabbas.
Alpha-CoVs sun kasance da alaƙa da HCO-229E.
Daga cikinsu akwai Kofi-Alpa Alpa.
Wasu dalilai na shaida sun tabbatar da cewa kwayar cutar ta kai tsaye daga barbashi zuwa mutum.
Na farko, mutane ba alpacas ba (dabba mai kama da tumaki amma mafi girma a cikin ƙuƙwalwa) na iya haɗuwa da bat da ba su da gani a cikin yanayin yanayi.
Maimakon haka, mutane suna da alaƙa da Alpacas.
Na biyu, HCoV-229E yana da alaƙa da kwayar cutar coronavirus ta bat kuma ba ta haifar da cuta a cikin bat, yayin da kwayar cutar alpha ta coronavirus ke haifar da yaduwar cututtukan numfashi a cikin dabbobi masu cutar.
A ƙarshe, ba a gano alpha-coronavirus na alpaca a cikin dabbobi masu rai ba.
Don haka, ba za a iya musanta yiwuwar cewa kwayar cutar HCoV-299E ta haɗu da kwayar cutar ta Alpha ba daga mutane.
A zahiri, kwari sune tushen kai tsaye na cututtukan mutum kamar su cutar rabies, Ebola, Napa virus da kuma anthrax.
Saboda haka, ba abin mamaki bane cewa baƙi masu makanta suna iya watsa kwayar cutar HCoV-229E kai tsaye ga mutane.
A gefe guda, yayin da alpha na kwayar cutar coronavirus ta bat yana aiki kamar gene pool na HCoV-299E, alpas da kuma alveoli na iya aiki a matsayin ƙwayoyin salin tsakiya waɗanda ke watsa ƙwayoyin cuta ga mutane. kamar yadda yake a cikin yanayin MERS-COV.
MERS-KOV yana aiki a matsayin mafi kyawun misali don watsawa a cikin nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau
An fara gano asalin MERS-COV a cikin barbashi tun lokacin da aka gano shi kuma an ƙarfafa shi ta hanyar binciken baya.
A bayyane yake cewa kwayar cutar ta kwayar cutar ta kwayar cutar tana da wadataccen nau'in kwayar cutar don canzawa daga nau'in zuwa lokaci da kuma watsawa tsakanin nau'in.
Tsayi, yawan mamayewar ƙwayoyin cuta, haɗuwa da kusan kusan ƙarfin tashi duk waɗannan yanayi ne masu dacewa don ƙudaje su zama "mai ɗaukar kwayar cutar".
A wani ɓangare kuma, an san MERS-COV a matsayin cutar kwayar cuta guda ɗaya na shekaru da yawa.
Ya dace da kwayoyin halitta da suka canza daga kwayoyin salin tsakiya zuwa na halitta da kuma na halitta.
MERS-COV yana haifar da cututtuka masu yawa kuma yana haifar da ƙananan adadin DNA da aka canza a cikin waɗannan dabbobi.
Yaduwar cutar ta hanyar haɗari ga mutane ba zato ba tsammani, mutane suna ƙarewa da ƙwayoyin cuta na MERS-COV, lokacin da ba za a iya ci gaba da yaduwa ba.
Ba kamar rawar da alfadarai ke takawa wajen watsa MERS-COV ba, rawar da dangin tsuntsaye ke takawa, idan akwai, ta bambanta da ta SARS-COV-2.
Musamman, pangolin beta coves yana da yawan rashin lafiya a cikin pangolins.
A ƙarshe, za su iya zama ƙwayoyin cuta masu mutuwa ga SARS-CoV-related beta-coronavirus, kamar yadda ya faru da SARS-CoV.
Akwai wasu hanyoyin da za a iya samun SARS-CoV-2 daga dabbobi zuwa mutane a cikin jinsuna da za a yi bincike ko kuma a gano a nan gaba.
Na farko, ƙudaje na iya ɗaukar kwayar cutar SARS-CoV-2 mai alaƙa da kwayar cutar da ta yi kama da SARS-CoV-2.
Mutane na iya raba yanayin muhalli tare da barbashi ta hanyar cin nama ko kuma ta hanyar amfani da kwal.
Na biyu, kwayoyin halitta na iya zama cibiyar haɓakar ƙwayoyin cuta fiye da SARS-CoV-2 wanda aka gano kwanan nan.
Mutane sun kamu da cutar ta hanyar sayar da nama da kuma farauta.
Duk waɗannan dabbobi masu shayarwa musamman dabbobin gida na iya zama masu saurin kamuwa da SARS-CoV-2.
Ana gwada su a cikin dabbobi da dabbobi don gano antibodies.
Na uku, kamar yadda aka ambata a sama, sake haɗuwa da daidaitawa na SARS-CoV-2 na iya faruwa a cikin nau'ikan halittu na uku waɗanda suka haɗu da duka bat da pangolin.
Har yanzu ana ci gaba da binciken asalin SARS-CoV-2.
Baya ga nau'ikan dabbobi masu ƙwayoyin saline, akwai manyan abubuwa uku a cikin ƙwayoyin cuta waɗanda ke da mahimmanci don sauƙaƙe ƙetare iyakokin halittu.
Da farko dai, yawan ƙetare RNA yana da yawa.
Idan aka kwatanta da sauran ƙwayoyin cuta na RNA, ƙididdigar ƙwayoyin cuta na COVs an sanya su a matsayin "matsakaici" zuwa "mai girma" tare da matsakaicin matsakaicin matsakaici - 10-4 maye gurbin kowace shekara a kowane shafin 2.
Kwayoyin suna da tabbacin - kamar su oxoribon-C (RNA ribbon-degrading enzyme), cirewa daga kowane sakamako yana da matukar damuwa kuma yana haifar da lalacewa da mutuwa ko kuma ba ya aiki.
Musamman, nucleotides masu kama da ƙwayoyin cuta an san su don hana coronavirus ta hanyar hana shiga cikin ƙwayoyin ƙwayoyin cuta da RNA mai dogara da RNA da kuma RNA mai ƙwayoyin cuta.
Remdesivir yana daya daga cikin kwayoyin cutar SARS-CoV-2 da ake gwadawa a cikin dakin gwaje-gwaje.
Koyaya, matsakaicin tsalle-tsalle na COVIDs ya kusan sau miliyan fiye da na sauran kwayoyin halitta.
Bugu da ƙari, yawanci yawan tsalle-tsalle yana ƙaruwa yayin da COVIDs ba su dace da masu karatu ba.
Idan aka kwatanta da SARS-CoV-2 wanda ke da matsakaicin matsakaicin matsakaici, an ba da shawarar cewa an sami matsakaicin matsakaici na tsalle-tsalle.
An yi imanin cewa, tare da wasu ƙwayoyin cuta na kusa da mutane, sun dace daidai.
Koyaya, ga SARS-CoV-2, wannan ya shafi MERS-CoV, wanda ya dace da raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman.
A ka'idar, wani ɓangare na bambancin da ke haifar da motsi na kwayoyin halitta wanda ke haifar da allurar rigakafi da maganin rigakafi ga SARS-CoV-2 shine ɓangaren da ba shi da tasiri.
Na biyu, babban RNA genome a cikin coronavirus yana ba da ƙarin ƙoƙari don daidaitawa a cikin yanayin canzawar don tsalle da sake haɗuwa, yana ƙara yiwuwar haɓaka cikin haɗin kai. wanda shine fa'idar haɗuwa da sabon kwayar halitta lokacin da yanayin ya inganta.
Wannan yana tallafawa ta hanyar tsarin karatun daidaito na musamman da kuma yadda furotin ke aiki akan rubutun lambar a ƙarshen mataki na uku na kwayoyin halitta.
Na uku, COVIDs suna canza tsarin su koyaushe a bazuwar lokacin rarraba RNA ta hanyar 'zaɓaɓɓen-sanya-daidaitaccen' inji.
A cikin kwayar halitta da ke aiki a matsayin akwatin haɗin gwiwa, sau da yawa ana yin tsalle a cikin ƙirar ƙirar lokacin da aka rubuta RNA.
RNAs masu kama da juna suna da cikakkiyar cikakkiyar cikakkiyar kuma suna iya yin kwafin kwayar halitta don samar da sabon COVID.
An gano hujja ta kwayoyin halitta game da yanayin sake haɗuwa a cikin duka HCOV-HKU1 da HCOV-OC43, kamar coronavirus na dabbobi kamar SL-COV na bat da COV-HKU9 na bat.
Haɗin kwayoyin halitta-kwayar cuta yana da alaƙa da yaduwar su.
Baya ga dalilai uku na kamuwa da kwayar cutar da aka ambata a sama, haɗuwa da kwayar cutar ta hanyar fitar da kwayar halitta wani abu ne wanda ke shafar yaduwar kwayoyin halitta.
A nan, an dauki tsarin SARS-CoV a matsayin misali mai kyau, wanda ya nuna shaidar zabin mai kyau a lokacin aikin watsawa.
Bisa ga nazarin kwatancen tsakanin bambancin ɗan adam da SARS-CoV, an yi tunanin SARS-CoV don fuskantar saurin daidaitawa a cikin ƙwayoyin cuta daban-daban, musamman tare da tsalle a cikin RBD na S-protein.
Gabaɗaya, RBD na COVID S yana haɗuwa da ƙwayoyin ƙwayoyin cuta kuma ana zaɓar shi ta hanyar amsawar rigakafin ƙwayoyin cuta.
A cikin SARS-CoV, RBD yana da 318 zuwa 510 amino acid a kan S1 sashi. wanda ke haɗuwa da ACE2 na mutum a matsayin hanyar shiga cikin kwayar cutar.
SARS-CoV RBD na iya gano asalin ACE2 na dabbobi daban-daban, gami da barbashi, civet, bera da kare, yana hana watsa ƙwayoyin cuta.
A zahiri, ragowar amino acid guda 6 ne kawai aka gano waɗanda suka bambanta da na ɗan adam da na CVT da aka ware daga RBD kuma 4 daga cikinsu sun kasance a kan mai karɓar mai karɓar mai karɓar mai karɓar ACE2.
Ciwon SARS-CoV yana da tsalle-tsalle a cikin K479N da S487T na RBD, wanda zai iya haɓaka haɓakar hulɗa a cikin furotin mai ƙwanƙwasa tare da mai karɓar ACE2 na ɗan adam.
A madadin haka, maye gurbin waɗannan amino acid biyu na iya zama ba su da mahimmanci ga dacewa da kwayar cutar ga mutane.
An yi imanin cewa SARS-CoV-2 yana da ƙwayoyin halitta iri ɗaya da SARS-CoV.
A cikin kashi 30 cikin dari na bambanci tsakanin SARS-CoV2 da SARS-CoV-1 suna da S1 na S-protein wanda ke da haɗin haɗin S-protein tare da ACE2 na mutum.
A gaskiya ma, nazarin EM na Cryogenics ya nuna cewa haɗuwa da wannan haɗin yana da 10 zuwa 20 mafi girma fiye da na ACE2 na mutum da kuma S ARS-KOVS.
Hakanan ya kamata a tantance ko kowane mai karɓar kwayar halitta yana buƙatar ɗaukar SARS-CoV-2.
Abin mamaki, kwayar cutar NL63 ta haɗu da ACE2 amma tare da wani ɓangare na S.
Akwai wasu masu karɓar H na kwayar cutar coronavirus, kamar su enzymes na aminopepidase N don kwayar cutar H na kwayar cutar 229E, da kuma 9-O sialic acid mai karɓar kwayar cutar H-OC43.
Wannan na iya zama dalilin da ya sa CoVs ke samun nasara a cikin mutane bayan wannan yaduwar tsakanin jinsuna daga dabbobi masu cutar.
Baya ga masu karɓar ƙwayoyin cuta, sakamakon yaduwar kwayoyin cuta tsakanin nau'ikan coronavirus yana ƙarƙashin ikon mai zaman kansa da kuma wasu ƙwayoyin cuta.
Yaduwar sunadarai na kwayoyin halitta tsakanin mutane da kuma wuraren da kwayoyin halitta na coronavirus kamar su bat, raƙuma da dabbobi masu rarrafe, na iya haifar da shinge ga watsawa tsakanin suns.
Kwayar cutar coronavirus dole ne ta mamaye tushen 'yancin kai na kwayar halitta kuma ta kawar da tushen iyakancewar kwayar halitta, don samun nasarar watsawa tsakanin kwayoyin.
A wannan yanayin, yana da mahimmanci a gano da kuma bayyana ƙwayoyin cuta masu kariya na yankin da cutar ke ciki da kuma kamuwa da ita.
Za a iya samar da wani nau'i mai mahimmanci na kwayoyin halitta wanda ke haifar da rashin daidaituwa da ƙuntataccen ƙwayoyin halitta na SARS-CoV-2 ta amfani da fasahar fasaha ta CRISPR.
Cutar Coronavirus: Komawa ga Farawa
Bambancin da ke tsakanin ƙwayoyin cuta na coronavirus yana ba da dama mai kyau don haɗuwa da HCoVs.
A cewarsa, ƙwararrun ƙwayoyin cuta na coronavirus suna yin aiki iri ɗaya da CoVs.
Koyaya, saurin maye gurbi da daidaitawar kwayoyin halitta suna jagorantar ci gaban kwayar cutar coronavirus kuma suna aiki azaman matakai biyu masu mahimmanci a cikin aikin.
Alal misali, samun ko rasa kwayoyin halitta masu gina jiki, yana da ikon sarrafawa ta hanyar samfurori masu yawa.
A cikin kwayoyin SARS-CoV, ORF8 da aka bari ya canza kuma yana da mahimmanci ga ɗan adam, wanda ya bambanta da kwayar cutar SARS-CoV, amma an gano cewa ya canza zuwa ORF8.
An gano rashi na SARS-CoV-29-nucleotide a cikin abubuwa daban-daban a farkon annobar.
Wannan rashin ƙarfi da ƙarancin haske, ORF8 ya rarraba zuwa ORF8a da ORF8b kuma ya bar canjin da ke inganta musayar ƙwayoyin cuta.
Bugu da ƙari, SARS-CoV yana da tarihin da ya dace da cutar coronavirus na alpha da gamma, wanda ke da yawan yankunan da ke cikin RNA-linked RNA polymers.
An gano wuraren waɗannan ƙungiyoyi a cikin nsp9, yawancin nsp10, da kuma wani ɓangare na nsp14.
Hakazalika, an nuna cewa cutar MERS-CoV ta kamu da cutar a lokuta daban-daban, kamar yadda ta faru a cikin raƙuman Saudiyya.
Baya ga SARS-CoV da MERS-CoV, an lura da wannan tsari a cikin coronavirus, wanda ya daidaita da kwayoyin halittar coronavirus tare da sauran kwayoyin coronavirus.
Ya kamata a lura cewa ganowar mutum zai iya haifar da sauye-sauye na kwayoyin halitta da ba a so, wanda zai iya haifar da yaduwar kwayar cutar a cikin yankin da aka gano, kamar tsarin garkuwar jiki.
Misali na irin wannan tasirin shine asarar ORF4 gaba ɗaya na kwayar cutar coronavirus-229 E ta farko, wanda ke haifar da rashi da ɓarna na 2-nucleotide.
Duk da yake ana iya ganin ORF4 mara lalacewa a cikin barbashi da kuma kwayar cutar HCoV-229E, kwayar cutar ta alpha ta nuna wani abu mai cike da ƙwayoyin cuta, sakamakon kamuwa da cutar.
A ƙarshe, haɓakar kwayar cutar coronavirus ta hanyar kwayoyin halitta tana sarrafawa ta hanyar bincike.
Rashin alamun, ko kuma bayyanar cututtuka masu sauƙi da rauni an gano lokacin da barbashi suka kamu da cutar coronavirus, wanda ke nuna yaduwar cutar coronavirus da barbashi.
Bat yana da alama yana da kyau a jiki da kuma ilimin halitta don dacewa da coronavirus.
Misali, rashin aikin amsawar kumburi a cikin barbashi, wanda ya ragu sosai a cikin yanayin rashin lafiya, ya ragu a cikin coronavirus.
Bugu da ƙari, yana hana aikin kwayoyin halitta na kwayoyin halitta, wanda ke haifar da raguwa a cikin ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwa
Hakanan, yawan iskar oxygen mai amsawa (ROS), wanda aka nuna ta hanyar yawan aikin ƙwayar cuta na ƙuda, na iya hana haɓakar kwayar cutar coronavirus da kuma tasiri akan enzyme acrobionuclease, don haka haifar da ƙarancin ƙwayar cuta, wanda ke haifar da ƙaruwa a cikin cutar lokacin da ta shiga cikin sabon kwayar halitta.
Ƙarfin ƙwayar cuta na sauran coronaviruses, wanda ya shiga cikin tsarin, yana haifar da karuwa a cikin furotin, ko kuma siffofin furotin a cikin salula.
Saboda haka, ba daidaituwa ba ne cewa nau'ikan coronaviruses uku sun haɗu a cikin shekaru ashirin da suka gabata.
Kwayar cutar coronavirus ba ta kama da cuta kuma tana haifar da alamun bayyanar cututtuka a cikin kwayoyin halitta kamar su barbashi da raƙumi.
Suna ƙaruwa sosai kuma suna ɗaukar su ba tare da amsawar rigakafin kwayar halitta ba.
Asirin dalilin da yasa suke kamuwa da cutar da ba su da alamomi, ya kasance a can; da abin da ke haifar da kamuwa da cutar a cikin mutane.
Alamun cututtuka na yau da kullum suna haifar da halayen jiki da kuma yawan aiki na tsarin rigakafi da kuma yawan adadin furotin, kuma mafi ƙarfin tsarin rigakafi, mafi tsanani shine lalacewar huhu.
A akasin wannan, masu ɗaukar hoto ba su da alamun bayyanar cututtuka, amma tsarin rigakafi ya bambanta da haɓakar CoV.
Irin wannan dabarun hana amsawar rigakafi na iya zama da amfani ga maganin SARS-CoV-2.
Sakamakon amsawar kwayoyin halitta na furotin da ke nuna cutar yana da ƙarfi sosai a cikin ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙ
Don haka, sarrafa furotin da aka fitar da kwayar halitta, aƙalla a farkon matakan SARS-CoV-2 a cikin ɗan adam, ya kamata ya kasance mai amfani.
Duk da haka, aikin NLRP3 mai gina jiki, ba a ƙare a cikin bat ba.
A cewar shi, kasancewar furotin mai bambancin NLRP3 tare da MCC950 na iya zama da amfani wajen magance cutar coronavirus.
Haɗuwa da SARS-CoV-2 ya haifar da sabon tsari, wanda SARS-CoV da MERS-CoV suka samo asali.
Yayinda beta-coronavirus ke da kashi 95% na haɗin nucleotide tare da SARS-CoV, kwayar cutar coronavirus ta kwari tana da kashi 96% na haɗin nucleotide tare da SARS-CoV-2.
Duk da yake an gano dabbobin Civet da sauran dabbobin kasuwa da ke dauke da kwayar cutar SARS-CoV-2, ba a gano wani kwayar halitta mai saurin shiga tsakanin SARS-CoV-2 ba.
An gano haɗuwa da beta-CoVs a cikin dabbobi masu kama da SARS-CoV-2, wanda ke nuna cewa dabbobi masu kama da su na iya aiki a matsayin matsakaiciyar mai karɓar bakuncin, ko kuma beta-CoVs na pangolin na iya fitar da kwayar halitta don sabon nau'in SARS-CoV-2.
Ko da yake tambayoyi sun kasance, babu wata hujja da ta nuna cewa SARS-CoV-2 ya haifar da mutum, da gangan ko kuma ba da gangan ba.
Cutar coronavirus ta samo asali ne daga ɓarkewar cutar SARS-CoV-2.
Binciken kwayar cutar coronavirus a cikin barbashi da sauran dabbobi ya canza ra'ayoyinmu game da mahimmancin asalin dabbobi da kuma yadda dabbobi ke ɗaukar kwayar cutar coronavirus don watsawa ga mutane.
Shaidar da aka samu ta nuna cewa SARS-CoV, SARS-CoV da SARS-CoV-2 sun ƙunshi asalin ƙuda kuma an watsa su ta hanyar kwayoyin halitta zuwa mutane.
Tun da yake kamuwa da SARS-CoV ya samo asali ne daga hulɗar mutum da dabbobi a cikin kasuwa, rufe kasuwanni da kashe dabbobi zai iya kawo ƙarshen cutar SARS.
Don wannan dalili, dabbobi masu kama da dabbobi suna buƙatar dakatar da su daga kasuwa don hana yaduwar dabbobi, saboda gano asalin beta-coronavirus da ke da alaƙa da SARS-CoV-2.
Koyaya, ko kuma yadda SARS-CoV-2 ke yaduwa ga mutane ta hanyar pangolins da sauran dabbobi masu shayarwa ya kasance don tantancewa a cikin gwaji na gaba.
A gefe guda, MERS-CoV ya daɗe yana ɓoye.
Waɗannan raƙuman suna da mahimmancin hanyar sufuri, saboda sune tushen kayan abinci na nama, madara, fata da abinci ga mazauna yankin.
An fi yaduwa a Gabas ta Tsakiya da Afirka.
Saboda haka, ba za a iya kashe dukan rakuma ba don magance cutar MERS, kamar yadda aka yi a kasuwar dabbobi a China, don hana yaduwar SARS-CoV-2 da SARS-CoV-2.
Don dakatar da wannan yaduwar MERS, dole ne a yi ƙoƙari sosai don haɓaka maganin rigakafi mai tasiri ga MERS-CoV don raƙuma, tare da matakan kula da kamuwa da cuta.
Duk da yake ba za mu iya kawar da wannan kwayar cutar ba, sabon nau'in kwayar halitta na iya haifar da yaduwar ta.
Yawancin nau'ikan coronavirus na dabbobi suna yaduwa a cikin yankunan tsaunuka.
Musamman, ƙwayoyin cuta na coronavirus waɗanda ke da asali na dabba sun bambanta.
Akwai yiwuwar cewa kwayar cutar coronavirus ta dabbobi za ta iya haɓaka da daidaitawa, wanda zai haifar da haɗuwa da sabbin kwayar cutar coronavirus waɗanda za su iya zama masu saurin yaduwa da / ko kisa ga mutane a nan gaba.
A wasu sassa na kasar Sin, ya kamata a dakatar da cin abincin namun daji don rage hulɗar da ba ta dace ba tsakanin mutane da dabbobi.
Tare da cututtukan SARS, MERS da coronavirus, ya kamata a sami shiri mafi kyau da shirye-shiryen amsawa da amsawa.
A gaskiya ma, yawancin ƙwayoyin cuta sun kasance a wannan duniyar a cikin dogon lokaci.
Sun kasance a cikin yanayin da suka dace, har sai akwai damar da za su yada.
Kodayake jemage suna da halaye da yawa waɗanda ke taimakawa wajen yada kwayar cutar, haɗarin haɗuwa da ɗan adam tare da jemage da sauran dabbobin daji za a iya rage su idan an koya wa mutane su guji su.
Ana buƙatar ci gaba da lura da dabbobi masu shayarwa don fahimtar yanayin CoVs da kuma yanayin halitta, wanda ke nuna fa'idodi na hana yaduwar dabbobi zuwa mutane da kuma ci gaban yaduwar su.
A ƙarshe, hanya mafi inganci don hana dabbobi daga ɗaukar cutar ita ce nisantar mutane daga yanayin da dabbobi ke ɗaukar kwayar cutar.
Har yanzu ba a gano wasu abubuwa game da asalin SARS-CoV-2 a cikin dabbobi ba.
Da farko, idan kwari ya kawo SARS-CoV-2 zuwa pangolin, zai zama da kyau a ga yadda kwari da pangolin ke da irin yanayin da suke da shi.
Na biyu, idan kwari suna da babban rawa wajen watsawa kai tsaye ga mutane, za a buƙaci a ƙayyade yadda mutane ke hulɗa da kwari.
Na uku, idan dabba mai mahimmanci ta uku ta kasance kamar mai kula da kwayoyin halitta, yadda ta yi hulɗa da mutane daban-daban, da bats da penguins, dole ne a bayyana.
A ƙarshe, saboda yawancin dabbobi masu shayarwa suna kamuwa da dabbobi na gida, waɗanda zasu iya zama masu saurin kamuwa da SARS-CoV-2, dole ne a gudanar da bincike da gwaji don kamuwa da cuta.
Ko dai ɗan kunama ne, pangolin ko kuma wani dabba mai shayarwa, ana tsammanin SARS-CoV-2 ko kuma wasu ƙwayoyin cuta masu kama da su, za a iya gano su a cikin yanayin ƙwayoyin a nan gaba.
Ci gaba da bincike ya nuna yadda SARS-CoV-2 ke ci gaba a cikin dabbobi, tare da ƙoƙarin kawar da cutar a cikin mutane.
Ana buƙatar sabunta ma'aunin gano COVID-19 "Lallai ne" da "Lallai ne".
A ranar 6 ga Fabrairun 2020, ƙungiyarmu ta buga jagorar shawarwari na gaggawa don ganowa da magance cutar 2019 (2019-nCoV) ta sabuwar coronavirus, wannan jagorar ta ba da kwarewarmu kuma ta nuna ƙalubalen da ke tattare da cutar a duniya.
Koyaya, cutar coronavirus ta 2019 (COVID-19) sabuwar cuta ce, kuma muna ci gaba da haɓaka faɗakarwarmu da iliminmu bisa ga binciken da ake ci gaba da samu da kuma ƙwarewar aikin asibiti; sabili da haka, ana ci gaba da sabunta dabarun bincike da magani.
A cikin wannan rubutun, mun amsa ga wata sharhi game da jagorarmu kuma mun ba da sabon ma'aunin ganewa don "Laifin da ake zargi" da "Laifin da aka tabbatar" bisa ga sabon Jagorar Ganowa da Kula da COVID-19 (Shirya ta 7) da Hukumar Kiwon Lafiyar Jama'ar Jamhuriyar Sin ta fitar.
A watan Disamba na 2019, sabon coronavirus na 2019 (2019-nCoV) ya fara bayyana, wanda yanzu aka fi sani da cutar coronavirus ta 2019 (COVID-2019) kuma an sake sanya wa kwayar cutar SARS-CoV-2 (SARS-CoV-2).
A ranar 11 ga Maris, 2020, Hukumar Lafiya ta Duniya ta ayyana COVID-19 a matsayin annoba ta duniya.
Don yaƙi da cutar SARS-CoV-2, ƙungiyarmu ta samar da jagorar shawarwari na gaggawa wanda aka buga akan layi a cikin Military Medical Research a ranar 6 ga Fabrairu, 2020.
Tun lokacin da aka buga shi, ya sami kulawa sosai.
Lura: Kodayake COVID-19 sabuwar cuta ce, faɗakarwarmu da iliminmu suna ƙaruwa a hankali bisa ga binciken da ake ci gaba da samu da kuma ƙwarewar aikin asibiti; sabili da haka, ana ci gaba da sabunta dabarun bincike da magani.
Misali, Hukumar Kula da Lafiya ta Jamhuriyar Jama'ar Sin ta fitar da Jagororin Gano da Kula da COVID-19 (http://www.nhc.gov.cn/), tsakanin 16 ga Janairu, 2020 zuwa 3 ga Maris, 2020, sun fitar da jimlar lambobi bakwai tare da wasu abubuwan da aka canza sosai.
Yanzu jagororinmu sun kasance maganganun Zhou et al. Hut, wanda ya ba da shawara mai sauƙi don yin la'akari da kwarewarsu ta asibiti.
Ayyukan su sun ba da sabon tabbaci ga jagororinmu kuma sun nuna godiya ga wannan annoba ta duniya.
Muna goyon bayan wannan aiki mai muhimmanci kuma muna godiya da su.
Koyaya, aikin su yana buƙatar sabuntawa bisa ga sabbin jagororin ganowa da maganin COVID-19 (matakin gwaji na bakwai) da sabbin bincike.
A cikin sashi na bakwai (Maris 3, 2020), don tabbatar da cewa yanayin da ake zargi ya kamata ya haɗa kowane ɗayan abubuwan da ke tattare da tarihin cutar tare da abubuwa biyu na alamun asibiti don yin cikakken bincike, ko kuma ya kamata ya ƙunshi abubuwa uku na alamun asibiti idan tarihin cutar ba shi da kyau:
Tarihin cutar: (1) Tarihin tafiya ko zama a Wuhan da kewayenta, ko wasu al'ummomin da aka ba da rahoton cutar COVID-19 a cikin kwanaki 14 da suka gabata kafin fara bayyanar cututtuka; (2) Tarihin haɗuwa da cutar SARS-CoV-2 (tare da gwajin nucleic acid mai kyau); (3) Tarihin haɗuwa da marasa lafiya tare da ko tare da cututtukan numfashi a Wuhan da kewayenta, ko wasu al'ummomin da aka ba da rahoton COVID-19 a cikin kwanaki 14 da suka gabata kafin bayyanar cututtuka; (4) Tarihin haɗuwa da wasu tabbatattun shari'o'i (>= 2 lokuta da / ko tare da cututtukan na respiratory polypes waɗanda suka faru a cikin makonni 2 a cikin ƙananan wurare, kamar gidaje, ofisoshi, makarantu, da sauransu).
Alamar asibiti: (1) har zuwa da / ko alamun cututtukan numfashi; (2) tare da halaye na cutar COVID-19; (3) ƙarancin adadin ƙwayoyin farin jini wanda ke nuna ƙimar al'ada, raguwa, ko ƙarancin ƙididdigar ƙwayoyin cuta a farkon farawa.
Dole ne a tabbatar da ganewar asali na tabbataccen yanayin bisa ga yanayin da ake zargi cewa kowane alamun cutar ko hujja ta ƙwayar cuta yana da kyau kamar haka: (1) gwajin lokaci na PCR mai kyau na SARS-CoV-2; (2) cikakken jerin kwayoyin halittar kwayar cutar wanda ke nuna asalin kwayar cutar coronavirus; (3) tabbatacce ga ƙwayoyin IgM na musamman da IgG na SARS-CoV-2 a cikin gwajin ƙwayar cuta; ko canji a cikin ƙwayoyin IgG na SARS-CoV-2 daga mara kyau zuwa tabbatacce, ko kuma ƙimar => 4 sau a lokacin farfadowa sama da lokacin kamuwa da cutar.
Za mu iya ganin cewa an ƙara gwajin PCR na ainihi don nucleic acid a cikin hanyar numfashi ko samfurin jini zuwa shafi na biyu (Janairu 18, 2020) da shafi na uku (Janairu 22, 2020).
An ƙara gano cutar a cikin samfurin jini a shafi na huɗu (Janairu 27, 2020) da shafi na biyar (Fabrairu 8, 2020); sannan an ƙara shaidar ƙwayar cuta a shafi na bakwai.
Waɗannan gyare-gyare sun dogara ne akan ci gaba da aikin masu bincike don neman kayan aikin gano kwayar nucleic acid don saurin ganewa, tare da samfurori na numfashi waɗanda suka haɗa da samfurin jini, wanda ya haɓaka wadatar bambancin samfurin, kuma ya taimaka wajen samar da sakamako mai kyau na antibody na musamman a cikin sigogi masu tabbaci.
Bugu da ƙari, akwai ƙarin shaidu da ke nuna cewa muna bukatar mu kula da cututtukan da ba su da alamun cutar.
Saboda haka, ya kamata a sake duba bayanan Zhou et al., saboda sun lissafa mutumin da ba shi da alamun asibiti a matsayin "mai haɗari".
Hakanan yakamata a bincika tsarin kimantawa a cikin ƙarin aikin asibiti da bincike.
A sakamakon haka, muna fatan za a sami ƙarin hujjoji na kai tsaye kuma muna gayyatar masu karatu su ba da ra'ayoyinsu.
Don gano "Lamarin da ake zargi" da "Lamarin da aka tabbatar", muna ba da shawarar bin diddigin da kuma bin sabbin umarnin ƙasashensu.
Ƙungiyarmu za ta ci gaba da sabunta jagororinmu na bayar da taimako a kan kari.
Bangladesh ta ba da rahoton sabbin mutuwar COVID-19 guda biyar, mafi yawan adadin yau da kullun
A ranar Litinin, Bangladesh ta tabbatar da sabbin mutuwar COVID-19 guda biyar a ranar.
Wannan shi ne adadin mutane da suka mutu a rana guda sakamakon cutar.
Tun jiya, Cibiyar Kula da Cututtuka da Kula da Cututtuka ta Bangladesh (IEDCR) ta ba da rahoton adadin masu kamuwa da cutar da ke da 114 masu aiki da 33 da suka warke a gida.
An samu mutuwar mutane 17.
A wani bayanin da aka yi a yanar gizo, Daraktan IEDCR, Mr. Mirjidai Sabrina Flora ya ce mutuwar ta kasance maza hudu da mace daya.
A cewar Dr. Mirzadari, mutane biyu sun fi shekaru 60, biyu tsakanin shekaru 51 zuwa 60, kuma daya daga cikin mutane 41 zuwa 50.
Ya kuma ce wadanda aka kashe 'yan Dhaka ne.
Hukumar Lafiya ta Duniya (WHO) ta ayyana COVID-19 a matsayin annoba a duniya a ranar 11 ga Maris.
Wani jami'in lafiya ya shaida wa kamfanin dillancin labarai na Anadolu Agency, cewa daya daga cikin wadanda suka mutu shine Jalal Saifur Rahman, darektan kwamitin yaki da cin hanci da rashawa na Bangladesh, wanda ake kula da shi a asibitin Kuwait Matri.
A ranar Asabar, a cikin wata sanarwa ta bidiyo ta yanar gizo, Ministan Sufuri da Hanyoyi, Obaidul Qadir ya ce za a dakatar da zirga-zirgar jama'a na tsawon lokacin da aka tsara, har zuwa ranar Asabar mai zuwa.
An fara dakatar da zirga-zirgar jama'a a ranar 26 ga Maris kuma an shirya za a kawo karshen ranar Asabar, 4 ga Afrilu.
Har yanzu an hana jigilar kayayyakin da ake bukata - magani, mai da abinci.
An fara samun mutum biyu da suka dawo daga Italiya tare da matar ɗaya daga cikin mutanen da ke fama da cutar a Bangladesh a ranar 8 ga Maris.
A ranar 19 ga watan Maris, mutane uku sun warke.
SARS-CoV-2 ya wuce kamuwa da cutar miliyan daya a duniya
A ranar Alhamis, jimlar adadin masu kamuwa da cutar coronavirus SARS-CoV-2 a duniya ya zarce miliyan daya, in ji bayanan Jami'ar Johns Hopkins.
Akalla mutane 52,000 ne suka mutu sakamakon cutar COVID-19, wadda cutar korona ke haifarwa.
Wannan canjin ya zo ne a ranar da Malawi ta sanar da kamuwa da cutar coronavirus ta farko da kuma Zambia ta sanar da mutuwar farko da ta shafi coronavirus.
A ranar Alhamis, Koriya ta Arewa ta yi ikirarin cewa tana ɗaya daga cikin ƙasashe kaɗan da ba su da cutar coronavirus.
A jiya, Hukumar Lafiya ta Duniya ta ba da rahoton mutane 1,051,635 da suka kamu da cutar, daga cikinsu akwai 79,332 a cikin sa'o'i ashirin da hudu kafin karfe 10 na safe agogon Turai na tsakiya (0800 UTC) a ranar 4 ga Afrilu.
A Amurka, an samu sama da mutane 244,000 da suka kamu da cutar coronavirus, wanda ya yi sanadiyar mutuwar mutane 5,900.
CBS ta sanar da cewa, bisa ga bayanan Jami'ar Johns Hopkins, sama da mutane 1,000 ne suka mutu a Amurka a ranar Laraba sakamakon kamuwa da cutar coronavirus.
A duk faɗin duniya, ƙasashe sun ba da sanarwar tsauraran matakai don dakatar da yaduwar cutar.
A ranar Alhamis, Sergei Sobyanin, gwamnan Moscow, ya tsawaita zaman gidansa har zuwa 1 ga Mayu.
A matakin ƙasa, Shugaba Vladimir Putin ya sanar da cewa za a biya ma'aikatan Rasha albashi ba tare da sun tafi aiki ba har zuwa 30 ga Afrilu.
Majalisar dokokin Portugal ta kada kuri'ar tsawaita dokar ta baci ta kasa na kwanaki 15; ta amince da kuri'u 215 a, goma a, da kuma daya a kan.
Saudiyya ta tsawaita dokar hana zirga-zirga a biranen alfarma na Makka da Madina har tsawon yini; a baya, dokar hana zirga-zirga ta kasance daga karfe 3 na yamma zuwa 6 na safe.
Thailand ta shirya aiwatar da dokar hana zirga-zirga tsakanin karfe 10 na dare zuwa 4 na safe.
Gwamnan Ohio, Mike Dwayne, ya sanar da cewa jihar ta tsawaita dokar hana fita ta gida har zuwa ranar 1 ga Mayu.
Shaguna a Ostiraliya suna rage adadin kayan wanka a kowane ma'amala.
A ranar Lahadi da yammacin Asabar, manyan shagunan Australiya na Woolworths da Coles sun rage iyakar sayayya don kayan wanka zuwa fakiti biyu da fakiti ɗaya a kowane ma'amala a duk shagunan a duk faɗin ƙasar.
A ranar Litinin ALDI ta kuma sanya takunkumin kunshin daya.
An sanya waɗannan ƙuntatawa a matsayin saƙo a kan ƙofofin da shafin Facebook na jerin.
An ba da rahoton cewa abokan ciniki suna sayayya da yawa saboda tsoron COVID-19 fiye da yadda mutane za su buƙaci keɓe kansu.
A ranar Laraba, Wolverines ta iyakance sayen kayan wanka zuwa gida zuwa kunshin daya kawai a kowace buƙata.
Waɗannan canje-canjen sun biyo bayan takunkumin da aka gabatar na kunshin huɗu da Wolverines da Coles suka sanar a ranar 4 da 5 ga Maris.
Coles, a cikin sanarwar da ta fitar a ranar 8 ga Maris, ta bayyana cewa, saboda takunkumin da aka yi na kunshin hudu, "mafi yawan shaguna suna sayar da kaya a cikin awa daya", kuma ta kira bukatar "ba zato ba tsammani", yayin da ALDI, a cikin wani sakon Facebook a ranar Talata, ta kira shi "ba zato ba tsammani".
A makon da ya gabata tallace-tallace sun yi nasara a cikin "babban tashin hankali", a cewar mai magana da yawun Wolverines.
A makon da ya gabata, kantin sayar da kayayyaki na Costco a Canberra ya sauya adadin da aka yarda ya zama fakiti biyu.
Don daidaita ƙarancin, Kohl's ya nemi ƙarin fakiti daga masu samarwa kuma ya ƙara lokutan isarwa, Woolworths ya nemi ƙarin kaya, yayin da ALDI ta ba da kayan aikinta don farkon isar da aka shirya a ranar Laraba.
Russell Zimmerman, babban daraktan Hukumar Kasuwancin Australiya, ya ce 'yan kasuwa suna ƙoƙari su haɓaka yawan kaya, amma ƙuntatawa na majalisa na gida akan lokacin isar da motoci yana wahalar da aikin.
Ana tsammanin farashin samarwa zai karu, saboda masu samarwa suna ƙoƙari su biya buƙata, kuma tare da ƙananan ƙayyadaddun.
A ranar Talata, ALDI ta sanar da cewa bayan da aka fara samar da kayayyaki, wasu shaguna ba za su iya ba da takamaiman Laraba ba.
A wani rahoto da aka bayar a News.com.au, Dr. Gary Mortimer, masanin sayar da kayayyaki a Jami'ar Queensland na Fasaha ya ce shagunan suna cika kaya a kowane dare.
Ya ce, "Klinks na gidan wanka abu ne mai girma, wanda ke haifar da karancin kayan aiki a cikin adadi, kuma, lokacin da aka siyar da su, yana sa ɗakunan ajiya su zama marasa ƙarfi, suna wahalar da ma'anar rashin ƙarfi".
A cewar ABC News, Russell Zimmerman ya ce Coles da Wolverines suna da ra'ayi [cewa] idan akwai wadataccen adadi a kan ɗakunan ajiya, idan an sayi kayayyaki kamar su kayan wanka da kayan wanka da kuma keɓewa, to, za ku iya rage tsoro.
Kamfanin kera kayan wanka na sake amfani da su na Who Gives a Crap ya ce a ranar Laraba sun rasa kayayyakin.
Kimberly-Clark, wanda ke kera kayan wanka na Kleenex da takarda mai amfani da Solaris wanda ke kera Sorbent, ya jaddada cewa suna aiki 24/7 don tabbatar da wadatar, a cewar wani rahoto daga News.com.au.
Domain.com, wani shafin yanar gizon gidaje, ya ba da rahoton cewa wasu masu sayar da gidaje na gidaje na gidaje na gidaje sun ba da kyauta ga masu ba da kyauta a Melbourne, yayin da aka yi karin kuɗi saboda masu sayarwa suna da lokaci mai yawa a lokacin hutun ranar aiki.
A ranar Alhamis, NT News, jaridar da ake buga a Darwin, ta ba da takarda mai shafi takwas don a yanke shi don amfani da shi azaman matattarar bayan gida.
Shagunan sun yi jinkirin sanya takunkumi, a cewar rahoton ABC Australia a ranar 3 ga Maris cewa ba su da shirin sanya takunkumin sayayya.
Russell Zimmerman ya kara da cewa wasu kayayyaki suna da matukar bukatar, kamar su masks, masu wankewa, kayan shafawa, sabulu mai ruwa da kuma sandar.
Hakanan, a waje da Ostiraliya, a ranar Lahadi da yamma aka lura cewa babban kantin sayar da kayan masarufi na Burtaniya Okado ya iyakance siyar da kayan kwalliyar gidan wanka na Andres zuwa fakiti biyu na 12 na al'ada.
Hukumar Lafiya ta Duniya ta ayyana COVID-19 a matsayin annoba ta duniya.
A ranar Laraba, Hukumar Lafiya ta Duniya (WHO) ta ayyana ci gaba da yaduwar COVID-19 - cutar da kwayar cutar coronavirus SARS-CoV-2 ke haifarwa - a matsayin annoba ta duniya.
Kodayake kalmar "annoba" tana nufin yadda cutar ta yadu ne kawai, ba yadda yanayin ke da haɗari ba, WHO ta ba da shawarar cewa gwamnatoci su ɗauki matakan da suka dace:
Darakta Janar na WHO Tedros Adhanom Ghebreyesus ya ce duk kasashen duniya na iya sauya yanayin annobar.
Idan ƙasashe suka ɗauki mutane, su yi musu magani, su warkar da su, su ware su kuma su bi su a matsayin amsa.
Muna da matukar damuwa game da yawan yaduwar cutar da kuma tsananin cutar da kuma yawan kamuwa da cutar.
A cewar Dokta Tom Friedin, tsohon darektan Cibiyar Kula da Cututtuka da Cututtuka ta Amurka, annobar "ba ta da tabbas".
Ya ce, a wani rahoto da CNN ta wallafa a watan Fabrairu, "Baya ga mura, babu wani kwayar cutar numfashi da aka lura da ita daga fitowar ta zuwa ci gaba da yaduwa a duniya".
Gabrisus ya yi magana game da irin wannan ra'ayi, yana cewa, "Ba mu taɓa ganin annoba ta coronavirus ba".
Ya kara da cewa, "Ba mu taba ganin annoba da za a iya sarrafawa a lokaci guda ba".
Wannan sabon yanayin cutar ya biyo bayan shawarar WHO a watan Janairu don ayyana shi a matsayin gaggawa na kiwon lafiyar jama'a na damuwa ta duniya.
"Darakta na Cibiyar Kula da Cututtuka da Cututtuka ta Amurka, Dr. Anthony Fauci ya ce game da barkewar cutar", "A takaice, yana da muni".
A ranar Alhamis, kamfanin dillancin labarai na Associated Press ya ba da rahoton cewa akwai aƙalla mutane 126,000 da suka kamu da COVID-19 a duniya, wanda ya haifar da mutuwar sama da 4,600.
Cutar annobar coronavirus ta 2019-20 wata cuta ce mai saurin yaduwa ta cutar coronavirus (COVID-19) wanda ke haifar da mummunar kamuwa da cutar cututtukan numfashi ta coronavirus 2 (SARS-CoV-2).
An gano barkewar cutar a Wuhan, China a watan Janairun 2019, an ayyana ta a matsayin gaggawa ta kiwon lafiyar jama'a na damuwa ta duniya a ranar 30 ga Janairun 2020, kuma an ayyana ta a matsayin annoba ta duniya a ranar 11 ga Maris, 2020.
Ya zuwa ranar 10 ga Afrilu, 2020, an samu kusan mutane miliyan 1.61 da suka kamu da cutar COVID-19 a kasashe da yankuna 210, wanda ya yi sanadiyar mutuwar mutane 97,000.
Kimanin mutane 364,000 sun warke.
An kiyasta yawan mutuwar a China ya kai kashi 4%, yayin da a duniya ya fara daga 13.04% a Algeria zuwa 0.08% a New Zealand.
Alamomin da aka saba gani sun hada da tari, tari da kuma numfashi mai wuya.
Matsaloli na yanayin na iya haɗawa da ciwon huhu da kuma bayyanar cututtuka na numfashi.
Lokacin da aka kamu da cutar don fara bayyanar cututtuka shine yawanci kwanaki biyar, amma zai iya zama daga kwana biyu zuwa goma sha huɗu.
Babu wani allurar rigakafi ko magani da aka sani game da cutar.
Maganin farko na bayyanar cututtuka da magani ne na gaba. Matakan da aka ba da shawarar sun haɗa da wanke hannu, rufe baki yayin shan kwayoyi, nisantar wasu, da kulawa da keɓewa ga waɗanda ake zargi da kamuwa da cutar.
A duk faɗin duniya, hukumomi sun amsa ta hanyar aiwatar da ƙuntatawa na balaguro, keɓewa, hana zirga-zirga, kula da haɗarin ma'aikata, da rufe cibiyoyi.
Cutar ta haifar da katsewar tattalin arzikin duniya, jinkirta ko soke abubuwan wasanni, addini, siyasa da al'adu, da kuma raguwar kayayyaki da yawa saboda sayayya da sauri.
Makarantun gaba da jami'o'i ko dai a matakin ƙasa ko na gida an rufe su a cikin ƙasashe 193, wanda ya shafi kusan kashi 99.4 na ɗaliban duniya.
An samu karuwar rashin fahimta game da cutar a yanar gizo, kuma an sami tashin hankali na tsoron baƙi da nuna bambanci ga 'yan ƙasar Sin, da sauran kabilun da ke gabashin da kudu maso gabashin China, da sauran mutane a yankunan da cutar ta kamu da ita.
Saboda rage yawan balaguro da rufe manyan masana'antu, an sami raguwar gurɓataccen iska da fitar da carbon.
Hukumomin kiwon lafiya a Wuhan, China (babban birnin lardin Hubei) sun ba da rahoton wasu cututtukan cututtukan huhu a ranar 31 ga Disamba, 2019, kuma an fara bincike a farkon Janairu, 2020.
Yawancin lokuta ana danganta su da kasuwar kayan abincin teku na Hawan kuma saboda haka ana tsammanin cutar ta samo asali ne daga dabbobi.
Kwayar cutar da ta haifar da barkewar cutar da aka sani da SARS-CoV-2, sabuwar kwayar cuta ce da aka gano da ke da alaƙa da kwayar cutar coronavirus ta bat, coronavirus na pangolin, SARS-CoV. Mutumin da aka sani da farko da ke da alamun cutar kuma daga baya ya kamu da rashin lafiya a ranar 1 ga Disamba, 2019 ba shi da alaƙa da ƙungiyar kasuwar naman sabo.
Daga cikin adadin mutanen da aka fara ba da rahoto a watan Janairun 2019, kashi biyu bisa uku suna da alaƙa da kasuwar naman alade.
A ranar 13 ga watan Maris na shekarar 2020, wani rahoto da ba a tabbatar da shi ba a cikin South China Monring Post ya ba da shawarar cewa wani lamari da aka gano a ranar 17 ga Nuwamba, 2019, daga wani mutum mai shekaru 55 a lardin Hubei, na iya zama na farko. A ranar 26 ga Fabrairun 2020, Hukumar Lafiya ta Duniya ta ce, yayin da sabbin cututtukan ke raguwa a China, amma ba zato ba tsammani sun tashi a Italiya, Iran, da Koriya ta Kudu, a karon farko yawan sabbin cututtukan da ke waje da China ya zarce adadin sabbin cututtukan da ke cikin kasar Sin.
Yawancin lokuta ana iya samun rashin rahoto, musamman a tsakanin waɗanda ke da ƙananan alamun cutar.
Zuwa 26 ga Fabrairu, ƙananan ƙananan lokuta ne aka ruwaito tsakanin matasa, waɗanda shekarunsu 19 da ƙasa da kashi 2.4% na shari'o'in a duniya.Babban mai ba da shawara kan kimiyya na Burtaniya, Patrick Valance, ya yi hasashen cewa kashi 60% na yawan mutanen Burtaniya za su kamu da cutar kafin a sami rigakafin cutar.
Lamura suna nuna yawan mutanen da aka yi wa allurar rigakafin COVID-19 kuma waɗanda aka tabbatar sun gwada tabbatacce bisa ga ƙa'idodin hukuma.
Har zuwa 23 ga Maris, babu wata ƙasa da ta gwada fiye da kashi 3% na yawanta, kuma yawancin ƙasashe suna da manufofin hukuma na hana yin allurar rigakafin waɗanda ke da alamun cutar kawai, kamar Italiya, Netherlands, Spain da Switzerland.
Wani bincike da aka fitar a ranar 16 ga watan Maris ya kammala cewa a China, a ranar 23 ga watan Janairu, kashi 86 cikin dari na masu kamuwa da cutar COVID-19 ba a gano su ba, kuma waɗannan marasa kamuwa da cutar sun haifar da kashi 79 cikin dari na masu kamuwa da cutar.
Wani bincike na kididdiga da aka fitar a ranar 30 ga Maris ya yi hasashen cewa adadin masu kamuwa da cutar a Italiya ya fi na wadanda aka bayar da rahoton.
Hasashen farko na yawan samarwa (R0) don COVID-19 ya kasance 1.4 zuwa 2.4.
Wani bincike da Cibiyar Kula da Cututtuka ta Amurka ta fitar ya nuna cewa a cikin wannan yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin yanayi mai kyau.
Yawancin mutanen da ke da COVID-19 suna murmurewa.
Ga waɗanda ba su warke ba, daga lokacin bayyanar cututtuka zuwa mutuwa yana tsakanin kwanaki 6 zuwa 41, wanda ya fi yawa kwanaki 14.
Ya zuwa ranar 10 ga Afrilu, 2020, kusan mutane 97,000 sun mutu sakamakon COVID-19.
A China, a ranar 5 ga Fabrairu, kashi 80% na mutuwar mutane sun haura shekaru 60, kuma kashi 75% suna da wasu matsalolin kiwon lafiya kamar cututtukan zuciya da ciwon sukari. Adadin mutuwar da aka yi a cikin annobar COVID-19 na yau da kullun yana nufin mutanen da suka mutu waɗanda suka gwada tabbatacce ga COVID-19 bisa ga ƙa'idodin hukuma.
Adadin ainihin mutuwar COVID-19 na iya zama mafi girma, saboda yana iya haɗawa da mutanen da suka mutu a lokacin gwaji - misali, a cikin gidajen tsofaffi, da sauransu.
Bayanai na wani ɓangare daga Italiya sun nuna cewa yawan mutuwar a lokacin annobar ya ninka na COVID sau 4-5.
"Magana daga Cibiyar Kula da Cututtuka da Cututtuka ta Amurka (CDC) ta ce, "Mun san cewa [ƙididdigar mutuwar da aka ruwaito] ba ta da tabbas", in ji wata sanarwa tare da rahoton cewa ba a ƙidaya mutane a Amurka ba. Sau da yawa wannan ƙididdigar ba ta faruwa a lokacin annoba, kamar annobar cutar N1H1 ta 2009.
Mutuwar farko a waje da China ta faru ne a Philippines a ranar 1 ga Fabrairu, kuma mutuwar farko a waje da Asiya ta faru ne a Faransa a ranar 14 ga Fabrairu.
A ranar 28 ga watan Fabrairu, a wajen kasar Sin, an samu mutuwar mutane sama da dozin a Iran, Koriya ta Kudu da Italiya.
A ranar 13 ga watan Maris, kasashe da yankuna sama da arba'in sun ba da rahoton mutuwar mutane a kowace nahiya sai Antarctica.
Waɗannan lambobin suna canzawa ta yanki da lokaci, kuma suna shafar yawan gwaji, ingancin tsarin kiwon lafiya, zaɓuɓɓukan magani, lokacin da cutar ta fara, da kuma halaye na yawan jama'a kamar shekaru, jinsi da lafiyar jama'a.
Bisa ga ƙididdigar Jami'ar Johns Hopkins, yawan mutuwar duniya ya kai kashi 6.0% (97,039/1,617,204) har zuwa 10 ga Afrilu 2020.
Yawan yana bambanta dangane da yankin.
A China, ƙididdigar yawan mutuwar ta ragu daga 17.3 (ga waɗanda suka fara bayyanar cututtuka daga 1-10 Janairu 2020) * zuwa 0.7% (ga waɗanda suka fara bayyanar cututtuka bayan 1 ga Fabrairu 2020). Sauran ma'aunin sun haɗa da ƙimar mutuwar mutum (CFR), wanda ke nuna yawan mutanen da aka gano sun mutu daga cutar, da kuma yawan mutuwar cutar (IFR), wanda ke nuna yawan mutanen da ke da cutar (masu ganewa da marasa ganewa) waɗanda suka mutu daga cutar.
Ba a tsara ƙididdigar lokaci ba kuma ana bin diddigin ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigarƙirar ƙididdigarƙirar ƙididdigarƙirar ƙididdigarƙirar ƙididdigarƙirar ƙididdigarƙirar ƙididdigarƙirar ƙididdigarƙirar ƙididdigarƙirar ƙididdigarƙirar ƙididdigarƙirar ƙididdigarƙirar ƙididdigarƙirar ƙididdigarƙirar ƙididdigarƙirar ƙididdigar ƙididdigarƙirar ƙididdigarƙirar ƙididdigarƙirar ƙididdigarƙirar ƙididdigar ƙididdigarƙirar ƙididdigarƙirar ƙididdigarƙirar ƙididdigarƙirƙirar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigarƙirƙirƙirƙir.
Yawancin masana kimiyya sun yi ƙoƙari su ƙididdige waɗannan lambobi don yawan mutane.
Cibiyar Nazarin Magunguna ta Jami'ar Oxford ta yi hasashen cewa yawan mutuwar cutar zai kasance tsakanin kashi 0.1% zuwa 0.39%.
Hasashen da ke sama da wannan adadin ya yarda da sakamakon gwajin farko na bazuwar COVID-19 a Jamus, da kuma nazarin ƙididdigar da ke nazarin tasirin gwaji akan hasashen CFR.
Hukumar Lafiya ta Duniya ta tabbatar da cewa cutar za ta iya zama cikin iko.
Ba a san lokacin da za a fara barkewar cutar ba kuma zai iya canzawa daga wuri zuwa wuri.
"Ba tare da gwaji ba, yaduwar cutar tana da yawa kuma tana farawa ta ragu lokacin da cutar ta ƙare", in ji Massey Boni na Jami'ar Jihar Penn.
Amma ba za ka iya faɗin lokacin da hakan zai faru ba".
Babban mai ba da shawara kan lafiya ga gwamnatin kasar Sin Zhong Nashen ya yi jayayya cewa "yana iya zama ƙarshen watan Yuni" idan duk ƙasashe sun kasance a shirye don bin shawarar WHO game da matakan da za su dakatar da yaduwar cutar.
A ranar 17 ga Maris, Adam Kocharski na Jami'ar Lafiya da Magungunan Yankin Yankin London ya ce SARS-CoV-2 "za ta kasance a cikin shekaru ɗaya ko biyu".
A cewar wani binciken da Kwalejin Kolejin ta jagoranci wanda Neil Ferguson ya gudanar, za a buƙaci nisantar zamantakewa da sauran matakan "har sai an sami allurar rigakafi (wataƙila watanni 18 ko fiye)".
"Ina ganin ba zai yiwu ba cewa cutar korona - saboda yawan kamuwa da ita - za ta ɓace gaba ɗaya" in ji William Schaffner na Jami'ar Vanderbilt "kuma yana iya zama wata cuta ta yanayi, ta dawo kowace shekara".
Rashin dawowa yana dogara ne akan juriya da yawan tsalle.
Alamomin COVID-19 na iya zama marasa gani kuma mutanen da ke fama da cutar ba za su iya nuna alamun cutar ba.
Alamomin biyu da aka fi sani da su sune tari (88%) da bushewar tari (68%).
Sauran alamun da ba a saba gani ba sun haɗa da taushi, ciwon numfashi, rashin jin daɗin dandano, numfashi mai wuya, ciwon tsoka da haɗin gwiwa, tari, ciwon kai, rashin jin daɗi, zubar jini, zubar da jini tare da tari, zawo, ko launin shuɗi. Hukumar Lafiya ta Duniya ta ce kusan kashi ɗaya cikin shida na mutane suna rashin lafiya sosai kuma suna da matsalar numfashi.
Cibiyar Kula da Cututtuka da Cututtuka ta Amurka (CDC) ta bayyana alamun gaggawa kamar matsalolin numfashi, ciwo ko ciwon kirji mai tsanani, zubar da jini, wahalar tafiya, da fuska ko lebe mai launin shuɗi; ana buƙatar kula da likita nan da nan idan waɗannan alamun sun kasance. Ƙarin bayyanar cutar na iya haifar da ciwon huhu mai tsanani, ciwon huhu mai tsanani, cutar jini, da mutuwa.
Wasu daga cikin waɗanda ke da cutar ba za su iya nuna alamun cutar ba, ba tare da alamun asibiti ba amma tare da sakamakon gwajin da ke tabbatar da cutar, don haka masu bincike sun ba da shawarar cewa waɗanda ke da kusanci da mutanen da ke da cutar za su iya yin rigakafi da rigakafi don hana cutar.
Ana hasashen cewa a China, yawan rashin alamun cutar zai kasance kadan zuwa 44%.
Lokacin rayuwa (lokacin da ke tsakanin kamuwa da cuta da bayyanar cututtuka) yana daga kwana ɗaya zuwa 14; mafi yawan lokuta kwanaki biyar ne. A matsayin misali mai ban mamaki, ƙididdigar yawan mutanen da ke da COVID-19 waɗanda suka rasa ƙanshi ya fara daga 30% sannan ya ragu zuwa 15%.
Har yanzu ba a san cikakken bayani game da yadda cutar ta kamu da cutar ba.
Ana tsammanin cutar ta samo asali ne a lokacin kusanci da ƙananan ƙwayoyin cuta yayin da ake yaduwa da cocaine, pidgin ko magana; kusanci yana cikin mita 1 zuwa 2 (3 zuwa 6 ft).
Bincike ya nuna cewa shan kwaya yana sa ƙwayoyin cuta su yi tafiya zuwa mita 4.5 (15 ft) zuwa 8.2 (27 ft).
Wasu sun ba da shawarar cewa ana iya yada kwayar cutar ta hanyar ƙananan ɗigon ruwa da ke cikin iska na dogon lokaci, wanda zai iya faruwa yayin magana. Ana iya haifar da ɗigon numfashi yayin numfashi, gami da magana, kodayake ba a yawan watsa kwayar cutar ta iska.
Ana iya sanya saukad da a cikin baki ko bakin mutane masu kusa ko kuma a cikin huhu.
Wasu hanyoyin likita kamar su CPR (Cardiopulmonary Resuscitation) da CPR (Cardiopulmonary Resuscitation) na iya haifar da ɓarkewar iska ta hanyar iska, don haka ya haifar da yaduwar iska.
Hakanan yana iya yaduwa lokacin da mutum ya taɓa ƙazamin abu, gami da fata, sannan ya taɓa idanunsu, bakinsu ko bakinsu.
Duk da yake akwai damuwa cewa za a iya yada shi ta hanyar sharar gida, ana ganin cewa wannan haɗarin ba shi da yawa.
Gwamnatin kasar Sin ta musanta yiwuwar yaduwar SARS-CoV2 ta hanyar bakin. Kwayar cutar ta fi yaduwa a cikin kwanaki uku na farko bayan bayyanar cututtuka, kodayake ana iya samun yaduwa kafin bayyanar cututtuka da kuma a cikin matakan cutar.
Mutane da yawa sun yi gwajin cutar har zuwa kwanaki uku kafin bayyanar cututtuka, wanda ke nuna cewa ana iya samun cutar kafin bayyanar cututtuka.
Rahotanni kaɗan ne kawai na tabbataccen yanayin rashin alamun cutar, amma an tabbatar da watsawar rashin alamun cutar ta wasu ƙasashe yayin binciken binciken.
Cibiyar Kula da Cututtuka ta Turai (ECDC) ta ce yayin da ba a san yadda cutar ke yaduwa ba, mutum ɗaya yakan kamu da mutane biyu zuwa uku. Kwayar cutar tana rayuwa a kan fuskoki na tsawon awanni.
Musamman, an gano kwayar cutar a kan filastik (polypropylene) da ƙarfe 304 na kwanaki uku, a kan alfarwa ta sujada na kwana ɗaya, da kuma jan ƙarfe na kwanaki huɗu.
Koyaya, wannan ya dogara da danshi da zafin jiki. Dabbobin gida da sauran dabbobin gida sun kamu da COVID-19.
Babu wata hujja da ta nuna cewa dabbobi za su iya yada cutar ga mutane, kodayake hukumomin Burtaniya sun ba da shawarar wanke hannu bayan taɓa dabbobi, kamar bayan haɗuwa da abin rufe fuska wanda mutane masu kamuwa da cutar za su taɓa.
Cutar coronavirus mai saurin kamuwa da cuta ta 2 (SARS-CoV-2) wata sabuwar cuta ce, da farko an ware ta daga mutane uku da suka kamu da cutar huhu mai saurin kamuwa da cuta a cikin wani rukunin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Dukkanin siffofin SARS-CoV-2 suna cikin yanayin kwayar cutar coronavirus. A waje da jikin mutum, ana kashe kwayar cutar ta sabulu na gida, wanda ke narkar da murfin mai karewa. SARS-CoV-2 yana da alaƙa da asalin SARS-CoV.
An yi imanin cewa yana da asalin dabba.
Nazarin gaba ɗaya ya nuna cewa kwayar cutar coronavirus ta haɗu da kwayoyin halittar kwayar cutar ta bactovirus, ta hanyar haɗin sarbicovirus (layin B) tare da kwayoyin halittar biyu da aka samo daga ƙuda.
Ya kasance daidai da kashi 96% na yanayin kwayoyin halitta na sauran samfuran kwayar cutar coronavirus na bat (BatCov TaTG13).
A watan Fabrairun 2020, masu binciken kasar Sin sun kammala cewa akwai bambancin amino acid guda daya a wasu sassan jerin kwayoyin halittar tsakanin kwayoyin halittar penguin da na mutane.
Zuwa yau, jimlar kwatancen kwayoyin halitta ya kai kusan kashi 92% na abubuwan da ke tattare da kwayoyin halitta tsakanin coronavirus na pangolin da SARS-CoV-2, wanda ba shi da isasshen ƙarfi don tabbatar da cewa pangolin shine mai kula da ƙwayoyin cuta.
Ana iya tantance cutar ta hanyar cutar ta hanyar alamomi, kodayake tabbacin ƙarshe zai kasance ta hanyar jujjuyawar polymerase chain reaction (rRT-PCR) na ƙwayar cutar ko CT.
Wani bincike da aka yi a Wuhan wanda ya kwatanta PCR da CT ya nuna cewa CT ya fi ƙarfin PCR, amma ba a bayyana shi sosai ba, tare da halayen hasken da ya dace da sauran cututtukan huhu da sauran cututtuka.
A watan Maris na 2020, Kwalejin Radiology ta Amurka ta ba da shawarar cewa "kada a yi amfani da CT don gwaji ko azaman gwajin farko don gano COVID-19".
Hukumar Lafiya ta Duniya ta buga wasu ka'idojin gwajin RNA don SARS-CoV-2, wanda aka fara fitarwa a ranar 17 ga Janairu.
Gwajin yana amfani da ainihin lokacin juyawa na sarkar polymer (rRT-PCR).
Ana iya yin gwajin akan numfashi ko samfurin jini.
Sakamakon zai kasance a cikin sa'o'i kadan zuwa kwanaki.
Ana yin wannan gwajin ne a kan allurar hanci-da-jifa ko da yake ana iya amfani da allurar hanci. Yawancin dakunan gwaje-gwaje da kamfanoni suna haɓaka gwajin serology, wanda ke gano ƙwayoyin cuta.
A ranar 6 ga Afrilu, 2020, babu ɗayan waɗannan da aka tabbatar da su don yarda da su don amfani da su.
A Amurka, gwajin ƙwayar cuta da Cellex ya haɓaka kuma an yarda da shi don amfani da gaggawa ta hanyar amintattun dakunan gwaje-gwaje kawai.
Abubuwan da ke tattare da hasken wuta na musamman a kan radiography da CT na mutane masu alamun sun hada da rashin haske na gilashin da ba a taɓa gani ba.
Ƙungiyar Radiology ta Italiya tana tattara bayanan bayanan yanar gizo na sakamakon radiation na tabbatar da yanayin.
Saboda haɗarin cututtuka kamar adenoviruses, ba tare da tabbatar da PCR ba, radiation yana da iyakantaccen amfani wajen gano COVID-19.
Wani babban bincike a China ya kwatanta sakamakon CT da PCR kuma ya nuna cewa yayin da radiography ba shi da ƙwarewa game da kamuwa da cuta, amma ya fi sauri da kuma mahimmanci, yana ba da shawarar yin amfani da shi azaman kayan aikin gwaji a yankunan da ke fama da cutar.
An haɓaka cibiyar sadarwar jijiyoyin jiki mai amfani da AI don gano halaye na radiography tare da radiography da CT.
Dabarun hana yaduwar cutar sun hada da kiyaye tsabtar jiki, wanke hannu, guje wa shan ido, hanci ko baki da hannayen da ba a wanke ba, shan kwaya ko pidgmin da clenks da kuma zubar da clenks kai tsaye a cikin shara.
An shawarci waɗanda ke da cutar da kansu su sanya abin rufe fuska a cikin jama'a.
An kuma ba da shawarar matakan nisantar jiki don hana yaduwar cutar. Yawancin gwamnatoci sun hana ko kuma ba da shawarar duk wani balaguron da ba dole ba kuma su guji ƙasashe ko yankuna da cutar ta bulla.
Koyaya, kwayar cutar ta kai matakin yaduwar al'umma a wurare masu nisa a duniya.
Wannan yana nufin cewa kwayar cutar tana yaduwa a cikin al'umma, kuma wasu membobin al'ummomin ba su san inda ko yadda aka kamu da ita ba. Masu ba da kiwon lafiya suna kula da mutumin da zai iya kamuwa da cutar wanda aka umurce su da su yi amfani da matakan faɗakarwa da ƙarancin haɗuwa da kariya ta ido. Binciken haɗuwa yana da mahimmanci ga hukumomin kiwon lafiya don gano asalin cutar da hana ci gaba da watsawa.
Amfani da bayanan wuri daga wayoyin hannu ta hanyar gwamnatoci don wannan dalili ya haifar da damuwar sirri, tare da Amnesty International da wasu kungiyoyi sama da 100 da ke ba da bayani da kuma neman a takaita irin wannan sa ido.
Yawancin aikace-aikacen hannu da yawa an aiwatar da su ko kuma an ba da shawarar don amfani da su ta hanyar son rai, kuma har zuwa 7 ga Disamba 2020, sama da ƙwararrun ƙwararrun masana suna aiki akan hanyoyin magance ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen.
Masu amfani za su sami saƙo idan sun kasance kusa da wani wanda ya sami COVID-19. An sami ra'ayoyi marasa kyau game da yadda za a hana kamuwa da cutar; misali, wanke hanci da wankewa da maganin wanke baki ba zai taimaka ba.
Babu riga-kafi ga COVID-19, kodayake ƙungiyoyi na iya aiki don haɓaka ɗaya.
Ana ba da shawarar wanke hannu don hana yaduwar cutar.
CDC ta ba da shawarar cewa mutane su wanke hannayensu da sabulu da ruwa aƙalla na dakika 20, musamman bayan sun je bayan gida ko kuma idan hannayensu sun kasance masu datti sosai; kafin cin abinci; da kuma bayan shafa hanci, cocaine ko pijamine.
Wannan saboda a waje da jikin mutum, ana kashe kwayar cutar ta sabulu na gida, wanda ke rage tasirinsa.
CDC ta ba da shawarar yin amfani da maganin wanke hanci wanda ya ƙunshi aƙalla kashi 60% na hanci lokacin da sabulu da ruwa ba su da yawa.
Hukumar Lafiya ta Duniya ta shawarci mutane da su guji taɓa idanu, hanci, ko baki da hannayensu da ba a wanke ba.
Ana iya wanke farfajiyar da yawa (a cikin minti daya na haɗuwa da mai tsabtace ƙarfe), wanda ya ƙunshi 62-71% na ethanol, 50-100% na isopropanol, 0.1% na sodium hydrochloride, 0.5% na hydrogen peroxide da 0.2-7.5% na iodine-povioidine.
Sauran kwayoyin halitta, kamar su benzalkonium chloride da gluconate chryohexidine ba su da tasiri sosai.
CDC ta ba da shawarar cewa idan an yi zargin ko tabbatar da cutar COVID a cikin wani wuri kamar ofis ko kulawa ta yau da kullun, duk wuraren da aka yi amfani da su kamar ofisoshi, dakunan wanka, wuraren da aka saba amfani da su, kayan lantarki da aka raba kamar su kwamfutar hannu, allon taɓawa, allon kebul, na'urar sarrafawa ta nesa, da na'urar ATM da mutum mai cutar ke amfani da su ya kamata a tsabtace su da maganin rigakafi.
Kungiyoyin kiwon lafiya sun ba da shawarar rufe baki da baki da kayan shafawa ko kuma clenks yayin shan kwayoyi ko pijamin, da kuma zubar da clenks nan da nan.
Ana ba da shawarar sanya abin rufe fuska ga waɗanda ke da yiwuwar kamuwa da cutar, saboda sanya abin rufe fuska zai rage girman da nisa na saukad da iska a cikin numfashi yayin magana, tari da tari.
Hukumar Lafiya ta Duniya ta ba da jagororin lokacin da kuma yadda za a yi amfani da abin rufe fuska.
A cewar Stephen Griffin, masanin ilmin kwayar cuta a Jami'ar Leeds, "saka abin rufe fuska na iya rage yawan mutanen da ke fama da cutar daga fuskokinsu, wanda shine babban tushen kamuwa da cutar ta hanyar rashin tsabtace hannu".
Hukumar Lafiya ta Duniya ta ba da shawarar sanya abin rufe fuska ta hanyar mutane masu lafiya idan suna cikin haɗari, kamar waɗanda ke kula da mai cutar COVID-19, kodayake sun yarda cewa sanya abin rufe fuska na iya taimaka wa mutane su guji asarar fuska.
Yawancin ƙasashe sun fara ƙarfafa amfani da abin rufe fuska ga jama'a.
A Amurka, CDC ta ba da shawarar sanya abin rufe fuska na likita wanda ba na masana'anta ba. China ta ba da shawarar musamman amfani da abin rufe fuska na likita wanda za a iya amfani da shi ta hanyar jama'a masu lafiya, musamman lokacin kusanci (mita 1 (ƙafa 3) ko ƙasa da haka) tare da wasu mutane.
Hong Kong ta ba da shawarar sanya abin rufe fuska na tiyata yayin amfani da jigilar jama'a ko kasancewa a wuraren da jama'a ke yawa.
Jami'an kiwon lafiya na Thailand sun ƙarfafa mutane su yi abin rufe fuska na masana'anta a gida kuma su wanke su kowace rana.
Jamhuriyar Czech da Slovakia sun hana fita waje ba tare da sanya abin rufe fuska ko rufe baki ba.
Tun daga ranar 16 ga Maris, Vietnam ta bukaci kowa da kowa ya sanya abin rufe fuska yayin da yake shiga wuraren jama'a don kare kansa da sauran mutane.
Gwamnatin Austriya ta ba da umarnin cewa duk wanda ya shiga shagon dole ne ya sanya abin rufe fuska.
Isra'ila ta bukaci duk mazauna kasar da su sanya abin rufe fuska a lokacin da suke cikin jama'a.
Taiwan, wacce ke samar da abin rufe fuska miliyan goma a kowace rana tun tsakiyar watan Maris, ta bukaci fasinjojin jiragen kasa da bas su sanya abin rufe fuska a ranar 1 ga Afrilu.
Panama ta tilasta sanya abin rufe fuska a lokacin da za a fita, yayin da ta ba da shawarar yin abin rufe fuska a gida ga waɗanda ba za su iya sayen abin rufe fuska ba.
Ana kuma amfani da abin rufe fuska a Japan, Koriya ta Kudu, Malaysia da Singapore.
Nisa ta zamantakewa (wanda aka fi sani da nesa ta zamantakewa) ya ƙunshi ayyukan sarrafa cututtuka da nufin rage yaduwar cutar ta hanyar rage kusanci tsakanin mutane.
Hanyoyin da ke cikin keɓewa, ƙuntata tafiye-tafiye; da rufe makarantu, wuraren tarihi, filayen wasa, gidajen wasan kwaikwayo ko manyan kantuna.
Mutane na iya yin amfani da hanyoyin nisantar da jama'a ta hanyar zama a gida, ƙuntata tafiye-tafiye, guje wa wuraren taron jama'a, amfani da gaisuwa mara ma'ana, da nisantar jiki.
Yawancin gwamnatoci yanzu suna ba da umarni ko kuma suna ba da shawarar nisantar da jama'a daga yankunan da cutar ta shafa.
Gwamnatin Amurka da kungiyoyin kiwon lafiya sun rage yawan taron jama'a daga mutane 250 (idan babu sanannen barkewar COVID-19 a yankin) zuwa 50, sannan zuwa 10.
A ranar 22 ga Maris, 2020, Jamus ta hana taron jama'a fiye da mutane biyu. Tsofaffi da waɗanda ke da yanayin kiwon lafiya kamar su ciwon sukari, cututtukan zuciya, cututtukan numfashi, hauhawar jini da matsalolin rigakafi suna fuskantar haɗarin kamuwa da cututtuka masu tsanani kuma CDC ta shawarce su da su zauna a gida har tsawon lokacin da za su iya a wuraren da cutar ta ɓarke. A ƙarshen Maris, 2020, WHO da sauran hukumomin kiwon lafiya sun fara canza amfani da ma'anar "nisan zamantakewa" zuwa "nisan jiki", don bayyana cewa makasudin shine rage haɗuwa ta jiki yayin hulɗar zamantakewa, ko kuma a zahiri ko a zahiri.
Yin amfani da manufar "nisanci na zamantakewa" ya sa mutane su shiga cikin cikakken nisantar zamantakewa, maimakon ƙarfafa su su kasance tare da wasu ta hanyar wasu dalilai. Wasu hukumomi sun ba da jagororin kiwon lafiyar jima'i don amfani a lokacin annobar.
Waɗannan sun haɗa da shawarar yin jima'i kawai tare da mutumin da kuke zaune tare, wanda ba shi da cutar ko alamun cutar.
Ana ba da shawarar keɓe kai a gida ga waɗanda ke da COVID-19 da waɗanda ake zargi da kamuwa da cutar.
Hukumomin kiwon lafiya sun ba da umarnin kai tsaye don keɓe kai. Yawancin gwamnatoci sun ba da umarni ko kuma sun ba da shawarar keɓe kai ga duk mazauna da ke zaune a yankunan da cutar ta shafa.
An ba da ƙa'idodin keɓe kai mafi ƙarfi ga waɗanda ke cikin rukunin haɗari.
Wadanda suka iya kasancewa cikin hulɗa da wani wanda ke da COVID-19 kuma waɗanda suka yi tafiya kwanan nan zuwa wata ƙasa ko yanki inda akwai yaduwar cutar an shawarce su da su keɓe kansu na kwanaki 14 daga lokacin da suka yi hulɗa da su.
Dabarun sarrafa yaduwar cutar sun haɗa da hanawa ko kawar da su, da ragewa.
Ana yin rigakafi a farkon lokacin barkewar cutar kuma ana nufin ganowa da kuma ware masu kamuwa da cutar tare da samar da wasu matakan kula da cutar da alluran rigakafi don dakatar da cutar daga yaduwa zuwa sauran yankuna.
Idan har ba a iya sarrafa yaduwar cutar ba, to, za a ci gaba da ƙoƙari don ragewa: ana ɗaukar matakan rage yaduwar cutar da rage tasirinsa ga tsarin kiwon lafiya da al'umma.
Ana iya ɗaukar matakan haɗuwa da ragewa a lokaci guda.
Rigakafin yana buƙatar matakan da suka fi girma, don sauya yaduwar cutar daga mutum zuwa mutum zuwa ƙasa da kashi ɗaya na gudanarwa da kuma magance ɓarkewar cutar ta kamuwa da cuta ta hanyar ƙoƙarin rage ƙimar yaduwar cutar ta hanyar daidaita yanayin yaduwar cutar.
Wannan yana rage haɗarin yawan aiki a kan ayyuka kuma yana ba da ƙarin lokaci don haɓaka allurar rigakafi da magani.
Ayyukan da ba na asibiti ba waɗanda za su iya sarrafa barkewar cutar sun haɗa da matakan kariya na mutum, kamar tsabtace hannu, sanya abin rufe fuska, da keɓewa; matakan al'umma don nisantar jiki kamar rufe makarantu da ƙin manyan tarurruka; sa hannun al'umma don ƙarfafa karɓar da shiga cikin irin waɗannan ayyukan; tare da matakan muhalli kamar tsabtace fuska.
Sauran ƙasashe sun ɗauki matakan da yawa don iyakance yaduwar cutar.
Koriya ta Kudu ta aiwatar da gwajin jama'a da keɓewar gida, kuma ta ba da gargaɗi game da motsi na mutanen da ke da cutar.
Singapore ta ba da tallafi na kuɗi ga waɗanda ke da cutar da ke keɓe kansu kuma ta sanya tsauraran takunkumi ga waɗanda ba su bi wannan ba.
Taiwan ta kara samar da abin rufe fuska kuma ta hukunta masu sayen kayan aikin likitanci. Hakanan ga Burtaniya da Amurka yana nuna cewa ragewa (ragewa maimakon dakatar da yaduwar cutar) da kawar da cutar (dakatar da ci gaban cutar) babban kalubale ne.
Manufofin ragewa masu kyau na iya rage buƙatun kula da lafiya da kashi biyu cikin uku da mutuwar rabin, amma har yanzu yana haifar da daruruwan dubban mutuwar da kuma lalata tsarin kiwon lafiya.
Ana iya yin amfani da maganin alurar riga kafi amma ya kamata a dakatar da shi har sai cutar ta bazu a cikin al'umma (ko har sai an sami allurar rigakafi, idan wannan shine farkon), saboda yaduwar zai iya haɓaka yayin da matakan suka sassauta.
Aikin da aka yi na dogon lokaci don kawar da cutar yana haifar da farashi na zamantakewa da tattalin arziki.
Babu takamaiman maganin rigakafin cutar COVID-19, amma ana ci gaba da ƙoƙarin haɓaka, gami da gwajin magungunan da ake dasu yanzu.
Samun maganin hana shan giya, shan ruwa, da hutawa na iya taimakawa wajen rage alamun.
Dangane da tsananin cutar, ana iya buƙatar maganin oxygen, ruwan jini, da kuma taimakon numfashi.
Yin amfani da masu motsa jiki na iya haifar da sakamako mafi muni.
Yawancin abubuwan da aka amince da su a baya don magance wasu cututtukan ƙwayoyin cuta ana nazarin su don amfani da su don magance COVID-19.
Hukumar Lafiya ta Duniya ta kuma ce wasu "magungunan gargajiya da na gida" na iya samar da saukin alamun cutar SARX-CoV-19.
Ƙara iyawa da samun damar kula da lafiyar da ke buƙatar marasa lafiya na COVID-19 an bayyana su a matsayin matakan da za su hana yaduwar cutar.
ECDC da ofishin Yankin Turai na WHO sun ba da umarni ga asibitoci da sabis na kiwon lafiya na farko don canza albarkatu a matakai da yawa, gami da mai da hankali kan sabis na gwaji zuwa gwajin COVID-19, ƙin ɗaukar matakan zaɓi a duk lokacin da ya dace, keɓe marasa lafiya masu cutar COVID-19, da haɓaka ƙarfin kulawa ta musamman ta hanyar horar da ma'aikata da haɓaka yawan injunan numfashi da gadaje da ake da su.
Akwai ra'ayoyi da yawa game da inda yanayin farko (wanda ake kira cututtukan lamba zero) ya samo asali.
Ana iya samun labarin farko na sabon coronavirus a ranar 1 ga Janairu, 2019 a Wuhan, Hubei, China.
A cikin wata guda, adadin masu kamuwa da cutar coronavirus a Hubei ya karu sosai.
Yawancin waɗannan suna da alaƙa da kasuwar kayan abincin teku ta Huan, wanda kuma ke sayar da dabbobi masu rai, kuma wata ka'idar ita ce cewa kwayar cutar ta fito ne daga ɗayan waɗannan dabbobi; ko kuma, a wata ma'anar, yana da asalin dabbobi. An lura da yanayin da ba a san dalilin cutar huhu ba a ranar 26 ga Disamba kuma an kula da shi ta hanyar Dr. Zhang Jixuan na Asibitin Yankin Hubei, wanda ya sanar da CDC na Jinghan a Wuhan a ranar 27 ga Disamba.
A ranar 30 ga Disamba, wata ƙungiyar likitoci a Babban Asibitin Wuhan ta gargadi abokan aikinta game da "Covid-19 mai kama da SARS".
Likitoci takwas, ciki har da Li Wenliang, sun sami gargadi daga 'yan sanda game da yada farfagandar karya, kuma wani, Ifen, ya fusata da shugabanninsa saboda tayar da hankali game da hadarin.
Daga baya, Hukumar Lafiya ta Wuhan ta ba da sanarwar sanarwa a ranar 31 ga watan Disamba kuma ta sanar da Hukumar Lafiya ta Duniya.
An sanar da manyan cututtukan cututtukan huhu da ba a san dalilin su ba ga hukumomin kiwon lafiya a Wuhan don fara bincike a farkon Janairu. A farkon farkon barkewar cutar, yawan masu kamuwa da cutar ya ninka kusan kowace kwana bakwai da rabi.
A farkon da tsakiyar watan Janairun 2020, kwayar cutar ta yadu zuwa wasu yankuna na kasar Sin, tare da taimakon ƙaura zuwa Sabuwar Shekarar Sin da kuma cewa Wuhan cibiyar sufuri da layin dogo ce.
A ranar 20 ga watan Janairun, kasar Sin ta sake samun wasu sabbin mutane 140, ciki har da mutum biyu a Beijing da kuma mutum daya a Shenzhen.
Bayan haka, bayanan hukuma sun nuna cewa a ranar 20 ga Janairun 2020, kusan mutane 6174 sun kamu da alamun cutar. A ranar 26 ga Maris, Amurka ta gabaci China da Italiya don samun adadin adadin wadanda aka tabbatar a duniya. A ranar 9 ga Afrilu, 2020, an samu sama da mutane miliyan 1.61 a duniya, sama da mutane 97,000 sun mutu kuma sama da 364,000 sun warke.
A cikin kusan ƙasashe da yankuna 200 da ke da aƙalla mutum ɗaya da ya kamu da cutar.
Saboda annobar a Turai, yawancin ƙasashen yankin Schengen sun ƙuntata motsi na kai tsaye kuma sun sanya kulawar kan iyaka.
Amsoshin ƙasa sun haɗa da matakan kariya kamar keɓewa (wanda aka fi sani da umarnin zama a gida, umarnin tsari, ko kuma keɓewa daga gida) da dokar hana zirga-zirga. A ranar 2 ga Afrilu, kusan mutane miliyan 300, kusan kashi 90% na yawan jama'a, suna ƙarƙashin wani nau'in keɓewa a gida a Amurka, sama da mutane miliyan 50 sun kasance a gida a cikin Philippines, kusan mutane miliyan 59 a Afirka ta Kudu sun kasance a gida, kuma biliyan 1.3 a Indiya suna cikin gida.
A ranar 26 ga Maris, mutane biliyan 1.7 a duniya suna ƙarƙashin wani nau'i na keɓewa a gida, wanda ya karu zuwa biliyan 2.6 a cikin kwanaki biyu masu zuwa - kusan kashi ɗaya bisa uku na yawan mutanen duniya.
An tabbatar da shari'ar farko ta COVID-19 a ranar 1 ga Disamba, 2019 a Wuhan; wani rahoto da ba a tabbatar da shi ba ya nuna cewa farkon lamarin ya kasance a ranar 17 ga Disamba.
Dr. Zhang Jixian ya lura da yanayin cutar sankarar bargo da ba a san dalilinsa ba a ranar 26 ga Janairu, wanda ya sa asibitin ya sanar da CDC na Wuhan Jianghan a ranar 27 ga Janairu.
Binciken farko na kwayoyin halittar marasa lafiya a ranar 27 ga Disamba, 2019 ya nuna cewa akwai kwayar cutar coronavirus mai kama da SARS.
Hukumar Kula da Lafiya ta Birnin Wuhan ta ba da sanarwar a ranar 31 ga watan Disamba.
An sanar da Hukumar Lafiya ta Duniya a ranar.
A lokacin da aka yi wannan gargadin, likitoci a Wuhan sun sami gargadi daga 'yan sanda game da "yaduwar farfaganda' game da cutar.
A farkon, Hukumar Lafiya ta Kasa ta kasar Sin ta yi ikirarin cewa babu "tabbacin tabbatacce" na yaduwar mutum zuwa mutum.
A ƙarshen watan Janairun, gwamnatin China ta fara wani kamfen na ta'addanci wanda Sakatare Janar na Jam'iyyar Kwaminis ta kasar Sin ya bayyana a matsayin "Yakin Jama'a" don dakile yaduwar cutar.
A cikin abin da aka bayyana a matsayin "garkuwa mafi girma a tarihin ɗan adam", an ba da sanarwar keɓewa a ranar 23 ga Janairu don dakatar da balaguro zuwa ciki da wajen Wuhan, wanda aka faɗaɗa zuwa birane 15 a Hubei, wanda ya shafi mutane miliyan 57.
An haramta amfani da motocin masu zaman kansu a cikin birnin.
An soke bikin sabuwar shekara ta kasar Sin (Janairu 25) a wurare da dama.
Hukumomi sun kuma sanar da cewa an kammala gina asibitin wucin gadi, asibitin Husein Shan, a cikin kwanaki 10.
Daga baya aka gina wani asibiti, asibitin Licheshan, don magance ƙarin cututtuka.
Baya ga sabbin asibitocin da aka gina, kasar Sin ta kuma mayar da wasu wurare 14 a Wuhan, kamar cibiyoyin taro da filayen wasa, zuwa asibiti na wucin gadi. A ranar 26 ga Janairu, gwamnati ta dauki wasu matakai don shawo kan cutar COVID-19, gami da fitar da sanarwar kiwon lafiya ga masu yawon bude ido da kuma tsawaita hutun bikin bazara.
An rufe jami'o'i da makarantu a duk fadin kasar.
Yankunan Hong Kong da Macau sun ɗauki matakai da yawa, musamman game da makarantu da jami'o'i.
An dakatar da ayyukan nesa a yankuna da dama na kasar Sin.
An sanya takunkumin hana zirga-zirga a ciki da wajen Hubei.
An dakatar da zirga-zirgar jama'a, kuma an rufe gidajen tarihi a duk faɗin ƙasar Sin na ɗan lokaci.
An aiwatar da kula da zirga-zirgar jama'a a birane da yawa, kuma an kiyasta cewa kusan mutane miliyan 760 (fiye da rabin yawan jama'a) za su fuskanci wasu nau'ikan takunkumin fita. Bayan barkewar cutar a duniya a watan Maris, hukumomin China sun ɗauki tsauraran matakai don hana "shigo da" kwayar cutar daga wasu ƙasashe.
Misali, Beijing ta sanya dokar killacewa ta kwanaki 14 ga duk masu yawon bude ido na kasa da kasa da ke shigowa cikin birnin. A ranar 23 ga Maris, a cikin kasar Sin akwai mutum daya da aka samu da cutar a cikin kwanaki biyar, a wannan yanayin ta hanyar wani matafiyi da ya dawo daga Guangzhou a Istanbul.
A ranar 24 ga Maris, 2020, Firayim Ministan kasar Sin Li Keqiang ya sanar da cewa an toshe cutar ta hanyar gida kuma an sarrafa ta a kasar Sin.
A ranar 26 ga watan Maris, 2020, Ma'aikatar Harkokin Wajen ta kasar Sin ta sanar da cewa za a dakatar da shiga kasar domin samun biza ko kuma izinin zama har zuwa ranar 28 ga watan Maris, ba tare da wani bayani game da lokacin da wannan manufar za ta kare ba.
Masu son shiga kasar Sin dole ne su nemi biza a ofishin jakadancin kasar Sin da ofishin jakadancin kasar Sin.
Gwamnatin kasar Sin ta ba da shawarar sake buɗe kasuwanni da masana'antu a ranar 30 ga Maris, kuma ta ba da kyautar kuɗi ga kamfanoni. Majalisar Jiha ta ba da sanarwar ranar makoki don fara da minti uku na shiru a karfe 10:00 na ranar 4 ga Afrilu, daidai da bikin Qingming, kodayake gwamnatin tsakiya ta nemi iyalai su ci gaba da yin hakan don yin la'akari da nisantar jiki don hana sake barkewar COVID-19.
A ranar 20 ga Janairun 2020, an tabbatar da barkewar cutar COVID-19 a Koriya ta Kudu daga China.
A ranar 20 ga watan Fabrairun, Hukumar Lafiya ta Kasa ta bayar da rahoton karuwar karuwar, wanda ya fi yawa daga taron kungiyar addinai a Daegu da aka sani da Church of Christ Shincheon.
An yi zargin cewa mutanen da ke birnin Shenzhen da ke birnin Wuhan da ke birnin Daegu ne suka haddasa annobar.
A ranar 22 ga watan Fabrairun, daga cikin mabiya 9,336 na Ikilisiyar, 1,261 ko kusan 13% suna da alamun. Koriya ta Kudu ta sanar da matakin gargadi mafi girma a ranar 23 ga Fabrairun 2020.
A ranar 28 ga watan Fabrairu, an samu karin mutane 2,000 da suka kamu da cutar a Koriya, wanda ya karu zuwa 3,150 a ranar 29 ga watan Fabrairu.
An killace dukkan sansanonin sojin Koriya bayan da aka tabbatar da cewa sojoji uku sun kamu da cutar.
Hakan ya shafi jadawalin jiragen sama kuma saboda haka an canza su. Koriya ta Kudu ta kirkiro abin da ake ganin shine mafi girma kuma mafi kyawun tsari a duniya don gwada yawan jama'a don cutar, ware duk wanda ya kamu da cutar da kuma bin diddigin waɗanda suka kamu da cutar.
Hanyoyin gwajin kai sun haɗa da tilasta yin rahoto daga sabbin masu isowa na duniya ta hanyar aikace-aikacen wayar hannu, gwajin cikin mota don cutar tare da sakamakon da za a samu a rana mai zuwa, da haɓaka ƙarfin gwaji don ba da damar yin allurar rigakafin mutane 20,000 kowace rana.
Shirin na Koriya ta Kudu ya kasance babban nasara wajen shawo kan cutar duk da cewa ba a killace dukkan biranen ba. Da farko dai al'ummar Koriya ta Kudu sun rabu kan yadda Shugaba Moon In-Jie ya amsa wa rikicin.
Yawancin 'yan Koriya sun sanya hannu kan ƙarar da ke neman a tuhumi Moon saboda sun yi zargin cewa gwamnati ba ta yi aiki da kyau ba game da barkewar cutar, ko kuma sun yaba da amsar da ta bayar.
A ranar 23 ga Maris, an ba da rahoton cewa Koriya ta Kudu ta sami mafi ƙarancin adadin masu cutar a cikin kwana ɗaya a cikin makonni huɗu.
A ranar 29 ga Maris, an sanar da cewa daga ranar 1 ga Afrilu duk matafiya da ke shigowa daga ƙasashen waje za su shiga keɓewa na makonni biyu.
A cewar rahotannin kafofin watsa labarai a ranar 1 ga Afrilu, Koriya ta Kudu ta karɓi buƙatun taimakon gwaji daga ƙasashe 121.
A ranar 19 ga watan Fabrairu, Iran ta sanar da tabbatar da cutar SARS-CoV-2 ta farko a Qom, inda a cewar ma'aikatar lafiya da ilimin likitanci, mutane biyu suka mutu a wannan ranar.
Matakan farko da gwamnatin ta sanar sun hada da hana kide kide da sauran abubuwan al'adu, wasannin motsa jiki, sallar Juma'a, da rufe jami'o'i, cibiyoyin ilimi da makarantu.
Iran ta ba da Riyal tiriliyan biyar don magance cutar.
Shugaban kasar Hassan Rouhani ya ce a ranar 26 ga watan Fabrairun 2020 cewa babu wani shiri na killace wuraren da cutar ta bulla, kawai za a killace mutane.
A watan Maris ne aka sanar da shirin takaita zirga-zirgar ababen hawa tsakanin biranen, kodayake an ci gaba da zirga-zirgar ababen hawa tsakanin biranen kafin sabuwar shekarar Farshi ta Nuur.
Har zuwa ranar 16 ga Maris, 2020, wuraren binne Shi'a a Qum sun kasance a buɗe ga mahajjata.
A ranar 28 ga watan Fabrairu, sama da kasashe goma sun mayar da cututtukan zuwa Iran, suna mai cewa cutar na iya zama mafi muni fiye da 388 da gwamnatin Iran ta bayyana a lokacin.
An rufe majalisar dokokin Iran, tare da 23 daga cikin mambobi 290 da suka kamu da cutar a ranar 3 ga Maris.
A ranar 12 ga Maris, Human Rights Watch ta bukaci hukumomin kurkuku na Iran da su saki masu kare hakkin dan Adam da aka kama saboda adawa da zaman lafiya, da kuma sakin duk wasu fursunoni masu cancanci.
Ya ce akwai babban hadarin yaduwar cutar a wuraren da aka rufe kamar cibiyoyin kula da marasa lafiya, inda ba a buƙatar kulawa ta likita.
A ranar 15 ga watan Maris, gwamnatin Iran ta sanar da mutuwar mutane 100 a rana daya, mafi yawan adadin da aka samu a rana daya a kasar tun lokacin da cutar ta fara.
Akalla 'yan siyasa 12 na yanzu ko na baya da jami'an gwamnati sun mutu daga cutar a ranar 17 ga Maris.
Har zuwa 23 ga Maris, Iran tana samun sabbin kamuwa da cutar coronavirus 50 a kowace awa da kuma mutuwa guda a kowane minti 10.
A cewar wani jami'in Hukumar Lafiya ta Duniya, adadin masu kamuwa da cutar a Iran ya ninka na da aka samu sau biyar.
An kuma ba da shawarar cewa takunkumin da Amurka ta sanya wa Iran na iya shafar ikon da kasar ke da shi na magance yaduwar cutar.
Babban Kwamishinan kare hakkin bil adama na Majalisar Dinkin Duniya ya yi kira da a sassauta takunkumin tattalin arziki da aka sanya wa kasashen da annobar ta shafa, ciki har da Iran.
An tabbatar da barkewar cutar a Italiya a ranar 31 ga Janairu, lokacin da matafiya biyu 'yan China a Rome suka kamu da SARS-CoV-2.
Cutar ta yi ta karuwa cikin sauri, wanda hakan ya sa gwamnatin Italiya ta dakatar da dukkan zirga-zirgar jiragen sama zuwa da kuma daga China kuma ta ayyana dokar ta baci.
Daga nan sai aka gano wasu mutane da ba su da alaƙa da COVID-19, tare da tabbatar da mutane 16 a Lombardy tun daga ranar 21 ga Fabrairu. A ranar 22 ga Fabrairu, majalisar ministoci ta ba da sabon umarni don hana barkewar cutar, kamar killace mutane sama da 50,000 a cikin birane 11 a arewacin Italiya.
Firayim Minista Giuseppe Conte ya ce, "Ba za a ba da izinin shiga da fita daga wuraren da cutar ta bulla ba.
An kuma umarci dakatar da ayyukan kasuwanci da kuma abubuwan wasanni a yankunan. "A ranar 4 ga Maris, gwamnatin Italiya ta ba da umarnin rufe dukkan makarantu da jami'o'i a kasar saboda Italiya ta kai 100 da suka mutu.
Duk manyan abubuwan wasanni, gami da wasannin kwallon kafa na Serie A, za a gudanar da su ba tare da motsa jiki ba har zuwa Afrilu, amma a ranar 9 ga Maris, an dakatar da dukkan wasanni gaba ɗaya na aƙalla wata ɗaya.
A ranar 11 ga Maris, Firayim Minista Giuseppe Conte ya ba da umarnin dakatar da kusan dukkanin ayyukan kasuwanci ban da manyan kantuna da kantunan magani. A ranar 6 ga Maris, Kwalejin Cirewa, Ragewa, Ragewa da Kulawa ta Musamman (SIAARTI) ta ba da shawarwari game da ka'idojin kimantawa da za a iya aiwatarwa.
A ranar 19 ga Maris, Italiya ta zarce China a matsayin ƙasa da ke da mafi yawan mutuwar da ke da alaƙa da cutar coronavirus a duniya bayan da aka ba da rahoton mutuwar 3,405 daga cutar.
A ranar 22 ga Maris, an sanar da cewa Rasha ta aika da jiragen sama na soja tara da kayan aikin likita zuwa Italiya.
Zuwa ranar 5 ga Afrilu, an tabbatar da kamuwa da cutar 128,948, mutuwar 15,887, da kuma warkewar 21,815 a Italiya, mafi yawan waɗannan an gano su ne a yankin Lombardy.
Wani rahoton CNN ya nuna cewa yawan tsofaffi da suka shigo Italiya da kuma rashin iyawar gwada duk waɗanda ke da cutar har zuwa yau na iya haifar da yawan mutuwar.
Amsar da Burtaniya ta bayar ga cutar coronavirus da farko ta kasance ɗaya daga cikin ƙasashe masu saurin kamuwa da cutar, kuma har zuwa 18 ga Maris, 2020, gwamnatin Burtaniya ba ta sanya matakan nisantar jama'a ko keɓewar jama'a a kan 'yan ƙasa ba.
A sakamakon haka, an soki gwamnati saboda rashin daidaito da rashin daidaito a cikin amsar da ta bayar ga damuwar da mutane ke fuskanta. A ranar 16 ga Maris, Firayim Minista Boris Johnson ya ba da sanarwar game da duk tafiye-tafiye da hulɗar zamantakewar da ba ta dace ba, yana ba da shawarar mutane su yi aiki daga gida kuma su guji wurare kamar kulab, gidajen abinci da gidajen wasan kwaikwayo.
A ranar 20 ga Maris, gwamnati ta sanar da cewa za a rufe dukkan wuraren nishaɗi kamar kulab da wuraren motsa jiki da wuri-wuri, kuma ta yi alkawarin biyan kashi 80% na albashin ma'aikata har zuwa £ 2,500 a wata don hana rashin aikin yi a lokacin rikicin. A ranar 23 ga Maris, Firayim Minista ya ba da sanarwar tsauraran matakan nisantar zamantakewa, hana tarurruka sama da mutane biyu da kuma takaita balaguro da ayyukan waje idan ya cancanta.
Ya bambanta da matakan da suka gabata, 'yan sanda sun aiwatar da waɗannan ƙuntatawa ta hanyar zaɓar da kuma watsa taron.
An ba da umarnin rufe yawancin kasuwancin, tare da keɓance waɗanda ake la'akari da "mahimmanci", kamar su manyan kantuna, kantin magani, bankuna, shagunan kayan aiki, gidajen mai da garages.
A ranar 20 ga Janairu, an tabbatar da shari'ar farko ta COVID-19 a Pacific Northwest a jihar Washington daga wani mutum wanda ya dawo daga Wuhan a ranar 15 ga Janairu.
A ranar 29 ga watan Janairu ne aka kafa tawagar kula da cutar coronavirus ta fadar White House.
A ranar 31 ga Janairu, gwamnatin Trump ta ayyana gaggawa ta kiwon lafiya, tare da sanya takunkumi kan masu yawon bude ido daga China.
A ranar 28 ga Janairun 2020, Cibiyar Kula da Cututtuka - babbar hukumar kiwon lafiyar jama'a a gwamnatin Amurka - ta sanar da cewa ta samar da kayan gwajin ta.
Duk da haka, Amurka ta yi jinkirin farawa a cikin gwaji, wanda ainihin adadin yaduwar cutar ya kasance a lokacin.
A watan Fabrairu, gwaji ya kasance cikin matsala saboda kayan gwajin cutar da gwamnatin tarayya ta samar, rashin amincewar gwamnatin tarayya ga kayan aikin da ba na gwamnati ba (daga jami'o'i, kamfanoni da asibitoci) har zuwa ƙarshen Fabrairu, da kuma iyakance ma'auni don mutane su cancanci yin gwaji har zuwa farkon Maris (daga baya an buƙaci umarnin likita).
A ranar 27 ga watan Fabrairu, Washington Post ta ruwaito cewa an gudanar da gwaje-gwaje kasa da 4,000 a Amurka.
A ranar 13 ga Maris, Atlantic ta ba da rahoton cewa an gudanar da gwaje-gwaje ƙasa da 14,000.
A ranar 22 ga Maris, Associated Press ta ruwaito: "Yawancin mutanen da ke da alamun da umarnin likita suna jiran sa'o'i ko kwanaki don gwaji". Bayan sanarwar mutuwar farko a Amurka a Washington a ranar 29 ga Fabrairu, Gwamna J. Inslee ya ba da sanarwar dokar ta baci, wani aiki da sauran jihohi suka bi.
Makarantun yankin Seattle sun sake komawa darussa a ranar 3 ga Maris, kuma a tsakiyar watan Maris, an rufe makarantu a duk faɗin ƙasar. A ranar 6 ga Maris, 2020, Amurka ta nemi ƙungiyar masana cututtuka a Kwalejin Imperial ta London don yin hasashen tasirin sabon coronavirus a ƙasar.
A ranar, Shugaba Trump ya rattaba hannu kan Dokar Kula da Shirye-shiryen Cutar Kwayar cuta ta Coronavirus, wanda ya ba da dala biliyan 8.3 na kudaden gaggawa ga hukumomin tarayya don magance cutar.
Kamfanoni sun sanya takunkumin hana ma'aikata tafiya, sun soke taron, kuma sun ƙarfafa ma'aikata su yi aiki daga gida.
An soke abubuwan da suka shafi wasanni da yanayi. A ranar 11 ga Maris, Trump ya ba da sanarwar hana tafiye-tafiye zuwa yawancin Turai, ban da Burtaniya, na kwanaki 30, daga ranar 13 ga Maris.
A rana mai zuwa, ya faɗaɗa takunkumin don ya haɗa da Burtaniya da Ireland.
A ranar 13 ga watan Maris, ya ayyana dokar ta baci ta kasa, inda ya samar da kudaden tarayya don amsa matsalar.
Tun daga ranar 15 ga Maris, yawancin kasuwancin sun rufe ko sun takaita lokutan aiki a duk faɗin Amurka don ƙoƙarin rage yaduwar cutar.
A ranar 17 ga Maris, an tabbatar da cutar a duk jihohi 50 da gundumar Columbia. A ranar 23 ga Maris, an ba da rahoton cewa New York City tana da mutane 10,700 da suka kamu da cutar coronavirus, fiye da adadin mutanen Koriya ta Kudu.
A ranar 25 ga Maris, Hakim ya ce nisantar zamantakewar al'umma ta kasance mai tasiri, kamar yadda aka yi hasashen ninki biyu daga kwanaki 2.0 zuwa 4.7.
A ranar 28 ga Maris, an tabbatar da shari'o'i 32,308 a Birnin New York, kuma mutane 672 sun mutu sakamakon cutar. A ranar 26 ga Maris, an ba da rahoton cewa Amurka tana da ƙarin tabbacin cutar coronavirus fiye da kowace ƙasa a duniya, gami da China da Italiya.
A cewar rahotannin kafofin watsa labarai a ranar 30 ga Maris, Shugaba Trump na Amurka ya yanke shawarar tsawaita umarnin nisantar da jama'a har zuwa 30 ga Afrilu.
A wannan rana, UNSS Comfort, wani jirgin asibiti mai dauke da gadaje kusan 1,000 ya sauka a New York.
A ranar 3 ga Afrilu, Amurka ta ba da rahoton mutuwar mutum 884 a cikin awanni 24 da suka gabata sakamakon cutar coronavirus.
A ranar 3 ga Afrilu, New York ta wuce mutane 100,000. An soki Fadar White House saboda rashin kula da barazanar da kuma sarrafa saƙon ta hanyar tura jami'an kiwon lafiya da masana kimiyya don yin aiki tare da bayyanawa da kuma fitar da bayanan jama'a game da cutar tare da ofishin mataimakin shugaban Amurka Mike Pence.
A cikin al'umma, yarda da gwamnatin Trump game da rikicin ya rabu da bangarori daban-daban.
Wasu jami'an Amurka da masu lura da al'amura sun soki dogaro da Amurka kan shigo da abubuwa masu mahimmanci, kamar kayan aikin likita na asali daga China.
An yi amfani da nazarin hanyoyin watsawa ta iska don ganowa da kuma hango yanayin yaduwar cutar kuma an buga shi a cikin mujallar Travel Medicine a tsakiyar Janairu 2020.
Bisa ga bayanan 2018 daga Hukumar Kula da Sufurin Jiragen Sama ta Duniya, Bangkok, Hong Kong, Tokyo, da Taipei sun fi yawan masu yawon bude ido daga Wuhan.
Dubai, Sydney da Melbourne sun kasance wuraren da aka saba zuwa daga Wuhan.
An bayyana Bali a matsayin mafi ƙarancin ƙarfi a cikin biranen 20 da aka fi amfani da su a cikin shirye-shiryen, yayin da biranen Ostiraliya suka kasance mafi ƙarfi.
Ya nuna cewa har yanzu akwai ƙarin abin da za a gano game da COVID-19, kuma Ostiraliya ta mai da hankali kan kula da kan iyakoki da sadarwa don amsa cutar.
A ranar 21 ga Maris, an ba da sanarwar gaggawa game da lafiyar ɗan adam a Ostiraliya.
Saboda keɓewar da ke shafar sufuri na jama'a a Wuhan da Hubei, ƙasashe da yawa suna shirin dawo da 'yan ƙasa da ma'aikatan diflomasiyyarsu daga yankin, galibi ta hanyar zirga-zirgar jiragen sama na gida, tare da ba da bayani ga hukumomin China.
Kasashen Kanada, Amurka, Japan, Indiya, Sri Lanka, Ostiraliya, Faransa, Argentina, Jamus, da Thailand na cikin na farko da suka fara shirin dawo da 'yan kasashensu.
Pakistan ta ce ba za ta mayar da wani daga cikin 'yan kasarta daga China ba.
A ranar 7 ga watan Fabrairu, Brazil ta dawo da 'yan Brazil 34 ko danginsu tare da' yan Poland hudu, wani dan kasar Sin, da kuma wani dan kasar Indiya.
'Yan ƙasar Poland, China, da Indiya sun sauka a Poland, yayin da jirgin na Brazil ya tsaya kafin ya ci gaba da tafiya zuwa Brazil.
An killace 'yan kasar Brazil da suka je Wuhan a wani sansanin soji da ke kusa da Brazil.
A ranar, an dawo da 'yan Kanada 215 (mutane 176 a jirgin farko, da 39 a jirgin biyu da gwamnatin Amurka ta yi hayar) daga Wuhan zuwa Trenton CFB don keɓewa na makonni biyu.
A ranar 11/2, wani jirgin sama na 185 na jirgin saman Kanada ya sauka a sansanin soja na Kanada a Trenton.
Gwamnatin Ostiraliya ta tura mutane 277 zuwa cibiyar karewa ta tsibirin Kirsimeti, wanda aka sanya su a matsayin wuraren keɓewa, inda za su zauna na kwanaki 14.
Kamfanin jirgin sama na New Zealand Air Transport ya isa Auckland a ranar 5/2; fasinjojinsa (wasu daga Australia da Pacific) da ba a keɓe su ba a sansanin jiragen ruwa na Hangapooro a arewacin Auckland.
A ranar 15/2. Majalisar Dinkin Duniya ta sanar da cewa za ta kwashe fasinjojin Amurka zuwa jirgin Diamond Princess.
A ranar 21/2, wani jirgin sama dauke da fasinjojin Kanada 129 da ke tashi daga Diamond Princess ya isa Trenton, Ontario.
A farkon watan Maris, gwamnatin Indiya ta fara jigilar 'yan ƙasa daga ƙasar ta Ira. A ranar 14 ga Maris jirgin saman sufuri na sufurin kaya na Afirka ta Kudu ya yi hayar da gwamnatin Afirka ta Kudu don kawo' yan Afirka ta Kudu 112.
An gudanar da gwajin likita don zafin jiki, kuma an sanya 'yan Afirka ta Kudu huɗu da ke da alamun cutar coronavirus cikin kulawa mai tsanani don rage haɗarin.
Sai kawai 'yan Afirka ta Kudu da aka tabbatar ba su kamu da cutar ba ne aka dawo da su.
Sakamakon binciken ya tabbatar da cewa duk 'yan Afirka ta Kudu, gami da ma'aikatan jirgin sama, matukan jirgi, ma'aikatan otal,' yan sanda da sojoji sun ci gaba da yin aikin soja. A matsayin maganin matsalolin, duk an sanya su cikin kulawa kuma ba a keɓe su ba na kwanaki 14 a Ranch Resort.
A ranar 20 ga Maris, Majalisar Dinkin Duniya ta fara ware dakarun soji daga Iraqi saboda barkewar cutar.
A ranar 5 ga watan Fabrairun, ministan harkokin wajen Sin ya sanar da cewa kasashe 21 (da suka hada da Belarus, Pakistan, Trinidad da Tobago, Masar da Iran) sun aika da tallafi da agaji ga Sin.
Wasu daliban Sinawa daga jami'o'in Amurka sun haɗu don aika taimako zuwa yankunan da cutar Sin ta shafa, tare da wani babban rukuni na ƙungiyar haɗin gwiwar yankin Chicago wanda a wani bangare ya ba da rahoton cewa ya jagoranci aikawa da abin rufe fuska 50,000 na N95 zuwa asibitocin yankin Hubei a ranar 30/1 .
A ranar 5 ga Fabrairu, Bill da Melinda Gates sun sanar da cewa za su ba da kyautar dala miliyan 100 ga duk wanda ya sami mafita da kariya "a cikin yankunan da ke cikin haɗarin Afirka da Kudancin Asiya".
Interaction ta ce gwamnatin Sin ta ba da kayan rufe fuska 200,000 ga 'yan Philippines a ranar 6 ga Fabrairu, bayan da Cibiyar Richard Gordon ta ba da kayan rufe fuska miliyan 3.16 a birnin Wan.
A ranar 19 ga Fabrairu, kungiyar agaji ta Singapore ta sanar da cewa za ta tura tallafin dala miliyan 2.26 zuwa Sin.
Japan ta ba da abin rufe fuska miliyan daya, Turkiyya ta aika da kayan aikin likita. Rasha ta aika da kayan aikin likita sama da tan 13 zuwa birnin Wan. Malaysia ta ba da gudummawar kayan aikin likita miliyan 18 ga Sin. Jamus ta aika da kayan aikin likitancin kwayar cuta da suka hada da rigunan rigakafin cutar 10,000. Majalisar Dinkin Duniya ta aika da tan 17.8 na kayan aikin likita zuwa Sin tare da alkawarin ba da tallafin dala miliyan 100 don taimakawa kasashen da ke fama da cutar.
A watan Maris, Cuba da Rasha sun aika da taimakon likita da ƙwararru zuwa Italiya don magance barkewar cutar a ƙasar.
Mai ciniki ya aika da kayan aikin likita miliyan 1.1, abin rufe fuska miliyan 6 da rigunan kariya 60,000 zuwa Addis Ababa, Habasha don rarraba ta hanyar Tarayyar Afirka.
Ya kuma aika da kayan aikin likita 5,000, kayan kwalliya 100,000 da na'urorin kwandishan 5 zuwa Panama.
Har ila yau, mun aika da kayayyakin kiwon lafiya zuwa Kanada. Netherlands, Spain, Turkey, Georgia da Jamhuriyar Czech sun ba da ra'ayoyinsu game da abin rufe fuska da kayan gwajin cutar Sin.
Misali, Spain ta dawo da kayan aikin likitancin COVID-19 58,000 da aka yi a cikin nono tare da ƙimar dawowa 30%. Netherlands ta dawo da abin rufe fuska 600,000 da ke da matsala.
Belgium ta dawo da abin rufe fuska 100,000 da ba a yi amfani da su ba, wanda aka yi imanin cewa an yi su ne a Sin, amma a zahiri an yi su ne a Colombia.
A gefe guda kuma, an yi maraba da taimakon Sin a sassan Latin Amurka da Asiya a ranar 4/2.
Hukumar Lafiya ta Duniya ta yaba wa kokarin da Sin ke yi na kula da kuma dakile yaduwar cutar.
Hukumar Lafiya ta Duniya ta lura da bambancin da ke tsakanin barkewar cutar SARS tsakanin 2002-2004. Gwamnatin Sin ta zargi ɓoyewar cutar da ke haifar da matsaloli ga ƙoƙarin hanawa da kawar da cutar da kuma rikicin yanzu inda gwamnatin tsakiya ta "ba da izinin doka don kauce wa cutar a hutun New York City".
A ranar 23 ga watan Janairun, a wani martani ga shawarar da gwamnatin tsakiya ta yanke na hana zirga-zirga daga birnin Wuhan, wakilin Hukumar Lafiya ta Duniya Gaudin Galya ya bayyana cewa yayin da "ba lallai ba ne umarnin kula da lafiya na duniya ya zama umarni" yana da matukar muhimmanci don hana yaduwar cutar a yankin da cutar ta fi karfi. Kuma an ce "ba a taba samun irin wannan ba a tarihin kiwon lafiya".
Darakta Janar na Hukumar Kula da Lafiya ta Duniya, Tedros Adhanom ya ce sanarwar gaggawa ta kiwon lafiya ta kasa ta haifar da "tsoron yaduwar cutar a duniya, musamman a kasashe matalauta da na tsakiya da ba su da tsarin kiwon lafiya mai karfi.
A cikin martani game da dokar hana tafiye-tafiye, Tedros ya bayyana cewa "babu wani dalili da zai sa a yi ƙoƙarin tsoma baki ba tare da buƙatar ba a cikin tafiye-tafiye da kasuwancin duniya" kuma "ba za a ba da umarnin ƙuntatawa ga kasuwanci da motsi ba".
A ranar 5 ga Fabrairu, Hukumar Lafiya ta Duniya ta nemi al'ummar duniya su ba da gudummawar dala miliyan 675 don samar da wannan kuɗin don shirya ƙasashe masu talauci, suna kira ga Majalisar Dinkin Duniya da ta tallafa wa ƙasashen da "ba su da tsarin kula da mutanen da ke fama da cutar, koda kuwa suna cikin mawuyacin hali".
Tedros ya kara da cewa "nasara ta zo ne ta hanyar kokarin da dukkanmu muke yi" kuma ya bukaci al'ummomin duniya da su "ba da gudummawa a yau ko kuma su biya daga baya".
A wannan rana, Tedros ya sanar da cewa Sakatare Janar na Majalisar Dinkin Duniya Antonio Guterres ya amince da samar da "dukkanin dakarun tsarin Majalisar Dinkin Duniya a cikin aiki".
An kunna wani shugaban kungiyar rikicin Majalisar Dinkin Duniya a sakamakon haka, yana ba da damar haɗin gwiwar Majalisar Dinkin Duniya wanda zai ba da damar WHO ta "mai da hankali kan amsar kiwon lafiya yayin da sauran ma'aikatan za su iya kawo kwarewarsu don haɗa kan al'umma, tattalin arziki da ci gaban yaduwar cutar".
A ranar 14 ga Fabrairu, an tura wani shugaban aikin aiwatar da manufofin lafiya na duniya tare da WHO don samar da ƙwararrun ƙwararrun ƙasashen duniya da WHO don ƙasar Sin don taimakawa wajen tantancewa da sarrafa cikin gida "ƙarfin cutar da yaduwar cutar". Shirya bita da ganawa tare da manyan hukumomin ƙasa da kuma gudanar da balaguron balaguro zuwa yankin don yanke shawara kan "matsayin tasirin ayyukan ga mutanen da ke zaune a cikin yankuna masu nisa da sauran matakan ƙasa, gami da tsara birane da ƙauyuka".
A sakamakon ci gaban barkewar cutar a Iran, Hukumar Lafiya ta Duniya ta tura wata ƙungiya ta musamman zuwa Iran don duba halin da ake ciki. A ranar 28 ga Fabrairu, Hukumar Lafiya ta Duniya ta sanar da cewa tsoron yaduwar cutar coronavirus a duniya ya tashi daga "mai girma" zuwa "mai girma sosai", wanda aka ƙaddara a matsayin matakin ƙararrawa mafi girma na haɗari da damuwa.
M. McRaean, shugaban shirin gaggawa na Hukumar Lafiya ta Duniya, ya yi gargadin duniya a cikin wata sanarwa cewa "akwai gwaji guda daya ga dukkan gwamnatocin duniya: farkawa.
Kwayar cutar na iya kasancewa a kan hanya kuma dole ne a kasance a shirye, "da fatan hanyoyin da suka dace na amsawa na iya taimakawa duniya ta guji mummunan yanayin cutar".
Ryan ya bayyana cewa bayanan da ake da su yanzu ba su ba da hujjar kiwon lafiyar jama'a don sanar da cutar ta duniya ba, yana mai cewa sanarwar ta nuna cewa "muna yarda cewa kowa a duniya yana cikin haɗarin kamuwa da cutar".
A ranar 11 ga Maris, Hukumar Lafiya ta Duniya ta ayyana cutar coronavirus a matsayin annoba.
Darakta Janar ya ce yayin da Hukumar Lafiya ta Duniya ta "ci gaba da yaduwa cikin tsauri da kuma saurin yaduwa, da kuma jinkirin yaduwar cutar", Hukumar Lafiya ta Duniya ta yi kira ga masu ba da shawara kan muhimman bayanai game da cutar, wanda ya hada da sanar da gaggawa na gaggawa na kiwon lafiya da kuma rarraba kwayar cutar a matsayin annoba.
Damuwar jama'a ta hada da takardar korafi ga Darakta Janar na Hukumar Lafiya ta Duniya Tedros Adhanom don gabatar da murabus, wanda mutane 733,000 suka sanya hannu a ranar 6/4.
A ranar 26 ga Maris, ƙungiyar masana haƙƙin ɗan adam ta Majalisar Dinkin Duniya ta tabbatar da cewa za a mutunta haƙƙin kowane mutum a lokacin annobar COVID-19.
Kungiyar ta ce kowa ya sami kwanciyar hankali kuma gwamnati ta dauki nauyin hakan.
Kungiyar ta jaddada cewa rashin albarkatu ko inshorar lafiya ba za a taɓa ba da hujja don nuna bambanci ga wani rukuni ba.
Masana sun jaddada cewa kowane mutum yana da hakkin samun lafiya, gami da nakasassu, kungiyoyin 'yan tsiraru, tsofaffi, mutanen da ke cikin gida, marasa gida, waɗanda ke rayuwa cikin talauci, mutanen da ke kurkuku, masu gudun hijira da kuma kungiyoyin da ba a san su ba waɗanda ke buƙatar tallafin gwamnati.
Gwamnatocin ƙasa sun hana tasirin tattalin arziki da zamantakewar al'umma daga rikicin COVID-19.
Cibiyar hadin gwiwar tattalin arziki da ci gaba ta kafa wani dandamali don samar da cikakken bayani da kuma lokaci don amsawa ta siyasa a ƙasashen duniya, da kuma ra'ayoyi da shawarwari.
Daga 'yan sanda zuwa ingantattun tsarin kiwon lafiya da tattalin arzikin duniya don nuna tasirin hana zirga-zirga da dakatar da tafiye-tafiye, jigon dijital na' yan sanda na ƙasa ya ƙunshi, kuma yana da niyyar taimaka wa ƙasashe su koya wa juna da sauƙaƙe haɗin gwiwar duniya don yaƙar cutar coronavirus.
Majalisar Dinkin Duniya da kuma ministan kula da ma'aikatar kasar Birtaniya Michael Gove da dan shugaban Brazil Eduardo Bolsonaro sun soki gwamnatin Sin saboda rashin kula da annobar, wacce ta barke a Sin a yankin Hubei.
An kori wasu 'yan tawayen Shuwa daga yankin Sin daga kokarin da ake yi na kwace yankin Sin, a matsayin wata alama ta rashin jin daɗi da aka nuna ta hanyar da aka yi wa siyasa a yankin.
Wasu masu sharhi sun yi imanin cewa an yi wannan yunkurin ne don kare babban sakataren jam'iyyar Shu Shu Xi Jinping daga yunwa a lokacin barkewar cutar.
Wasu daga cikin jami'an Sin, kamar Shuang Lijian sun yi watsi da amincewar farko da cutar coronavirus ta barke a birnin Wan, suna goyon bayan shirin COVID-19 na Amurka ko Italiya.
Gwamnatin Donald Trump ta kira wannan cutar "Covid-19" ko "Covid-19", tana mai cewa masu kula da cutar ta korona sun bunkasa cutar da ta zama annoba a duniya.
Shafin Daily Beast ya ruwaito cewa wani bangare na shirin na Majalisar Dinkin Duniya yana yin yarjejeniyar musayarwa tare da wani babban jami'in tsaro na kasa, kuma an tsara dabarun da aka kira "Dukkanin Sin".
An gaya mana mu yi ƙoƙari mu watsa saƙon ta kowane hali, a taron manema labarai da kuma bayyanar talabijin, majiyoyi kamar 'yan siyasa,' yan sanda na ƙasashen waje da Bloomberg sun bayyana cewa ƙoƙarin Sin na taimaka wa ƙasashen da ke fama da cutar wani nau'i ne na yaɗa labarin cutar.
Shugaban hukumar 'yan sanda ta Tarayyar Turai, Joseph Borel ya yi gargadin cewa asalin yanayin siyasa na rikici ga cutar ya ƙunshi hanyoyin magance siyasa da kuma nuna karimci.
Borel ya kara da cewa "Sin tana ba da saƙo da ƙarfi cewa, a matsayin Majalisar Dinkin Duniya, tana da alhakin amintaccen abokin tarayya.
Sin ta kuma nemi Majalisar Dinkin Duniya ta dauki matakin hukunta Syria, Venezuela da Iran, wadanda ta ce a baya sun ba da taimako ga kasashen biyu.
An kama kyautar Jack Ma na masks 100,000 zuwa Cuba ta sashen hukuntawa na Majalisar Dinkin Duniya a ranar 3/4.
An kuma zargi Majalisar Dinkin Duniya da sauya manufar ba da taimako daga wata ƙasa zuwa kanta.
An kuma kulla yarjejeniyar samar da abin rufe fuska tsakanin kasashen da suka hada da Jamus, Austria da Switzerland da Jamhuriyar Czech da Italiya.
Bugu da kari, Turkiyya ta kwace wasu kayan aikin sanyaya iska da aka kebe wa Spain.
A farkon watan Maris, gwamnatin Italiya ta soki rashin tallafin EU ga masu kamuwa da cutar coronavirus a Italiya.
Maurizio Massari, jakadan Italiya a EU ya ce "wani abu ne kawai da Sin ta yi da ya shafi abokan tarayya".
Hakika, wannan ba alama ce mai kyau ba ce ta goyon bayan Turai.
A ranar 22 ga Maris, bayan tattaunawa ta waya da Firayim Ministan Italiya Giuseppe Conte, Shugaban Rasha Vladimir Putin ya shirya sojojin Rasha don aika da sojojin likita, motocin kashe ƙwayoyin cuta, da sauran kayan aikin likita zuwa Italiya.
Jaridar La Stampa ta Italiya ta kawo hujja daga wani babban jami'in siyasa da ba a bayyana sunansa ba cewa kusan kashi 80 na tallafin Rasha ba su da amfani ko kuma ba su da amfani ga Italiya.
Majiyar ta zargi Rasha da yin amfani da siyasa da diflomasiyya wajen magance matsalar da kuma kai hari kan bangarorin.
Shugaban Lombard, Attilio Fontana da Ministan Harkokin Wajen Italiya Luigi Di Maio sun yi watsi da rahotannin kafofin watsa labarai kuma sun yi godiya.
Rasha ta kuma aika da jirgin sama mai dauke da kayan aikin likitanci zuwa Amurka.
"A lokacin da yake aikawa da agaji ga Majalisar Dinkin Duniya, Putin ya ce idan masana'antar ta Majalisar Dinkin Duniya ta kawo kayan aikin likitanci da kayan aiki, za su kasance a shirye don musayar idan ya cancanta", in ji kakakin Kremlin Dmitry Pesgov.
A lokacin da aka fara gudanar da atisayen, an yi amfani da wasu daga cikin manyan jiragen sama da aka yi amfani da su a cikin jirgin sama.
Kamfanin yakin basasa na Janar Kate Hudson ya soki horon soja na 2020 na lauya, "A cikin rikicin kiwon lafiyar jama'a na yanzu, wannan yana sanya rayuwar mutane cikin haɗari ba kawai sojojin Majalisar Dinkin Duniya da yawancin ƙasashen Turai ba amma kuma yawan mutanen da ke yin hakan".
Shugaban Iran Hassan Rouhani ya rubuta wata wasika ga shugabannin duniya yana neman taimako a ranar 14/3/2020, yana mai cewa kasarsa na fama da yaduwar cutar saboda rashin samun damar shiga kasuwannin duniya a matsayin wani ɓangare na takunkumin Majalisar Dinkin Duniya kan Iran, yaduwar cutar ta sa aka tuntubi Majalisar Dinkin Duniya kai tsaye don ɗaukar matakan zamantakewar al'umma a ƙasashe masu tasowa, wanda ya haɗa da kula da lafiya ta duniya, kula da yara na duniya, hukumar kula da iyali, da kuma manyan matakan biyan kuɗi don lafiyar jama'a.
Masu sharhi kan siyasa sun yi hasashen cewa hakan na iya shafar nasarar da Trump ya samu na sake zabarsa a zaben shugaban kasa na 2020.
Koriya ta Kudu ta soki "kokarinta na munafunci da rashin ƙarfi" na Japan.
Kungiyar Koriya ta Kudu ta rabu biyu game da yadda Shugaba Moon Jae-in ya amsa rikicin.
Yawancin 'yan Koriya sun yi korafin cewa ko dai a gurfanar da Maw don laifin rashin kula da yaduwar cutar. Ko kuma a bayyana kokarinsa. Cutar ta ba da damar ƙasashe su zartar da dokoki a cikin gaggawa.
Wasu masu sharhi sun yi jayayya cewa hakan zai ba gwamnatoci damar ƙara iko.
A Hungary, majalisar ta kada kuri'ar ba Firayim Minista Viktor Orban damar fitar da dokar hana fita, da kuma dakatar da majalisa da zaben da kuma hukunta wadanda suka yada labaran karya game da cutar da kuma yadda gwamnati ke magance rikicin.
An zargi yaduwar cutar coronavirus da misalai kamar raguwar tallafi. hana karuwar amfani da kayan yaƙi yayin da cutar ke yaduwa a duniya, tsada, da mawuyacin yanayi ga masana'antu da ayyukan sufuri na soja.
Hukumar Abinci da Magunguna ta Majalisar Dinkin Duniya ta bayyana matsalar karancin magunguna da kayan aikin likita saboda karuwar bukatar masu sayayya da kuma tara kayan aiki a cikin mawuyacin hali.
Yawancin yankuna sun ga tsada mai yawa tare da ɗakunan ajiya marasa amfani, kamar abinci, kayan wanka, da ruwa, wanda ke nuna rashin kayan aiki.
Masana'antar fasaha ta musamman tana faɗakar da mu game da jinkirin jigilar kayan lantarki.
A cewar Darakta Janar na Hukumar Lafiya ta Duniya Tedros Adhanom, bukatar kayan kariya ta mutum ya karu da kashi 100.
Wannan bukatar ta kara farashin zuwa 20 na al'ada. Sun kuma yarda da jinkirta kayan aikin likita na watanni hudu zuwa shida.
Hakan ya kuma haifar da raguwar kayan aikin kariya na mutum a duk duniya, tare da gargadin Hukumar Lafiya ta Duniya cewa wannan yana haifar da haɗarin lafiyar ma'aikata.
A Ostiraliya, annobar ta ba da sabon dama ga shagunan sayar da kayayyakin Australiya a Sin.
Wannan ya haifar da matsalar karancin madarar jarirai ga manyan kantunan sayar da abinci kuma daga baya gwamnatin Australiya ta dakatar da shi. Duk da haka, yawan adadin COVID-19 a arewacin Italiya da yankuna, da kuma buƙatar abinci mai kyau, duk yankuna biyu sun sha wahala daga karancin abinci.
China da Italiya sun yi nasara wajen neman tallafin abinci da kudade da kuma cinikin kayayyakin da aka yi zargi, suna guje wa matsalar karancin abinci da ake tsammani a Turai da Arewacin Amurka.
Ba a samu raguwar yawan kayan gona a arewacin Italiya ba, amma farashin zai iya ƙaruwa a cewar masana'antun.
Rashin kayan abinci na ɗan lokaci ne, har ma a birnin Wuhan, yayin da jami'an gwamnatin Sin suka rarraba kayan naman alade don tabbatar da cewa an rarraba abinci ga mazauna.
Akwai irin wannan doka a Italiya don buƙatar masana'antun abinci su adana abinci don gaggawa.
An ji tasirin tattalin arzikin duniya a Sin; a cewar wani rahoto na kafofin watsa labarai a ranar 16 ga Maris, tattalin arzikin kasar Sin ya yi rauni sosai a farkon watanni biyu na 2020 saboda matakan da gwamnati ta dauka don rage yaduwar cutar, kuma yawan tallace-tallace na mutum ya ragu zuwa kashi 20.5.
A matsayin babban yanki na nahiyar Sin, babban tattalin arziki da cibiyar kasuwanci ne. An yi la'akari da yaduwar cutar a matsayin babbar barazana ga tattalin arzikin duniya.
Agassi Desmarias na Sashen Kula da Tattalin Arziki ya yi hasashen cewa kasuwanni za su ci gaba da kasancewa cikin haɗari har sai an sami cikakken hoto game da sakamakon ci gaba.
A watan Janairun 2020, wasu manazarta sun yi hasashen cewa mummunan tattalin arzikin da annobar ta haifar a kan ci gaban duniya na iya zama mafi nasara fiye da barkewar cutar SARS a 2002-2004.
Wani bincike da wani kwararre a Jami'ar Washington da ke St. Louis ya yi ya nuna cewa an samu dala biliyan 300 a cikin jerin tanadin duniya da za su iya ci gaba har tsawon shekaru biyu.
Kungiyar kasashen da ke fitar da man fetur ta OPEC ta ce ta "fara aiki" bayan da farashin man ya fadi kasa sakamakon karancin bukatarsa a Sin.
An fara rufe kasuwannin duniya a ranar 24 ga watan Janairu saboda alamun karuwar masu kamuwa da COVID-19 a kasashen waje.
A ranar 27 ga Fabrairu saboda damuwa game da yaduwar cutar coronavirus, kasancewar cutar a cikin Majalisar Dinkin Duniya wanda NASDAQ-100, S&P 50, ya mamaye, Dow Jones ya ba da matsakaicin mafi munin masana'antar masana'antu a 2008 wanda ya kai maki 1,191, mafi girma a cikin rana ɗaya a cikin rikicin kuɗi na 2007-2008.
Dukkanin lokuta uku sun ƙare mako da sama da kashi 10%.
A ranar 28 ga Fabrairu, Scoob Ratings GmbH ta tabbatar da matsakaicin kudin shiga na Sin, amma ta ba da ra'ayi mara kyau.
Rikicin kuɗi ya sake farawa saboda tsoron cutar coronavirus, mafi girman adadin asarar ya kasance 16/3.
Mutane da yawa suna tunanin cewa ana iya tsammanin koma bayan tattalin arziki.
Masanin tattalin arziki Muhammad E-Erian ya gode wa babban bankin da kuma jiharsa saboda kokarin da suka yi a wannan gaggawa.
Babban bankuna sun amsa da sauri fiye da yadda suka amsa matsalar tattalin arziki ta 2008.
Balaguro yana ɗaya daga cikin mafi munin lalacewa ta hanyar dakatar da tafiye-tafiye, rufe wuraren taron jama'a da ke rufe abubuwan da ake so, da kuma shawarwarin gwamnati game da duk wani tafiya a duniya.
A sakamakon haka, an yi watsi da yawancin jiragen sama saboda raguwar buƙata, gami da British Airways, Eastern Sinais, da Qantas Airways, yayin da aka rufe yankin Flyby Airport.
Wannan ya shafi masana'antar shigo da kaya da yawa a matakin da ba a taɓa gani ba.
An kuma rufe tashoshin jirgin kasa da tashoshin jiragen ruwa da yawa.
Cutar ta shafi bikin Tsunehyun, da kuma yawancin tafiye-tafiye na yanayi da ke da alaƙa da hutun Sabuwar Shekarar Sin.
Yawancin abubuwan da suka shafi taron jama'a da aka hana su daga gwamnatocin ƙasa da na yanki, ciki har da bikin Sabuwar Shekara na shekara-shekara, kamfanoni masu zaman kansu sun dakatar da balaguro zuwa Hong Kong Disneyland da Shanghai Disneyland.
An dakatar da bukukuwan Sabuwar Shekara da tafiye-tafiye da yawa don hana taron jama'a, misali, garin da aka haramta a Beijing da kuma ci gaban al'adun gargajiya.
A cikin larduna 24, birni da yankuna 31 na Sin, gwamnati ta tsawaita hutun shekara har zuwa 10/2, ta ba da shawarar cewa ba za a iya buɗe wuraren kasuwanci ba har sai an sake buɗe su.
Wannan yanki ya ƙunshi kashi 80% na ma'aikatan samar da kayayyaki na kasar da kashi 90% na ƙwararrun ma'aikata.
Hong Kong ta ɗaga matakin amsawa ga kamuwa da cutar zuwa matakin mafi girma kuma ta ba da sanarwar dokar ta baci, rufe makarantu har zuwa Maris da kuma soke bikin Sabuwar Shekara.
Ziyarar kasuwanci a Turai da Latin Amurka ta ragu da kashi 40 cikin ɗari.
Kasuwancin Kudancin Amurka da Gabas ta Tsakiya sun yi asarar kashi 50-60%.
Wannan kuma ya haifar da asarar kashi 33-43% na masu tafiya a kan titi a cikin manyan kantuna a watan Maris idan aka kwatanta da Fabrairu.
Manajan manyan kantunan kasuwanci a duk duniya sun ba da shawarwari da yawa, kamar ƙara injin tsabtace jiki, samar da na'urorin duba zafin jiki ga abokan ciniki, da kuma taron jama'a. A cewar Hukumar Tattalin Arziki ta Amurka don Latin Amurka, annobar cutar za ta iya haifar da talauci ga mutane miliyan 14 zuwa 22 a Latin Amurka waɗanda ke cikin halin da ba a yi annobar ba.
A watan Janairu da Fabrairun 2020, a lokacin da annobar ta tashi a birnin Wan, kusan mutane miliyan 5 sun rasa ayyukansu a Sin.
Yawancin ma'aikatan karkara a Sin, kusan miliyan 300, an tura su gida zuwa yankunan ruwa ko kuma an tsare su a yankin Hubei. A watan Maris na 2020, sama da Amurkawa miliyan 10 sun dakatar da ayyukansu kuma sun nemi taimakon gwamnati.
Cutar coronavirus ta dakatar da ayyuka miliyan 47 a Amurka kuma rashin aikin yi ya kai kashi 32%. A cewar kimantawar Babban Bankin Tarayya na T. Louis, dokar hana fita a Indiya ta bar ma'aikata miliyan goma ba tare da aiki ba (wanda ake biyan su albashi na yau da kullun).
A cikin rabin rabin watan Maris, ma'aikata Faransa miliyan 4 sun nemi biyan bashin rashin aikin yi da ma'aikata na Burtaniya miliyan 1 suka nemi shirin biyan kuɗi na duniya. Kusan kamfanoni miliyan rabin a Jamus sun ba da kuɗin gwamnati ga ma'aikatansu ta hanyar shirin gajeren lokaci wanda aka sani da Kurzarbit.
An yi amfani da shirin rarraba kuɗin aiki na ɗan lokaci na Jamus a Faransa da Ingila.
Ayyukan fasaha da al'adun gargajiya sun yi tasiri sosai ta hanyar cutar, kuma sun shafi ayyukan da aka hana, wanda ya shafi ma'aikata da masu sha'awar duniya.
Ƙungiyoyin al'adu da al'adu sun yi ƙoƙari su haɓaka (kuɗin da aka tara) don samar da damar yin amfani da kayan tarihi ga al'umma, ci gaba da kiyaye wuraren su da kuma tallafawa masu fasaha idan ya cancanta.
A cikin Maris 2020, a duk duniya, jami'o'i, gidajen tarihi, dakunan karatu, wuraren gabatarwa da sauran cibiyoyin birni sun rufe ba tare da sanarwa ba kuma an soke ko kuma an jinkirta baje kolin, abubuwan da suka faru da gabatarwa.
A cikin martani ga ƙoƙarin da aka yi na yin hidima ta hanyar dandamali na dijital, sabon cutar da cutar ta haifar da mummunan cutar ta dakatar da ayyukan addini da wasanni da abubuwan da suka shafi zamantakewa, kamar bukukuwa da kide-kide da taron fasaha da kuma nuna samfurin.
An kuma yi wa fim din kwalliya, kuma Vatican ta sanar da cewa an soke mako mai tsarki a birnin Rome, wanda ke cikin karshen mako na tuba na Krista a lokacin Lent.
Yawancin limamai sun gaya wa tsofaffin Kiristoci su zauna a gida kuma kada su halarci ayyukan ibada a ranar Lahadi; wasu majami'u suna ba da sabis na addini ta hanyar rediyo ko kai tsaye ta yanar gizo ko talabijin, yayin da wasu ke ba da sabis a kan titi.
Tare da rufe cocin Roman Katolika a Rome, an rufe majami'u da rassa da wuraren ibada na Krista, kuma mutane na wasu addinai sun dakatar da ayyukansu da tarurruka a majami'u da masallatai da wuraren ibada na Yahudanci da wuraren ibada na Sikh.
Ministan lafiya na Iran ya ce an rufe sallar Juma'a da masallatai a yankunan da cutar ta shafa, kuma Saudiyya ta dakatar da masu aikin hajji daga kasashen waje zuwa wuraren ibada na Makka da Madina.
Cutar ta haifar da babbar matsalar hana ayyukan wasanni a duk duniya tun bayan Yaƙin Duniya na II.
Yawancin abubuwan wasanni an dakatar da su ko an jinkirta su, gami da gasar cin kofin zakarun Turai ta 2019-2020, gasar Premier ta 2019-2020, kakar NBA ta 2019-2020, kakar NHL ta 2019-20.[1]
Cutar ta haifar da matsala ga shirye-shiryen wasannin Olympics na bazara na 2020, wanda aka shirya gudanarwa a watan Yuli. Kwamitin Olympics na kasa ya sanar a ranar 24/3 cewa an jinkirta gasar Olympics zuwa bayan 2020 amma ba za a jinkirta zuwa bayan bazara na 2021 ba, an rufe gidajen caca a duk duniya kuma an dakatar da ko an jinkirta wasannin caca.
Wannan ya sa masu caca suka shiga cikin yanar gizo, shafukan yanar gizo da yawa na caca sun sami karuwar sabbin masu shiga, wuraren nishaɗin jama'a sun lalace, kuma ƙungiyoyin kiɗa sun jinkirta ko dakatar da wasan kwaikwayon yayin da cutar ta fara.
Yawancin wasan kwaikwayo na Broadway sun dakatar da duk ayyukan su.
Wasu masu fasaha sun yi ƙoƙari su gwada sababbin hanyoyin da za su samar da kayayyakinsu da kuma rarraba ayyukansu a kan Intanit a matsayin wani zaɓi don nuna al'adun rayuwa, kamar ƙirƙirar wasan kwaikwayo na kan layi ko ƙirƙirar shafukan yanar gizo na bikin don masu fasaha su bayyana.
A kan layi, an buga abubuwa da yawa na ban dariya game da cutar coronavirus waɗanda ke ɗauke da kurakurai da matsaloli.
Tun bayan barkewar COVID-19, an lura da ƙiyayya da yawa, tsoron maƙwabta, da wariyar launin fata tsakanin Sinawa da mutanen kudu maso gabashin Asiya, da kuma mutanen da ke cikin yankuna na siyasa na Turai, Majalisar Dinkin Duniya da sauran ƙasashe.
An lura da mummunan hali da rashin amincewa a ƙasashe da yawa, musamman a Turai, Gabashin Asiya, Arewacin Amurka, da yankin Asiya ta Pacific.
Rahotanni daga watan Fabrairu (lokacin da yawancin cututtukan ke faruwa a Sin) sun nuna cewa kungiyoyin cutar a duniya suna nuna wariyar launin fata da ke cewa mutanen Sin sun cancanci cutar ko kuma sun hana abin da suke so a matsayin abin da ya dace.
Wasu kasashen Afirka ma sun nuna tsananin nuna wariya ga 'yan kabilar Sin.
Yawancin mazauna biranen Wan da Hubei sun bayyana rabuwa saboda asalin yankin.
Akwai tallafi ga masu shayarwa, ta hanyar kai tsaye da kuma ta hanyar layi, suna ba da taimako ga yankunan da ke fama da cutar.
An samu karuwar yaduwar cutar a kasashe masu tasowa. Italiya, kasar Turai ta farko da aka samu karin masu dauke da cutar COVID-19, ta haifar da shakku da fargaba. Mutane a Malaysia, New Zealand, Singapore da Koriya ta Kudu sun yi korafi kan hana 'yan kasar Sin shiga kasarsu, a kokarin dakile cutar.
A Japan hashtag #Sinanci_Maje_zuwa_Japan ya mamaye Twitter.
Sinawa kamar sauran Asiya a Burtaniya da Amurka sun ba da rahoton karuwar launin fata na Farisa, da kuma hare-haren tunanin mutum.
Shugaban Amurka Donald Trump ya fuskanci suka saboda ambaton coronavirus a matsayin "Covid-19", wanda masu sukar suka kira wariyar launin fata da kuma anti-Covid.
Masu zanga-zangar na Ukraine sun kai hari kan bas din da ke dauke da 'yan Ukraine da' yan kasashen waje da aka kawo daga birnin Van zuwa Novi Sanjari.
Masu binciken sun fito ne daga arewacin Indiya da ke makwabtaka da Sin, kuma sun gudanar da gwaje-gwaje masu yawa na kimiyya kan yaduwar cutar coronavirus a jami'o'in Indiya da yawa.
Shugaban jam'iyyar Bharatiya Janata Party a West Bengal, Dilip Bhashe ya ce 'yan Sin sun lalata dabi'arsu kuma "wannan shine hukuncin Allah a kansu".
Daga bisani sai aka yi ta yin zanga-zanga a kan 'yan kasar Sin da ke Kolkata, wanda aka kira "kuskuren bayanai". A Sindh, an yi ta nuna nuna nuna wariyar launin fata da nuna wariyar launin fata ga 'yan kasar Sin da ke zaune a kasar saboda annobar, kuma an bayyana su a matsayin "waɗanda suka rage" da nufin fitar da su.
Yawancin 'yan jarida da ke da shafukan yanar gizo sun share labaran su saboda labarin cutar coronavirus.
Yawancin masu wallafa labaran kimiyya sun yi magana game da yaduwar cutar yayin da aka raba labarin.
Wasu masana kimiyya sun zaɓi buga sakamakon su da sauri a kan layi kamar shafin yanar gizon bioRxiv.
Bayyanar cutar - Bayyanar dalilin da yasa cutar ta kamu da cutar, bambanci ne a cikin yadda ake yaduwa da kuma watsa su.
Duniya da cututtuka - Ƙididdigar duniya da cututtuka masu yaduwa.
Jerin cututtuka da annoba - jerin mutanen da suka mutu saboda wata cuta.
Sufuri da kuma warewar namun daji - Akwai haɗarin kiwon lafiya da ke tattare da cinikin namun daji.
Gwaje-gwajen dakin gwaje-gwaje don cutar numfashi ta cutar coronavirus ta 2019 (COVID-19) da kuma alaƙar SARS-CoV-2 sun haɗa da abubuwan da ke bincika don gano cutar da kuma waɗanda ke bincika samar da ƙwayoyin cuta ga kamuwa da cuta.
Ana iya gano cutar a cikin samfuran ta hanyar RT-PCR wanda ke nazarin RNA na coronavirus.
Wannan gwajin na musamman ne kuma an tsara shi ne kawai don nazarin RNA na SARS-CoV-2.
Ana amfani da wannan don yin amfani da sabon ƙwayar cuta mai aiki.
Ana iya amfani da nazarin antibody don ganewar asali da kuma lura da yawan jama'a.
Gwaje-gwaje na antibody ya nuna yawan mutanen da ke da cutar, wanda ya haɗa da waɗanda ba su da alamun bayyanar cututtuka da kuma waɗanda ba su da alamun bayyanar cututtuka.
Ana iya ƙayyade ainihin mutuwar cutar da yawan mutuwar jama'a ta hanyar gwaje-gwaje.
A cewar gwajin iyaka, a watan Maris na 2020, babu wata ƙasa da ke da ingantaccen bayani game da yaduwar cutar a cikin jama'arta.
A ranar 23 ga Maris, babu wata ƙasa da ta yi gwajin fiye da kashi 3% na yawanta.
Wannan bambancin yana zama babban tasiri ga yawan cututtukan cututtuka, wanda ke fuskantar ƙimar da ta dace a wasu ƙasashe.
Ana iya yin gwajin ta amfani da kwafin kwayar halittar polymerase chain reaction (rRT-PCR) akan samfurin cutar numfashi da nau'in kwayar cutar ta samu.
Sakamakon zai kasance a cikin sa'a daya zuwa kwana biyu.
Gwajin RT-PCR da aka yi tare da gwajin ƙwayar cuta shine kawai gwajin da za a iya dogara da shi a farkon makon cutar.
Daga nan kwayar cutar za ta iya ɓace a cikin iska yayin da take ci gaba da ƙaruwa a cikin huhu.
Ga mutanen da ke da cutar sankarar jiki a mako na biyu, ana iya ɗaukar samfurin daga cikin bututun mai ta hanyar na'urar gwaji ta likita ko ta hanyar yin amfani da liquefaction.
An haɓaka ɗayan gwajin PCR na farko a Jami'ar Charité a Berlin a watan Janairun 2020 wanda ke amfani da kwafin amsawar sarkar polymer (rRT-PCR). kuma an samar da kayayyakin kiwon lafiya 250,000 don rarraba ta Hukumar Lafiya ta Duniya (WHO).
Birtaniya ta haɓaka gwaji a ranar 23/1/2020. Kamfanin Cogenebiotech na Koriya ta Kudu ya gano sabuwar hanyar shiga likita, PCR mai dogaro da SARS-CoV-2 (Gano ƙarfin kwayar cutar coronavirus) a ranar 28/1/2020.
Gwajin ya bincika kwayoyin halitta na "E" wanda ke yaduwa a cikin dukkan masu karɓar kwayar cutar coronavirus, da kuma kwayoyin halitta na SARS-CoV-2 na musamman na RdRp.A Sin, BGI Group na ɗaya daga cikin kamfanoni na farko da suka karɓi kayan gaggawa daga Ma'aikatar Kula da Kiwon Lafiya ta Sin, kayan aikin PCR na SARS-CoV-2 na Amurka da Cibiyar Kula da Cututtuka da Cututtuka (CDC) sun ba da sabon gwajin coronavirus 2019 (RT-PCR) don ba da tabarau ga dakunan gwaje-gwajen kiwon lafiya na jama'a ta hanyar hanyoyin bincike na duniya.
Wani gwaji na kwayoyin halitta don samfurin gwajin ya haifar da sakamakon rashin inganci saboda amfani da magungunan gwaji da gilashin gwaji a CDC a Atlanta; wannan ya haifar da ƙarancin alamun 100 a kowace rana a cikin Fabrairu 2020.
Ba a tabbatar da gwajin da aka yi amfani da abubuwa biyu ba a ranar 28/2/2020. Har zuwa lokacin ba a sanar da cewa an ba da izinin gwaje-gwaje na gida da na jihohi don yin gwajin ba.
Hukumar Abinci da Magunguna ta amince da gwajin a karkashin kulawar gwamnati a cikin gaggawa. Dakunan gwaje-gwaje na Majalisar Dinkin Duniya sun fara gwajin a farkon Maris 2020.
A ranar 5/3/2020 LabCorp ya sanar da wadatar gwajin COVID-19 na ƙasa wanda ya dogara da RT-PCR.
Hukumar Kula da Kula da Cututtuka ta CDC ta kuma fitar da jerin abubuwan da ke nuna cutar COVID-19 a duk fadin kasar a ranar 9/3/2020.
Ba a ba da umarnin ƙayyadaddun bayanai ba, ana buƙatar tattara samfurori da bin diddigin da aka tsara bisa ga umarnin CDC.
A Rasha, Cibiyar Nazarin Kwayoyin Cutar Kwayoyin Cutar VECTOR ce ta haɓaka da kuma samar da gwajin COVID-19.
A ranar 11/2/2020 ne aka yi rajistar gwajin ta Hukumar Kula da Kiwon Lafiya ta Tarayya. A ranar 12/3/2020, Mayo Medical ta sanar da cewa ta haɓaka gwajin don nazarin kamuwa da COVID-19. A ranar 13/3/2020, Hukumar Kula da Cututtukan Cututtuka ta Roche ta sami amincewar FDA don gwajin da za a iya yi a cikin awanni 3.5 a cikin masu fama da cutar, don haka ba da damar na'urar da za ta iya yin gwaje-gwaje 4,128 a cikin awanni 24.
A ranar 19/3/2020, FDA ta ba da izinin EUA ga Abbott Laboratories don gwaji a kan tsarin Abbott na mita 2000. FDA ta ba da izinin izini na farko ga Hologic, LabCorp da Sermo Fisher Scientific.
A ranar 21/3/2020, Cifid ya kuma sami izinin EUA daga FDA don gudanar da gwajin da ya ɗauki minti 45.
FDA ta amince da gwajin da ke amfani da fasahar hada nucleic acid maimakon PCR.
Saboda wannan ba ya buƙatar jerin canje-canje na zafin jiki, wannan hanyar tana iya ba da sakamako mai kyau a cikin minti 5 da sakamako mara kyau a cikin minti 13.
A halin yanzu akwai kusan 18,000 na irin waɗannan na'urori a cikin Majalisar Dinkin Duniya. Kuma Abbott yana tsammanin haɓaka wannan adadin don yin gwaje-gwaje 50,000 a kowace rana. Gwajin da ke amfani da bayanan antibody da kuma haɗin haɗin N-protein na sabon coronavirus ana haɓaka shi a Taiwan, tare da fatan zai iya ba da sakamako daidai cikin mintuna 15 zuwa 20 kamar yadda gwajin saurin mura yake.
Wani bita na wallafe-wallafen Maris 2020 ya bayyana cewa "Hotunan kirji suna taka rawar gani a cikin gano cutar a farkon matakan. Yayin da aka gano a cikin CT (hoto na kirji mai ƙidaya) na iya kasancewa tun kafin bayyanar cututtuka. "
Hanyoyin yau da kullum a kan CT sun haɗa da na'urar da ke da nau'i biyu na gilashi da na'urar hoto da na'urar da ba ta dace ba da kuma rarraba baya.
Ana kula da cutar subplural, rashin hankali da rigidity a matsayin ciwon ci gaba.
Wani bincike na kimiyya wanda ya kwatanta PCR da CT a birnin Wuhan a farkon annobar ya nuna cewa CT ya fi dacewa da PCR, kodayake ba shi da cikakkiyar bayani, tare da nuna bambancin yanayin da ke tattare da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututututtukan cututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
A watan Maris na 2020, Kwalejin Radiology ta Amurka ta ba da sanarwar cewa "Ba za a iya amfani da CP don gwajin gano COVID-19 ba". A watan Maris na 2020, CDC za ta sanar da amincewa da PCR don maganin farko.
Wani ɓangare na amsawar rigakafi ga kamuwa da cuta shine samar da ƙwayoyin cuta waɗanda suka haɗa da IgM da IgG.
Ana iya amfani da waɗannan don yin bincike a kan mutane a cikin kwanaki 7 na farkon kamuwa da cuta ko bayan bayyanar cututtuka na farko don tantance rigakafi da kuma gano cutar a cikin masu ilimin lissafi. Ana iya yin gwaje-gwaje a cibiyoyin bincike (CLT) ko ta hanyar gwajin wuri (PoCT).
Babban adadin tsarin sarrafa kansa zai kasance a cikin dakunan gwaje-gwaje na likita don yin waɗannan gwaje-gwaje amma samunsu ya dogara da matsakaicin samarwa ga kowane tsarin.
Don CLT ana amfani da samfurin jini na waje, duk da haka ana iya amfani da jerin samfurin don jinkirta amsawar yanke.
Don PoCT ana samo samfurin jini ta hanyar huda fata.
Ba kamar matakan PCR ba, ba a buƙatar matakin fitarwa kafin gwajin. A ranar 26/3/2020, FDA ta buga sunayen hukumomin izini 29 waɗanda suka ba da sanarwar amfani da shi kamar yadda aka buƙata kuma yanzu suna nan don rarraba maganin gwajin su.
A ranar 7/4/2020, FDA ta amince da gwajin guda ɗaya kawai a ƙarƙashin ikon amfani da gaggawa.A ƙarshen Maris 2020, Cibiyar Nazarin Magunguna ta Urine da Epithet ta sami amincewar Turai don kayan aikin su na gwaji, wanda zai iya bincika antibodies IgG da IgA akan kwayar cutar a cikin samfurin jini.
Gwajin yana iya ɗaukar samfuran sa'a ɗaya kuma saboda haka ya fi sauri fiye da gwajin PCR na yau da kullun don RNA na kwayar cutar.
Ana iya gano ƙwayoyin cuta a cikin kwanaki 14 na farkon kamuwa da cuta, kuma a farkon Afrilu Birtaniya ba ta sami ƙwayoyin cuta a cikin dakin gwaje-gwaje ba, don haka ta sayi ƙwayoyin cuta waɗanda suka dace don amfani.
Hong Kong ta tsara shirin da ke ba da damar marasa lafiya da ake zargi su zauna a gida, sashen gaggawa zai ba marasa lafiya sirinji don karɓar samfurin, su yi amfani da shi kuma su dawo da shi sannan su karɓi sakamakon gwaje-gwajen. NHS na Burtaniya ta ba da sanarwar cewa za ta gwada shirin don bincika waɗanda ake zargi a gida, waɗanda ke da haɗarin kamuwa da cutar ta hanyar mai haƙuri idan sun zo asibiti ko kuma idan an buƙaci motar asibiti.
Cibiyoyin bayar da agaji sun taimaka wa Koriya ta Kudu, suna yin wasu gwaje-gwaje mafi sauri da yawa a cikin ƙasar. A Jamus, Kungiyar Kula da Kula da Lafiya ta Duniya ta Duniya ta ce a ranar 2/4 tana da damar yin gwaje-gwaje 12,000 a kowace rana a cikin aikin yawo, kuma an gudanar da gwaje-gwaje 10,700 a makon da ya gabata.
Asusun inshorar lafiya zai biya kuɗin idan likita ya nemi a yi gwajin.
A cewar shugaban cibiyar Robert Koch, Jamus na da damar yin gwaje-gwaje sama da 160,000 a kowane mako.
An gabatar da gwajin balaguro a manyan birane da yawa a ranar 19 ga Maris.
A ranar 26/3/2020, ba a san yawan gwaje-gwajen da aka yi a Jamus ba, saboda sakamakon tabbatacce ne kawai aka bayar.
Gidan gwaje-gwaje na farko ya nuna cewa a cikin mako na 12/2020 an yi aƙalla samfuran 483,295 da aka yi wa allurar rigakafi kuma an sami sakamako mai kyau na SARS-CoV-2 tsakanin mako na 12/2020 da 33,491 (6.9%). A Isra'ila, masu bincike a asibitin Teknion da Rambam sun haɓaka da gwada sabuwar hanyar don bincika samfuran ga marasa lafiya 64 a lokaci guda, tare da tattara samfuran da kuma yin cikakken bincike don tabbatar da yiwuwar tabbataccen samfurin hade.
Ta hanyar sa ido ta hanyar wanda ya kafa BGI Wang Jian da kuma kwanaki 5, ayyukan sun nuna cewa yawan masu cutar a Hubei zai kasance sama da kashi 47% kuma farashin da aka ƙayyade na ƙoƙarin keɓewa zai ninka idan ba a sami damar gwaji ba.
An haɗa dakin gwaje-gwaje na Wan kai tsaye da dakin gwaje-gwaje na Hu-Yan a Shenzhen da Tianjin da Beijing da Shanghai a cikin birane 21 na kasar Sin.
A ranar 4/3/2020, yawan gwajin yau da kullun ya kai 50,000 a kowace rana. An buga taswirar taswirar tushen budewa, wanda aka ba da sanarwar ta hanyar gwajin Origami wanda zai iya gwada samfurori 1122 na marasa lafiya don COVID-19 ta amfani da gwaje-gwaje 93 kawai. Ana iya amfani da waɗannan taswirar a cikin ƙananan dakunan gwaje-gwaje ba tare da buƙatar na'urar gwajin ruwa ba.
A watan Maris, saboda karancin gilashin sinadarai, an yi amfani da gilashin mulberry don gwaje-gwaje masu ƙarfi a Turai da Burtaniya.
Wannan ya sa marubuta suyi nazarin tsarin shirye-shiryen gwaji wanda ya hada da samfurin a zafin jiki na 98 ° C (208 ° F) na minti 5 don nuna kwayoyin RNA don cikakken gwaji. An sanar a ranar 31 ga Maris cewa UAE tana yin gwajin coronavirus ga kowane mutum fiye da sauran ƙasashe, kuma suna ƙoƙari su haɓaka matakan gwaji zuwa mafi girman yawan jama'a.
Wannan ya danganta da haɗin ƙarfin gwajin mai tafiya da siyan kayan aikin dakin gwaje-gwaje daga ƙungiyoyi 42 da BGI (wanda ke da alaƙa da dakin gwaje-gwaje na gaggawa na Hu-Wan a Sin).
Tare da kiyaye su har tsawon kwanaki 14, dakin gwaje-gwaje na iya yin gwaje-gwaje 10,000 na ST-PCR a kowace rana kuma kashi na farko da aka rubuta a waje da Sin.
An samar da gwaje-gwaje daban-daban na masu karɓar kwayoyin don gano nau'ikan kwayoyin cutar coronavirus a China, Faransa, Jamus, Hong Kong da Majalisar Dinkin Duniya.
Hukumar Lafiya ta Duniya ta ɗauki ra'ayin Jamus don samar da kayan gwaji da aikawa ga ƙasashe matalauta waɗanda ba su da albarkatun da za su haɓaka kayan aikin kansu.
An fitar da ra'ayin Jamus a ranar 17/2/2020, yarjejeniyar da Cibiyar Kula da Cututtuka ta Majalisar Dinkin Duniya ta haɓaka ba ta samuwa har zuwa 28/2, jinkirin samun gwajin a Sin da Majalisar Dinkin Duniya.
A akasin wannan, masana sun ce yawan gwajin da Koriya ta Kudu ta yi ya taimaka wajen rage yaduwar sabon coronavirus.
An samar da gwaje-gwaje masu yawa, masu zaman kansu na musamman a cikin shekaru da yawa a kan gwamnatin Koriya ta Kudu.
A ranar 16 ga Maris, Hukumar Lafiya ta Duniya ta yi kira da a kara yawan shirye-shiryen rarrabawa don inganta yanayin cutar ta COVID-19. Babban buƙatar gwaji saboda yaduwar cutar ya haifar da dubban gwaje-gwaje da ba a yi ba a dakunan gwaje-gwaje na Majalisar Dinkin Duniya, da kuma samar da kayan gwaji da gilashin sinadarai.
A watan Maris na 2020, Sin ta ba da rahoton cewa akwai matsala game da daidaito da daidaito na kayan aikin da aka yi.
A Amurka an samar da kayan gwaji a cikin CDC wanda ke da kuskure sannan gwamnati ta kawar da shingen doka, wanda ya hana su yin gwaji na musamman. Spain ta sayi kayan gwaji daga kamfanin Sin Xinjiang Biotechnology Biotechnology Co Ltd, amma ta gano cewa sakamakon bai dace ba.
Kamfanin ya bayyana cewa sakamakon da ba daidai ba na iya zama sakamakon kuskuren tattara samfurori ko kuskuren amfani da kayan aiki.
Ma'aikatar ta Spain ta ce za ta mayar da kayan aikin da ke ba da sakamako mara kyau, kuma za ta maye gurbin su da kayan aikin gwaji daban-daban da aka kawo daga Shenzhen Biodiesel. 80% na kayan aikin da Jamhuriyar Czech ta saya daga Sin sun ba da sakamako mara kyau. Slovakia ta sayi kayan aikin gwaji miliyan 1.2 daga Sin wanda ya zama ba daidai ba.
Firayim Ministan Slovakia Matovic ya ba da shawarar a tura su zuwa Danube. Atis Kara na Ma'aikatar Lafiya ta Turkiyya ya ce kayan aikin gwajin da Turkiyya ta saya daga Sin "sun yi kuskure sosai", kuma "ba a yi amfani da su ba". Birtaniya ta sayi kayan aikin gwaji miliyan 3.5 daga Sin amma a farkon Afrilu 2020 ta ce ba su da amfani.
Ana iya yin gwaji, keɓe waɗanda suka gwada tabbatacce da kuma gano waɗanda suka taɓa yin hulɗa da masu cutar SARS-CoV-2 da kuma waɗanda suka kamu da cutar tun lokacin da suka kamu da cutar.
Masu binciken sun yi aiki a garin Voye na Italiya, inda aka fara samun mutuwar COVID-19. sun gudanar da gwaje-gwaje biyu ga dukkan ma'aikatan, kusan mutane 3,400, a cikin kwanaki goma.
Kusan rabin mutanen da suka gwada tabbatacce ba su da alamun cutar, kuma duk waɗanda aka gano an killace su.
Ta hanyar tafiya zuwa yankuna na musamman, ba a kawar da sabon yanayin ba.
Tare da tsauraran matakan bincike, ƙuntata ƙa'idodin tafiye-tafiye, da gwaji da keɓewa, annobar COVID-19 a Singapore ta bazu a hankali fiye da sauran ƙasashe masu tasowa.
An soke wasu abubuwan da suka faru, kuma Singapore ta fara ba da shawarar mazauna su zauna a gida daga 28/3 amma an sake buɗe makarantu a kan lokaci bayan hutun 23/3.
Yawancin ƙasashe sun magance cutar ta hanyar keɓewa da dakatar da tafiye-tafiye, gwaji da keɓewa, amma ba tare da tsauraran ƙuntatawa na zirga-zirga kamar Iceland da Koriya ta Kudu ba.
Wani bincike ya nuna cewa ƙasashe da ke da yawan gwaje-gwaje da ke da alaƙa da yawan mutuwar suna da ƙananan adadin kisa, wanda zai iya zama dalilin da ya sa waɗannan ƙasashe suka fi dacewa don yin gwaji ga mutanen da ke da rauni ko marasa alamun cutar.
Hukumar Lafiya ta Duniya ta ce ƙasashe da ba su da ƙarfin gwaji da kuma dakunan gwaje-gwaje na ƙasa da ke da ƙwarewa game da COVID-19 za su aika da samfuran farko na biyar masu kyau da goma marasa kyau na COVID-19 zuwa ɗaya daga cikin wuraren bincike 16 na Hukumar Lafiya ta Duniya don tattara gwaje-gwaje.
Daga cikin cibiyoyin bincike 16, 7 suna cikin Asiya, 5 a Turai, 2 a Afirka, 1 a Arewacin Amurka, da 1 a Ostiraliya.
A cikin jerin, "Kwancen gwajin gwaji mai kyau" shafi ne wanda aka haɓaka ta hanyar 'yan sanda na gwaji na ƙasa.
Kasashen da ke gwada waɗanda aka kwantar a asibiti kawai suna da yawan masu cutar fiye da ƙasashen da ke gwada dukkan jama'a, ko suna da alamun cutar ko a'a, sauran abubuwa daidai ne.
Wanke hannu (ko wanke hannu), wanda aka fi sani da tsabtace hannu, shine aikin tsabtace hannu don kawar da ƙura, mai, microbes da sauran abubuwa marasa kyau.
Wanke hannu da sabulu don tabbatar da "lokacin haɗari" a cikin rana yana hana yaduwar cututtuka da yawa, misali, gudawa, kwalara da ake yadawa ta hanyar stool.
Mutane kuma suna iya kamuwa da cututtukan numfashi kamar mura ko mura, misali, idan ba su wanke hannayensu ba kafin su taɓa idanunsu ko bakinsu.
Sau biyar masu mahimmanci a rana lokacin da wanke hannu da sabulu ke da mahimmanci; kafin da bayan wankewa, bayan wanke tufafin yara ko canza jaririn jariri, kafin ciyar da yaro, kafin cin abinci da kuma bayan shirya abinci ko shirya nama, kifi, tsuntsu.
Idan sabulu da ruwa ba su da yawa, zaku iya wanke hannayenku da toka. Hukumar Lafiya ta Duniya ta ba da shawarar wanke hannu a:
Kafin da kuma bayan dafa abinci.
Kafin da kuma bayan kula da mara lafiya.
Bayan canza kayan wanka ko wanke yaro bayan ya shiga bayan gida.
Bayan cire hanci da kwayoyi da kuma pidgin.
Bayan an gama sarrafa dabbobi, abinci da kayan dabbobi.
Tsabtace lafiyar hannu tana nufin aikin tsabtace hannu wanda ya shafi kayayyakin kiwon lafiya.
Wanke hannu kafin yin aiki ko kulawar likita na iya hana ko rage yaduwar cututtuka.
Babban manufar aikin likita na wanke hannu shine tsabtace hannu daga ƙwayoyin cuta (ƙwayoyin cuta, ƙwayoyin cuta, ko wasu ƙwayoyin cuta waɗanda zasu iya haifar da cuta), da kuma sunadarai waɗanda zasu iya haifar da lahani ko cuta.
Wannan yana da mahimmanci ga mutanen da ke shirya abinci ko aiki a cikin wani yanki na likita, amma kuma yana da mahimmanci ga ayyukan jama'a.
Wanke hannu yana da fa'idodi da yawa na kiwon lafiya, gami da rage kamuwa da mura da kwayar cutar coronavirus da sauran cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Hakanan rage yawan mutuwar jarirai da aka haifa a gida.
Wani bincike na kimiyya na 2013 ya nuna cewa inganta aikin wanke hannu na iya taimakawa wajen haɓaka haɓakar yara a cikin yara a ƙarƙashin shekaru 5.
A cikin ƙasashe masu tasowa, yawan mutuwar yara da ke da alaƙa da cututtukan numfashi da zawo za a iya rage su ta hanyar gabatar da halaye daban-daban kamar wanke hannu da sabulu.
Wannan aikin mai sauƙi zai iya rage yawan mutuwar a waɗannan ƙasashe da kusan kashi 50%.
Shawarwarin likitoci sun ce wanke hannu zai iya rage kusan kashi uku na yawan cututtukan na ciki, wanda hakan zai iya zama mafi girma ta hanyar samar da ruwa mai tsafta a yankunan da ke fama da talauci.
Rage kashi 48 cikin ɗari na cututtukan gudawa ana iya danganta su da wanke hannu da sabulu. Wanke hannu da sabulu yana ɗaya daga cikin hanyoyin da suka fi dacewa da kuma mafi arha don hana gudawa da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututut
Cutar sankarar bargo, babban ɓangare na ARI shine babban dalilin mutuwar yara a ƙarƙashin shekaru biyar, tare da mutuwar kimanin miliyan 1.8 a kowace shekara.
Cutar gudawa da huhu suna kashe yara kusan miliyan 3.5 a kowace shekara.
A cewar UNICEF, wanke hannu da sabulu kafin cin abinci da bayan bayan bayan bayan gida a matsayin al'ada mai mahimmanci zai iya ceton rayukan mutane fiye da duk magunguna da magunguna, yana hana mutuwar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututututututututututututututututututut
Ana yawan haɗa wanke hannu da sauran tsabtace jiki kamar ruwa da kuma wanke ruwa da kuma wankewa.
Wanke hannu zai kuma kare ka daga kamuwa da cututtukan fata da ke yaduwa ta hanyar saduwa ta jiki.
Wani mummunar illa mai tsanani na wanke hannu shine cewa wanke hannu da yawa zai iya haifar da lalacewar fata ta hanyar bushewar fata.
Wani binciken kimiyya na Danish na 2012 ya gano cewa wanke hannu da yawa na iya haifar da ƙwanƙwasawa da yanayin fata da aka sani da ƙwanƙwasa hannu, wanda ya zama ruwan dare a cikin ma'aikatan kiwon lafiya.
Ana ganin yawan wanke hannu a matsayin daya daga cikin alamun bayyanar cututtuka na OCD.
Akwai lokuta biyar a rana da wanke hannu da sabulu ke da mahimmanci don rage haɗarin kamuwa da cuta ta hanyar stool; bayan wanka (shan fitsari da fitsari), bayan wanke tufafin yara (canza tufafi), kafin cin abinci da kafin da bayan shirya abinci ko shirya nama, kifi da kaji.
Sauran lokutan da ya kamata a yi amfani da hanyoyin wanke hannu don hana yaduwar cuta, sun haɗa da kafin da bayan maganin rauni, bayan an cire sutura ko sutura, bayan zubar da ƙazamar dabba ko sarrafa dabba, da kuma bayan zubar da ƙazamar dabba.
A ƙasashe da dama, akwai ƙananan adadin wanke hannu da sabulu.
Wani binciken wanke hannu a cikin kasashe 54 a shekarar 2015 ya nuna cewa a matsakaita kashi 38.7% na mutane suna wanke hannayensu da sabulu a gida. Wani binciken na 2014 ya nuna cewa Saudiyya tana da mafi girman adadin wanke hannu da kashi 97%, yayin da Amurka ke da matsakaiciyar kashi 77, kuma Sin tana da mafi ƙarancin wanke hannu da sabulu da kashi 23%. Akwai canje-canje da yawa na halaye yanzu don haɓaka yawan aikin wanke hannu da sabulu a lokacin da ake buƙata.
Shirin kula da lafiyar yara na asali wanda aka aiwatar a sassan Turai a Philippines misali ne mai kyau na inganta lafiyar yara da ilimi.
Ana yin gyaran gashi sau biyu a shekara. Bugu da ƙari, wanke hannayen hannu da sabulu a kowace rana, wanke hakora a kowace rana tare da wankewa, babban ɓangare na wannan shirin na duniya.
An yi wannan nasarar ne a Indonesia.
Ana iya samar da maganin ƙwayoyin cuta a kan fata ta hanyar ƙara sabulu ko taushi zuwa ruwa.
Babban aikin sabulu da ta'addanci shine rage ƙuntatawa da haɓaka ƙarfin ɗaukar hoto.
Ruwa kawai shine mai tsabtace fata saboda ƙwayoyin cuta da furotin, wanda ba ya haifar da gurɓataccen abu.
Ana iya taimakawa wajen wankewa ta hanyar ruwa mai gudana.
Sabulu mai tsauri, saboda yanayin sake amfani da shi, yana riƙe da ƙwayoyin cuta da masu amfani da su suka buƙata.
Wasu ƙananan bincike da suka yi aiki a kan kwayoyin cuta masu yaduwa a cikin sabulu mai cire ruwa sun gano cewa masu yaduwa suna ƙara kwayoyin cuta a cikin kumfa.
CDC har yanzu ta ce "sabulu mai ruwa tare da sarrafa hannu don tsabtace yana da kyau".
Sabulu masu maganin cututtukan cututtuka suna da tsada sosai don samun kulawar kiwon lafiya.
A halin yanzu, babu wata hujja da ta nuna cewa amfani da maganin rigakafi ko maganin kashe ƙwayoyin cuta zai iya haifar da rigakafin ƙwayoyin cuta a cikin yanayi.
Duk da haka, sabulu na antibacterial ya ƙunshi magungunan antibacterial na yau da kullum kamar masu samar da maganin rigakafi, wanda ke da jerin sunayen nau'o'in rigakafi ga kwayoyin.
Don haka, koda ba a gano nau'ikan rigakafin ƙwayoyin cuta ba don sabulu na ƙwayoyin cuta, ƙila ba zai zama mai tasiri kamar yadda aka tallata shi ba.
Tare da sabulu da kayan shafawa na fata, ƙwararrun kayan aiki na iya haɗawa da acid (acetic acid, ascorbic acid, lactic acid) a matsayin mai kula da pH, benzoic acid mai aiki da kwayoyin cuta da kuma kayan aikin fata (alone vera, bitamin, menisols, tsire-tsire na shuka). Wani bincike mai zurfi daga Jami'ar Oregon School of Public Health ya nuna cewa sabulu na yau da kullum kamar sabulu mai aiki yana da tasiri mai hana kwayoyin cuta da hana kwayoyin cuta daga hannayen hannu.
Ruwan zafi wanda yake da kyau don wanke hannuwanku bai isa ya kashe kwayoyin ba.
Kwayoyin cutar suna girma da sauri a zafin jiki (37 °C).
Koyaya, ruwan sabulu mai zafi ya fi tasiri fiye da ruwan sabulu mai sanyi don kawar da ƙwayoyin cuta da ƙwayoyin cuta.
Wannan ya sabawa al'adun kasa. Gwaje-gwajen kimiyya sun nuna cewa amfani da ruwan zafi ba shi da tasiri wajen rage ƙwayoyin cuta a hannayen.
Ruwan wanke hannu ko wanke hannu shine mai tsabtace hannu ba tare da amfani da ruwa ba.
A ƙarshen shekarun 1990s da farkon karni na 21, masu tsabtace hannu na giya ba tare da amfani da ruwa ba (wanda aka fi sani da tsabtace hannu na giya, kayan tsabtace giya, tsabtace hannu) sun zama masu amfani ga jama'a.
Yawancin su sun dogara ne akan isopropyl ko ethanol da aka haɗa tare da kayan shafawa na microbial kamar carbomers (polymers na acrylic acid) don maganin shafawa, ko kuma duka biyu kamar glycerin don maganin shafawa, ko kuma don sauƙaƙe amfani ko don rage tasirin bushewar barasa.
Ƙara oxygen oxide yana ƙara aikin antimicrobial. Sanitizer na hannu yana da aƙalla kashi 60% zuwa 95% na barasa wanda shine mai kashe ƙwayoyin cuta.
Magungunan shan giya suna kashe kwayoyin cuta, kwayoyin cuta masu jurewa da yawa (MRSA da VRE), tarin fuka, da wasu ƙwayoyin cuta (ciki har da HIV da cututtukan mahaifa da RSV da kwayar cutar Reno, kwayar cutar vaccina da mura da hepatitis) da fungi.
Ruwan wankewa na barasa yana kashe kashi 70% na barasa, kashi 99.97% (Logarithm na ragewa 3.5, daidai da 35 na ragewa na murya) na kwayoyin cuta a hannu 30 seconds bayan aikace-aikacen da kashi 99.99 zuwa 99.99% (4-5 logarithms na ragewa) na kwayoyin cuta a hannu minti daya bayan aikace-aikacen, wanke hannu yana da tasiri sosai akan kwayoyin cuta kuma ba shi da tasiri sosai akan kwayar cutar.
Ruwan wanke hannu mai shan giya ba shi da tasiri a kan ƙwayoyin cuta masu yaduwa (ko Norovirus) irin su ƙwayoyin cuta, wasu daga cikinsu suna haifar da cututtukan ciki, dole ne a yi amfani da kayan wankewa ko kayan wankewa don wanke hannuwan hannu ko rufe su.
Ana wanke gaba da bayan hannu biyu da tsakanin yatsunsu da ƙarshen yatsunsu na tsawon sakan 30 har sai ruwan, kumfa, ko kayan ruwa sun narke.
Dole ne a wanke yatsunsu da kyau kuma a sanya su a cikin hannu. Cibiyar Kula da Cututtuka ta Majalisar Dinkin Duniya ta ba da shawarar wanke hannu kafin wanke hannu da ruwa, musamman lokacin da hannuwan suka kasance masu datti.
Yawan waɗannan abubuwa ya dogara da sauƙin amfani da saurin kashe ƙwayoyin cuta, duk da haka, bai kamata su zama madadin wanke hannu ba sai dai idan sabulu da ruwa suna samuwa.
Yin amfani da maganin wanke hannu mai shan giya da yawa na iya haifar da bushewar fata sai dai idan an ƙara creams ko moisturizers.
Za a iya rage ko hana tasirin bushewar giya ta hanyar ƙara glycerin cream ko wasu creams na fata don aikin.
A cikin maganin likita, masu tsabtace hannu masu shan giya suna da creams na fata waɗanda ba su da yawa fiye da sabulu da takunkumin ƙwayoyin cuta da ke haifar da ciwo ko bushewar fata.
Rashin jin daɗin ƙwayar cuta, ƙwayoyin cuta na ƙwayar cuta ko rashin jin daɗin barasa ko kayan shafawa na ƙwayoyin cuta ba safai suke faruwa ba.
Ƙananan shirye-shirye don ƙara ƙuƙwalwar ajiya ya zama mafi sauƙi fiye da wanke hannu da sabulu da ruwa.
Duk da tasirin su, masu tsabtace hannu ba su wanke dukkan sassan hannu ba amma suna tsabtace su kawai.
Wannan shine lokacin da kayan wanke hannu kamar sabulu da ruwa ba su da tasiri wajen hana yaduwar cututtuka da yawa, saboda haka cututtukan har yanzu suna kan hannu.
Ƙarfin hannu mai maye yana dogara ne akan kayan aiki da kuma zane, kuma a tarihi ya kasa.
A kwanan nan, an nuna cewa magungunan da ke amfani da benzalkonium chloride suna da ci gaba da aiki na antimicrobial da aka tara bayan amfani, sabanin barasa, wanda aka nuna yana da tasiri sosai bayan sake amfani, watakila saboda yawan rashin jin daɗi na fata.
Mutane da yawa a ƙasashe masu talauci ba su da sabulu kuma suna amfani da ƙura ko toka a maimakon haka.
Ƙura ko toka na iya zama mafi tasiri fiye da ruwa kadai, amma yana iya zama ƙasa da tasiri fiye da sabulu.
Damuwa ɗaya ita ce idan ƙura ko toka ta gurɓata da ƙwayoyin cuta, zai iya ƙara yaduwar cutar maimakon rage ta.
Kamar sabulu, ƙura da toka, sun kashe kwayoyin cuta saboda haɗuwa da ruwa, suna samar da ƙwayoyin cuta.
Hukumar Lafiya ta Duniya ta ba da shawarar turɓaya da toka a matsayin madadin sabulu lokacin da sabulu bai kasance ba.
Hanyoyin wanke hannu da aka ba da shawarar Cibiyar Kula da Cututtuka ta Majalisar Dinkin Duniya don hana yaduwar cuta sun haɗa da waɗannan matakan:
Ku wanke hannuwanku da ruwan zafi da sanyi.
Ana ba da shawarar ruwan da aka yi amfani da shi saboda yana iya zama mai ƙazanta idan ya kasance a cikin ruwa, yayin da zafin jiki na ruwa ba zai zama bambanci ba.
Tsabtace hannu ya haɗa da wankewa da sabulu, bayan hannu, tsakanin yatsun hannu da ƙarƙashin ƙusa.
Sabulu yana kawar da ƙwayoyin cuta a fata, kuma binciken kimiyya ya nuna cewa mutane sun fi son wanke hannayensu a gaban sabulu fiye da wanke hannayensu da ruwa kawai.
Rub da sabulu a hannu na akalla 20 seconds.
Goge hannayenka da sabulu yana haifar da rubbing, wanda ke taimakawa wajen kawar da ƙwayoyin cuta daga fata, kuma idan ka shafe hannayenka da yawa, yawancin ƙwayoyin cuta suna kashewa.
Wanke hannaye da ruwa mai gudana.
Wanke hannuwanku a cikin ruwa zai iya datti hannayenku.
Ka bushe shi da tsabtace tsabta ko ka bar shi ya bushe a cikin iska.
Hannun rigar suna da saukin ƙazanta, mafi yawan wuraren da ke da haɗarin ƙazanta sune ƙwanƙwasawar doki, ƙaho, tsakanin yatsunsu da ƙusa.
Ƙaƙwalwar ƙusa da ƙusa na ƙusa na iya zama wurin taro na microbes.
Ana ba da shawarar sanya kayan shafawa don kare hannayen daga bushewa, bushewar fata na iya haifar da lalacewar fata wanda zai iya ƙara yawan kamuwa da cuta.
Zaɓuɓɓukan rigakafin ƙwayoyin cuta na iya kasancewa don sauƙaƙe wanke hannu lokacin da ba a samun ruwan wanka da sabulu, misali adana ruwa a cikin kwalba ko kwalban kwalba na kwalba ko amfani da toka idan ya cancanta a ƙasashe masu tasowa. A wasu lokuta don iyakance samar da ruwa (kamar makarantu ko yankunan karkara na ƙasashe masu tasowa), akwai hanyoyin adana ruwa kamar "ruwa a cikin kwalba" da sauran zaɓuɓɓuka masu arha.
A cikin ruwa mai tsabtace ruwa fasaha ce mai sauƙi ta amfani da injin da aka ɗora a kan igiya, da kuma mai amfani da ruwa don zubar da ruwa a hannayen hannu da sabulu.
Drying hannu yana da muhimmiyar mahimmanci a aikin tsabtace hannu, amma akwai wasu ra'ayoyi game da tasirin wanke hannu a cikin wanke hannu.
Wani littafi mai tasowa na bincike ya nuna cewa ɗakunan wanka suna da tsabta fiye da na'urar bushewa ta lantarki a wasu ɗakunan hannu.
A shekara ta 2008, wani bincike da Jami'ar Westminster ta London ta gudanar, wanda masana'antar samar da wankin bayan gida ta Turai ta tallafawa, don kwatanta matakan tsabtace wankin bayan gida, da kuma yanayin iska mai zafi da na'urar goge hannu.
Bayan wankewa da kuma bushe hannuwan hannu tare da na'urar bushewa mai zafi, yawan kwayoyin cuta a kan yatsunsu ya karu da kashi 194% kuma a kan hannu ya karu da kashi 254%.
Gwanin hannu mai saurin iska ya nuna cewa yawan kwayoyin cuta a kan yatsunsu ya karu da kashi 42% kuma a cikin hannuwan hannu ya karu da kashi 15%.
Bayan wankewa da kuma wanke hannu da wanke wanka, yawan kwayoyin sun ragu zuwa kashi 76 cikin dari a kan yatsunsu da kashi 77 cikin dari a cikin hannayen hannu. Masana kimiyya sun kuma gudanar da gwaje-gwaje don gano yiwuwar haɗuwa da sauran masu amfani da tawul tare da yanayin dakin a sakamakon hanyoyin wanke hannu.
Na'urar bushewa ta hannu mai inganci wacce ke fitar da iska a saurin 180m/s (650km/h;400) tana da ikon lalata kwayoyin cuta a hannu da sashi kuma tana gurɓata sauran masu amfani da tawul ɗin a ɓoye kuma tana gurɓata yanayin wanka na tsawon mita 2.
Amfani da na'urar busar da hannu mai zafi yana watsa kwayoyin cuta zuwa tsayin mita 0.25 daga na'urar.
A shekara ta 2005, wani bincike da TUV Product da Umwellet suka yi, sun kimanta hanyoyin wanke hannu.
An lura da canje-canje a cikin ƙididdigar ƙwayoyin cuta bayan wanke hannu:
Akwai masu tsabtace hannu da yawa, kuma an kwatanta tsabtace hannu da tsabtace bayan gida.
Wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke hannu da wanke.
Ya kamata a yi amfani da kayan wanke hannu da ke dauke da barasa da kashi 60 cikin dari.
Wanke hannu na likita ya zama dole bayan likitan Hungary Ignaz Semmelweis ya gano tasirinsa (a cikin 1846) a hana cututtuka a cikin yanayin asibiti.
Akwai na'urorin lantarki da ke tunatar da ma'aikatan asibiti su wanke hannayensu idan sun manta.
Wani bincike ya nuna cewa wanke hannu yana rage yawan kamuwa da cuta.
Wanke hannu na likita na akalla 15 seconds, ta amfani da sabulu mai tsabta da ruwa ko ruwa don wanke dukkan sassan hannu.
Dole ne a wanke hannaye ta hanyar haɗa da shafawa da kuma shafawa.
Idan akwai datti a ƙarƙashin yatsunsu, ana iya amfani da goga mai kaifi don cire shi.
Tun da kwayoyin cuta na iya kasancewa a cikin ruwa a kan hannayenka, yana da muhimmanci a wanke hannuwanka da kyau kuma ka bushe su da tsabta.
Bayan wankewa, dole ne a yi amfani da wanka na bayan gida don cire ruwa (ko buɗe kofar da aka rufe idan ya cancanta).
Wannan yana hana hannayen su sake gurɓata saboda fuska.
Manufar wanke hannu a tsarin kiwon lafiya shine kawar da abubuwan da ke haifar da cuta.
Jaridar New England Journal of Medicine ta ce rashin wanke hannu yana da matukar damuwa a cikin yanayin likita kuma yawancin likitoci da ma'aikatan jinya sun manta da wanke hannayensu kafin su taɓa marasa lafiya, don haka suna watsa ƙwayoyin cuta.
Wani bincike ya nuna cewa wanke hannu da kyau da sauran ayyuka na iya rage kamuwa da ƙwayoyin cuta a cikin jini da kashi 66%, Hukumar Lafiya ta Duniya ta ƙaddamar da shawarar da ta dace don wanke hannu da tsabtace hannu a bangarorin kiwon lafiya.
Za a iya samun jagorar wanke hannu ta hanyar gudanarwa a shafin yanar gizon jama'a.
An yi bincike mai kyau da Hetty da sauransu.
Masu amfani da kayan aiki na kasuwanci zasu iya gwadawa da tabbatar da tsabtace hannu, idan an buƙaci nunawa na daidaitawa.
Hukumar Lafiya ta Duniya ta ba da "lokatai biyar" don wanke hannu:
Bayan haɗuwa da jini.
Kafin aikin tsabtace microbial, da kuma
Bayan kula da marasa lafiya. Ƙarin sabulu mai tsabta (mai magani ko sabulu na antimicrobial) yana ba da aikin kashewa ta hanyar aikin wanke hannu.
Ana iya yin amfani da shi a matsayin kisa don yin tiyata ko kuma a cikin saitunan da ke da kwayoyin cuta masu yawa.
Dukkanin ƙwayoyin cuta dole ne a cire su.
Wannan aikin yana buƙatar wanke hannu da wanke hannaye har zuwa bushe, yawanci cikin minti 2-6.
Wanke hannu na dogon lokaci (minti 10) ba lallai ba ne.
A lokacin wanka, dole ne a hana ruwa mai zurfi daga komawa hannun.
Bayan an gama wanke hannu, a bushe hannayen da tawul mai tsabta kuma a sa tawul na likita.
Don rage yaduwar kwayar cutar, yana da kyau a wanke hannu ko amfani da kayan wanke hannu kafin da kuma bayan kula da mai rashin lafiya.
Don sarrafa cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Wankewa da sabulu na yau da kullun yana haifar da sau uku mafi yawan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututututututututututututututututututut
Amma sabulu da ruwa sun fi inganci fiye da maganin wanke hannu na barasa don rage cutar H1N1. cutar da ƙwayar cuta ta Clostridium a hannaye. Ayyuka don inganta tsabtace hannu a cikin ƙungiyar kiwon lafiya na iya haɓaka ilimi ga ƙungiyoyin wanke hannu, haɓaka wadatar maganin wanke hannu, da rubuta umarnin tunatarwa ga ƙungiyoyi.
Ana buƙatar ƙarin bincike don ayyukan da suka fi tasiri wajen gudanar da kiwon lafiya daban-daban.
A cikin ƙasashe masu tasowa, wanke hannu da sabulu an san shi da mahimmin kayan aiki don cimma kyakkyawan kiwon lafiya, har ma da ingantaccen abinci.
Koyaya, rashin ingantaccen ruwa mai ɗora ruwa, sabulu ko wuraren wanke hannu a cikin gidajen jama'a, makarantu da wuraren aiki ya haifar da ƙalubale don gabatar da al'adun wanke hannu a duniya.
Misali, a yawancin yankunan karkara na Afirka, ba a samun wanke hannu a kusa da gidajen wanka na jama'a da na masu zaman kansu, kodayake akwai wasu zaɓuɓɓuka masu arha don samar da wanke hannu.
Duk da haka, rashin wanke hannu zai iya haifar da rashin lafiya mai tsanani saboda rashin sabulu da ruwa.
Ƙara da kuma inganta wanke hannu da sabulu zai iya tasiri ga yanke shawara na siyasa da kuma fadada hankali game da amfanin wanke hannu da kuma kasancewa al'ada a cikin al'umma.
Don wannan ya yi aiki yadda ya kamata, ana buƙatar kulawa da kimantawa.
Wani tsarin nazarin nazarin nazarin kimiyya 70 ya nuna cewa hanyoyin zamantakewa sun fi tasiri wajen inganta wanke hannu a cikin LMICs, yayin da kamfen ɗin tallan zamantakewar ba shi da tasiri sosai. Misali na haɓaka wanke hannu a makarantu shine "Hanyar Tauraruwa Uku" ta UNICEF wanda ke ƙarfafa makarantu suyi koyi, mataki mai sauƙi don tabbatar da cewa ɗalibai suna wanke hannayensu da sabulu a tsakanin sauran buƙatun tsafta.
Lokacin da aka sami mafi ƙarancin ƙimar, ana iya canza makarantu daga tauraro ɗaya zuwa uku.
Gina wuraren wanke hannu na iya zama wani ɓangare na ƙarin kamfen na wanke hannu da aka aiwatar don rage cututtuka da mutuwar yara.
Ranar wanke hannu ta duniya wani misali ne na kamfen na wayar da kan jama'a game da wanke hannu wanda ke ƙoƙarin canza halaye, a sakamakon cutar coronavirus ta 2019-2020, UNICEF ta saki emojis na wanke hannu.
Wasu nazarin sun gano tasirin wanke hannu a ƙasashe masu tasowa waɗanda aka hana su yin hulɗa da DALY.
Koyaya, wani bita ya ba da shawarar cewa ƙara sabulu don wanke hannu ya fi tasiri fiye da ruwa da sauran kayan wanke hannu.
Tasirin wanke hannu ga lafiyar ɗan adam - musamman ga mutane a cikin mawuyacin yanayi kamar uwaye masu haihuwa ko sojoji da aka ji rauni a asibiti - an fara ba da rahoto a cikin karni na 19 ta hanyar masu binciken tsabtace hannu biyu: likitan Hungary Ignaz Semmelweis wanda ke aiki a Vienna, Austria da Florence Nightingale, wanda ya kirkiro tsarin kulawa na Ingilishi.
A lokacin, mutane da yawa sun yi imani cewa cututtuka ne ke haifar da ƙanshin ƙazanta da ake kira ƙanshin mazma.
A cikin shekarun 1980, cututtukan abinci da kuma rashin lafiyar cututtuka da ke tattare da cututtuka sun sa Cibiyar Kula da Cututtuka da Cututtuka ta Amurka ta ƙara amfani da wanke hannu a matsayin hanya mai mahimmanci don hana yaduwar cututtuka.
Barkewar cutar mura ta alade a cikin 2009 da cutar COVID-19 a cikin 2020 sun haifar da haɓaka wayar da kan jama'a game da mahimmancin wanke hannu da sabulu a ƙasashe da yawa don kare mutane daga cututtukan da ke tattare da su.
Alal misali, an rataye takardu masu taken "Hanyoyin wanke hannu da kyau" a gefen tawul a bayan gidajen wanka na jama'a da kuma bayan gida a gine-gine da filayen jiragen sama a Jamus.
Kalmar "wanke hannu" tana nufin sanar da kurma ya ɗauki alhakin abu ko ya shiga cikin shi.
Wannan ya fito ne daga wani nassi na Matiyu wanda ya nuna cewa Bilatus Bilatus ya wanke hannunsa a yanke shawarar gicciye Yesu, amma wannan ya zama sanannen magana a wasu al'ummomin Ingilishi.
A cikin littafin Shakespeare na Macbeth, Macbeth ya fara wanke hannayensa a ƙoƙarin share wani tunani mai lalata, lamirinsa yana jin laifin da ya aikata kuma ya rinjayi matarsa ta yi.
An gano cewa bayan mutane sun sami ra'ayin yin lalata, suna amfani da wanke hannu fiye da sauran abubuwa, suna amfani da kayan wanke hannu.
Bugu da ƙari, waɗanda aka tsara su wanke hannayensu bayan tunani suna da ƙarancin shiga cikin sauran ayyukan tsabta, kamar aikin sa kai.
Addinai suna bayyana wanke hannu don dalilai na tsabta da kuma alama, alamar wanke hannu, amfani da ruwa maimakon amfani da sabulu don wanke hannu yana daga cikin al'adun wanke hannu a addinai da yawa, kamar Baha'i, Hindu, Tiwilah, da Netilat Yadaim a Yahudanci, da Lavabo a addinin Kirista, da kuma Musulunci, addinai suna bayyana wanke hannu musamman bayan yin ayyuka.
Addinin Hindu, Yahudanci da Musulunci sun bukaci wanke hannu bayan bayan gida.
Har ila yau, addinin Hindu, Buddha, Sikh, Yahudanci da Musulunci sun bukaci wanke hannaye kafin da kuma bayan cin abinci.
Kula da cutar COVID-19 a wuraren aiki
Kula da haɗarin COVID-19 na wurin aiki shiri ne na samar da matakan lafiya da kiwon lafiya don sarrafa haɗari don hana cutar coronavirus ta 2019 (COVID-19).
Ingantaccen kula da haɗarin a wuraren aiki ya dogara da wurin aiki da aikin aiki, dangane da haɗarin kamuwa da cutar a cikin ma'aikatar, tsananin cutar a cikin al'umma da haɗarin abubuwan da ke tattare da ma'aikata na iya zama masu rauni ga tsayayya da COVID-19.
A cewar Hukumar Kula da Lafiya da Lafiya ta Amurka (OSHA), rashin haɗarin haɗarin aiki yana da alaƙa da mafi ƙarancin jama'a da ma'aikatan kamfanin, don haka an ba da sanarwar mahimman matakan kariya na kamuwa da cuta, wanda ya haɗa da wanke hannu da ƙarfafa ma'aikata su kasance a gida idan suna da rashin lafiya ko matsalolin numfashi da tsaftacewa na yau da kullun da kuma hana kamuwa da cuta a cikin yanayin aiki.
Babban haɗarin aiki ya haɗa da waɗanda ke buƙatar rufe hulɗa tare da mutanen da ba a san su ba ko waɗanda ake zargi da COVID-19, amma waɗanda za su iya kamuwa da cutar ta hanyar zirga-zirgar jama'a ko balaguron ƙasa da ƙasa.
Wannan ya haɗa da ma'aikata da ke hulɗa da jama'a kamar makarantu da manyan wuraren aiki na masana'antu masu ƙwarewa da kuma wasu manyan wuraren tashi.
Kula da haɗarin ga wannan rukunin, da kuma mahimman hanyoyin hana kamuwa da cuta, gami da samun iska mai kyau tare da matattarar iska mai inganci da masu kare jiki da kuma samun kayan kariya na musamman idan mutum yana da COVID-19.
OSHA ta ɗauki ma'aikatan kula da lafiya da masu kula da gawawwakin da ke da haɗarin kamuwa da COVID-19 a matsayin masu haɗari, kuma haɗarin ya ƙaru sosai idan ma'aikacin ya yi amfani da iska mai iska ko tattara samfuran waɗanda ake zargi da cutar ko waɗanda ke da cutar COVID-19.
Kula da lalacewar da ta dace ga ma'aikata da ke aiki a cikin sashen injiniya na sarrafawa kamar ɗakunan musayar iska mai matsin lamba da kayan aikin kare mutum wanda ya dace da aikin.
Barkewar COVID-19 na iya haifar da tasiri mai yawa a wuraren aiki.
Ma'aikata na iya yin watsi da aikin saboda haɗarin rashin lafiya da buƙatar kula da wasu ko tsoron kamuwa da cutar.
Abokan hulɗa na kasuwanci na iya canza buƙatun kayan da aka nema da kuma dalilin da yasa ake buƙatar waɗannan kayan (kamar su sayarwa a lokacin da mutane ke zuwa kasuwa ko kuma isar da kaya ko sayarwa).
A kwanan nan, ana iya dakatar da jiragen ruwa masu jigilar kaya a yankunan da ke fama da cutar COVID-19. Shirye-shiryen kamuwa da cuta da kuma shirin fuskantarwa za a iya amfani da su don aiwatar da ayyukan kariya.
Shirye-shiryen za su bayyana matakan haɗari dangane da wuraren aiki na cutar da ayyukan aiki, gami da tushen kamuwa da cuta da kuma daidaita abubuwan haɗari a gida da al'umma da abubuwan haɗari na mutum kamar tsofaffi ko yanayin rashin lafiya mai tsawo.
Sun kuma bayyana abubuwan da ake buƙata don magance haɗarin da kuma shirye-shiryen gaggawa don yanayin da zai iya ƙara yaduwar cutar.
Shirye-shiryen cututtuka da tsare-tsaren cututtuka na iya zama batun umarnin ƙasa da na ƙasa.
Manufofin magance cutar sun haɗa da rage yaduwar cutar a cikin ƙungiyar, kare mutanen da ke da haɗarin kamuwa da cuta da kuma rage tasirin tasirin cutar a kan sauran masu cutar ta hanyar haɗin gwiwar su.
Matsayin cutar ya dogara ne akan yadda al'ummomin da cutar ta shafa suka amsa.
Ƙara yawan lalacewar lalacewa shine ra'ayin da aka saba amfani dashi a cikin aikin tsaro da aminci ga rukunin lalacewar lalacewa ta hanyar aiki.
Lokacin da ba za a iya sarrafa lalacewar COVID-19 ba, iko mafi inganci shine sarrafa injiniyoyi wanda ke bin kayan aiki da kayan kariya na mutum.
Gudanar da aikin injiniya ya ƙunshi kauce wa ma'aikata daga lalacewa ba tare da dogaro da halayyar ma'aikaci ba kuma zai iya zama mafi kyawun mafita don aiwatarwa.
Gudanar da sarrafawa shine canji a cikin aikin aiki ko matakan da ke buƙatar aiki daga ma'aikata.
Kayan kariya na mutum (PPE) ba su da tasiri sosai kamar na injiniya da sarrafawa, amma suna iya taimakawa dan kadan wajen hana kamuwa da cuta.
Duk nau'ikan PPE dole ne a ƙayyade su dangane da cutarwar ma'aikata, a daidaita su yadda ya kamata (misali matsalolin numfashi), a kula da su yadda ya kamata, a daidaita su, a tsaftace su, a iya gano su, idan ya cancanta, a cire su yadda ya kamata, a tsabtace su, a adana su ko kuma a shirya su don kauce wa gurɓata su.
A cewar Hukumar Kula da Lafiya da Tsaro ta Majalisar Dinkin Duniya (OSHA), ƙananan haɗarin aiki suna da alaƙa da mafi ƙarancin jama'a da ma'aikatan kamfanin.
Hanyoyin rigakafin cututtuka na asali sun ba da shawarar cewa duk wuraren aiki su wanke hannayensu sosai kuma su ƙarfafa ma'aikata su zauna a gida idan suna da rashin lafiya da matsalolin numfashi ciki har da tari da ƙura, samar da tsabtace jiki da ƙura, shirya don sadarwa ta nesa ko musayar sauyawa idan ya cancanta, sanar da ma'aikata game da amfani da kayan aiki da kayan aiki da kuma tsawaita ayyukan tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace
Karfafawa don ganowa da nisantar mutane masu cutar yana da mahimmanci don kare ma'aikata, abokan ciniki, baƙi da sauran mutane a wurin aiki.
Cibiyar Kula da Cututtuka ta Majalisar Dinkin Duniya (CDC) ta ba da shawarar cewa ma'aikata da ke da alamun rashin lafiya su zauna a gida har sai sun warke daga cutar, alamun cutar da sauran alamun cutar na aƙalla awanni 24 ba tare da amfani da maganin ragewa ko wasu magunguna ba, kuma da zarar cutar ta lafa, a ba ma'aikata damar zama a gida don kula da marasa lafiya a cikin iyalansu, da ma'aikatan da ke da masaniya game da matakan.
A cewar OSHA, haɗarin aiki na tsakiya ya haɗa da waɗanda ke da kusanci ko kusanci da mutane masu tsayi shida (1.8m) waɗanda ba masu ɗaukar COVID-19 ba ne ko kuma waɗanda ake zargi da cutar, amma suna iya kamuwa da SARS-CoV-2 ta hanyar watsawa ta al'umma ko kuma saboda mutum ya yi balaguron ƙasa da ƙasa zuwa yankin da ke da cutar COVID-19.
Waɗannan sun haɗa da sarrafawa don yin hulɗa tare da wuraren jama'a kamar makarantu, wuraren aiki na masana'antu ko ƙuntatawa na sayarwa da siyarwa. Injiniyan sarrafawa don wannan da kuma rukunin haɗarin haɗari masu haɗari sun haɗa da shigar da matattarar iska mai inganci da haɓaka yawan iska da kafa shingen likita kamar masu kare filastik na rai da kafa sabis na taga don isa ga abokan ciniki. Gudanar da sarrafawa don wannan da karewa daga haɗarin haɗari sun haɗa da ƙarfafa ma'aikata marasa lafiya su zauna a gida, sauyawa tsakanin ƙungiyoyi don haɗuwa da haɗari ta hanyar amfani da kayan aikin lantarki, sanya takunkumin canzawa da hana yaduwar abubuwan da ba dole ba ga ma'aikata a wuraren da COVID-19 ya ɓarke, haɓaka shirye-shiryen aiki masu tasiri, samar da hanyoyin da za a bi don magance wannan da kuma kare masu cutarwa daga COVID-19, da kuma samar da ilimi da ƙwarewa game da yadda za a kula da yanayin da ake ciki da kuma yadda za a kula da masu amfani da kayan aikin da keɓaɓɓun kayan aiki da ke tattare da COVID-19.
Ma'aikata a cikin wannan rukunin haɗari ba sa yawan buƙatar yin amfani da injin numfashi.
Idan mutum ya kamu da rashin lafiya a filin jirgin sama, ana iya aiwatar da matakan da suka dace don kare ma'aikata da matafiya waɗanda suka haɗa da keɓewar mai haƙuri daga wasu ta tsawon ƙafa 6 da sanya wani a cikin rukunin don kula da mai haƙuri, samar da abin rufe fuska ga mai haƙuri ko buƙatar mai kula da baki da baki don yin amfani da clenches lokacin da yake tari ko ƙidaya.
Ma'aikatan rukunin dole ne su sa safofin hannu na likita lokacin da suke hulɗa da matafiya marasa lafiya ko kuma suna riƙe da ruwa na jiki ko ƙazanta da kuma ƙara kayan kariya na mutum idan matafiyin mara lafiya yana da tari ko kuma numfashi mai tsanani.
Dole ne a shirya kayan aiki da kayan aiki a cikin jakar filastik kuma dole ne a tsabtace da kuma tsabtace kayan da aka ƙazantar. Don kasuwannin kaya, wanda ya haɗa da kasuwancin kasuwanci da jiragen ruwa, kula da lalacewa wanda ya haɗa da jinkirta tafiya lokacin da ba shi da lafiya ko keɓewa na mutum da kuma sanar da cibiyar kiwon lafiya ta jirgin kai tsaye idan wani ya kamu da cutar ko wasu alamomi a kan jirgin.
A cikin yanayin da ya dace, dole ne a sami magani a gidan wanda ba a keɓe shi ba. Makarantun da sassan kula da yara da CDC za su sanar da rufewar ɗan gajeren lokaci don tsabtace ko kuma kashe kwayoyin cutar idan mutum mai cutar ya kasance a cikin ginin makaranta don la'akari da yaduwar zamantakewa.
Lokacin da akwai ƙananan ƙoƙari don rage keɓewar zamantakewa, ana iya aiwatar da matakan nisantar zamantakewa kamar ƙin tafiya da tarurruka da sauran manyan tarurruka kamar ilimin likita ko tarurrukan addini ko cin abinci tare a cikin kantin, ƙara tsawon lokaci tsakanin tebur da shirya tafiye-tafiye da hutun ɗalibai da iyakance balaguron da ba dole ba da kuma amfani da wurin ofishin likita don yara masu alamun mura.
Lokacin da akwai yaduwar cutar a cikin al'umma, duk da kasancewar hanyoyin nisantar zamantakewa, ana iya yin la'akari da tsawaita hutun makaranta. Don aiwatar da dokar hukumar don aiwatar da ayyukan yau da kullun, CDC ta ɗauki haɗarin lafiya na kai tsaye da ƙarancin.
An shawarci jami'an tsaro da ke da alaƙa da mutanen da ke da cutar ko waɗanda ake zargi da cutar COVID-19 da su bi irin waɗannan fasahohin gaggawa na likita, waɗanda suka haɗa da kayan kariya na sirri.
Idan akwai kusanci a lokacin haɗari, ma'aikata su wanke bel ɗin motar su kuma sake amfani da su, ta amfani da kayan tsabtace gida da na hannu, da kuma amfani da daidaitattun ayyuka don tsabtace.
OSHA ta tabbatar da cewa ma'aikatan kiwon lafiya da masu mutuwa suna da haɗari sosai.
Babban haɗarin aiki wanda ke tattare da isar da kiwon lafiya, tallafi, dakin gwaje-gwaje, da jigilar likitocin ma'aikata waɗanda aka sani ko ake zargin suna da cutar COVID-19.
Ma'aikata suna cikin haɗari idan ma'aikata suna amfani da na'urar musayar iska ko tattara samfuran marasa lafiya ko waɗanda ake zargi da COVID-19.
Na'urar musayar iska ta iska ta hanyar maganin ciwon makogwaro da na'urar motsa jiki da na'urar gwajin iska da wasu na'urorin gwaji ko na'urorin gwaji.
Babban haɗarin aiki a cikin ɗakunan ajiya na gawawwaki shine ma'aikata waɗanda ke shirya gawarwakin da ke da cutar COVID-19 a lokacin mutuwarsu; ma'aikata masu haɗari idan sun yi aikin gyaran jiki, ƙarin sarrafa injiniya don waɗannan rukunin haɗarin suna sanya ɗakunan keɓewa ga marasa lafiya waɗanda ke da cutar ko ana zargin COVID-19, lokacin da ake amfani da na'urar musayar numfashi.
Na'urorin matsa lamba mara kyau na numfashi na iya zama dacewa a wasu saitunan kiwon lafiya da kuma mutuwa.
Za a yi amfani da samfurin a cikin gwajin matakin 3.
Hukumar Lafiya ta Duniya (WHO) ta gargadi marasa lafiya da su nisanta kansu daga wuraren da ake jiran gwajin COVID-19 da ake zargi.
A cikin Majalisar Dinkin Duniya, NIOSH ta inganta N95 masks masu tacewa ko mafi kyau don amfani a cikin wurare masu yawa, rubutaccen shirin kariya na numfashi wanda ya haɗa da gwajin numfashi da horo da gwajin likita.
Sauran na'urorin numfashi suna ba da ƙarin kariya da kwanciyar hankali ga ma'aikata. Hukumar Lafiya ta Duniya ba ta ba da shawarar suturar likita kamar COVID-19 ba amma ana yaduwa ta hanyar ruwa.
Hukumar Lafiya ta Duniya (WHO) ta ba da shawarar kawai rufe fuska na tiyata don gwajin marasa lafiya.
Ga waɗanda ke tattara alamun matsalar numfashi daga kulawa da jigilar marasa lafiya na COVID-19 ba tare da na'urar musayar iska ba, WHO ta ba da shawarar rufe fuska na tiyata, tabarau, masu kare fuska, rigunan likita da safar hannu.
Idan ana amfani da na'urar musayar numfashi, za a canza abin rufe fuska na tiyata zuwa N95 ko FFP2.
Ganin cewa an amince da taimakon PPE daban, WHO ta ba da shawarar cewa a rage buƙatun PPE don watsa bayanai, ƙuntatawa na likita kamar windows, kawai waɗanda ke da alaƙa kai tsaye da kulawa za a ba su izinin shiga ɗakin marasa lafiya na COVID-19, kawai amfani da buƙatun PPE don takamaiman aiki, ci gaba da amfani da kayan aikin numfashi guda ɗaya ba tare da cire su ba yayin kula da marasa lafiya ta hanyar gano cutar, saka idanu da daidaita jerin abubuwan taimako na PPE, da kuma ba da shawarar amfani da abin rufe fuska ga waɗanda ba su da alamun cutar.
Daga: Katherine Maher, Kamfanin Wikimedia Foundation Shugaba.
Ga: Duk ma'aikatan Wikimedia Foundation.
Taken shine: [Covid-19] Rage kaya da shirya don nan gaba.
Lokaci da ranar ƙarshe: 14/3/2020 da karfe 00:24.
Lasisi: CCO: Babu haƙƙin mallaka.
Za mu sami kanmu a cikin wani yanayi a wannan watan.
Cutar ta COVID-19 ta zama abin da ke hana haɗin zamantakewarmu na duniya da alhakinmu ga juna.
Ba mu da fifiko kan kalubalen da muke fuskanta, amma mun san cewa mafi kyawun amsarmu ta dogara ne da jinƙai da haɗin kai da haɗin kai wanda zai zama babban ɓangare na wannan shirin.
Muna ganin tausayi da kuma sha'awar tsakanin dukkan abokanmu ta hanyar imel da kira da hira wanda shine babban taimako na ɗan adam wanda muke farin cikin amfani da shi.
Ba zan iya yin godiya fiye da haka ba, don na sa ku a cikin aikin nan na Allah.
A makon da ya gabata, wasu mutane sun yi mini ba'a don aikinmu.
Sun yi tunani game da abin da wannan ke nufi ga duniya don samun damar shiga Wikipedia a yanzu, da kuma yadda za a iya ganin alamomi masu ƙarfi a matsayin tushen yanar gizo kuma a ba kowa damar yin amfani da su.
Ayyukanka suna sa su faru, ko da ka sa shafin ya yi aiki ko kuma ka biya kuɗin abokan aikinmu ko kuma ka yi amfani da rukunin yanar gizonmu.
Duniya na buƙatar bayanin da Wikipedia ke bayarwa, yanzu fiye da kowane lokaci.
Yanzu ba kawai abin da muke yi ba, amma yadda muke yi, yana da tasiri mai ma'ana a duniya.
Saboda muhimmancin wannan aiki da kuma rawar da kuke takawa, za mu yi wasu manyan shirye-shirye kan yadda za mu yi aiki tare, za mu fara wannan makon.
Ƙaƙƙarfan aiki da jadawalinmu
Kamar yadda Robin ya ambata a farkon, a daren jiya ne kungiyar C ta gana don tattauna kan hanyarmu da jadawalinmu na kwanaki da watanni masu zuwa.
A cikin wannan tattaunawar, mun yi la'akari da cewa ra'ayoyinmu zasu zama muhimmiyar amsa ga abin da muke fuskanta kuma zai zama hanya mafi kyau don ci gaba da jagorancinmu a wannan lokacin.
A mafi yawancin lokuta, muna so mu rage matsa lamba kuma mu ci gaba da aiki tare don dogon lokaci.
Idan kana bukatar ragewa, ba matsala.
Ga dukkan ma'aikata, masu kwangila, alkawarin ma'aikata:
Aikinmu na yau da kullum yana da kimanin sa'o'i 4, ko kuma a mafi yawan sa'o'i 20 a mako.
Ba mu da hutu - idan za ku iya yin aiki fiye da sa'a, aikin zai iya amfani da ku.
Koyaya, duniya tana cikin yanayi mara tabbas, kuma idan kuna buƙatar kula da ƙaunatattunku, je kantin magani ko zuwa likita, lafiyar ku ita ce mafi mahimmanci.
Ba za mu ɓata lokacinku ba.
Idan kana rashin lafiya, kada ka yi aiki.
Dole ne a yi hakan ba tare da an ce ba, amma mun ce haka.
Babu ranar rashin lafiya ko biyan kuɗi na rashin lafiya, kawai sanar da mai sarrafa ku kuma ku taimaki ƙungiyar ku ta hanyar canza jadawalin aiki da jadawalin don tabbatar da cewa an kula da ayyukan yanki.
(Idan kana da cutar COVID-19, don Allah ka gaya wa Bryan T&C Ops, T&C na iya taimaka maka ta hanyar tallafawa da tabbatar da cewa an kula da yanayin da ya dace ta hanyar kulawa.)
Ana biyan mutane cikakken albashi a kowace awa.
Mun faɗi haka kuma muna maimaitawa tare da alfahari ga abokan cinikinmu da abokan aikinmu da abokan aikinmu.
Kowane mutum yana samun albashinsa bisa ga yawan sa'o'in da ya yi a cikin al'ada.
Wannan ya haɗa da waɗanda ke da rashin lafiya ko rashin iya aiki.
Idan kana son yin aiki, za mu goyi bayan ka.
Yawancin mutane suna amfani da aiki a matsayin hanyar da za su iya kawar da matsalolin duniya.
Abin da za mu iya bayarwa, musamman a wannan lokacin.
Bugu da ƙari, wannan game da kula da kanka ne.
Muna so ka yi magana da mai kula da kai, don mu san abin da za mu yi tsammani kuma mu yi shiri.
Wasu ayyuka suna da mahimmanci.
Akwai wasu abubuwa da ya kamata mu ci gaba da yi.
SRE, HR Ops, Trust&Safety, Fundraising (da sauransu) ƙungiyoyi suna yin aiki mai mahimmanci wanda zai iya buƙatar tallafi.
Mun fara aiki tare da dukkan sassanmu don daidaita manufofinmu na yanzu kuma muna mai da hankali kan haɗin gwiwa wanda shine tushen aikinmu.
Dukkanmu muna da ayyuka da yawa da za mu yi, amma muna mai da hankali ne kawai ga ayyukan da suka fi dacewa.
Sanyi yanzu ba zai cutar da ku ba daga baya.
Ba mu da shirin "gwada wani abu sau biyu" da zarar annobar ta wuce.
Ba za mu ci gaba da yin aiki don samun lasisi ba, wanda yanzu ya zama mummunan aiki.
Mun yarda cewa yanayin ya canza, kuma muna aiki don saita sabbin manufofi da lokacin da ya dace.
Menene zai faru da APP (Tsarin Shekara-shekara)?
Don daidaita sabon aikinmu da lokutan aiki na yau da kullun, muna da niyyar daidaita jadawalin isar da shirinmu na shekara-shekara na 2020-2021.
Muna da niyyar ba da shawarar sake fasalin shirinmu na 2019-2020 wanda zai ba mu ƙarin lokaci don tara kuɗi don ba ma'aikata damar yin mahimman ayyuka da kula da kansu da kula da ƙaunatattunmu yayin taimaka wa waɗanda ke buƙatar rage jadawalin su na makonni masu zuwa.
Wannan jadawalin ƙari yana rage nauyin aikin yanzu da kuma matsa lamba akan duk abubuwan da aka hana.
Za mu gabatar da shawarwarinmu ga majalisar a mako mai zuwa kuma mu sanar da wakilanmu da kungiyoyinmu kan matakin da za mu dauka nan gaba da zarar mun yi aiki.
Na gode wa ƙungiyar APP don jagorantar wannan.
Ofishin Yanayi, Hadari da Tsabtace
A makon da ya gabata, mun sami labarin cewa ɗaya daga cikin abokanmu na FS-based na iya kamuwa da cutar COVID-19.
Koyaya, ba tare da yin la'akari da yawa ba, mun kafa ƙungiyar tsabtace mu don tsabtace dukkan bangarorin ofishin San Francisco.
Sun yi amfani da maganin rigakafin cutar a asibitin don tsabtace dukkan fuskokin, da dakunan jiran da ɗakunan ɗakunanmu.
Ginin yana da masu kula da lafiyarsu waɗanda ke tallafawa lafiyar masu haya.
Muna jin daɗin cewa ofishin yana shirye sosai don lokacin da muka yanke shawarar dawowa.
Ofishinmu na DC yana cikin WeWork, wanda ya ba mu da duk ma'aikatan DC ƙa'idodin COVID-19 na likita.
A makon da ya gabata, ofishinmu na DC ya koma wurin da aka kafa layin tsaro a San Francisco.
Kamar yadda wasu daga cikin abokanmu na NYS suka sani, muna tattaunawa don yin hayar wani wuri a Brooklyn.
Ana ci gaba da tattaunawar amma ana iya jinkirta ta.
Wasu daga cikin abokanmu suna aiki daga gidajensu, a karon farko.
Ma'aikata masu dogon lokaci suna aiki daga gida sun san cewa zai iya zama tsari, kuma muna so mu ba ku wasu shawarwari:
Ka ƙayyade lokacin da za a yi aiki a cikin sa'o'i ɗaya ko biyu.
Idan an nemi taron da ya fi tsayi, yi la'akari da yadda za a kammala karatun a cikin kwanaki da yawa.
Ka bayyana taron a fili, ka tsara yadda za ka yi taron, kuma ka gabatar da abin da za ka koya.
Tattauna batutuwa ta hanyar bidiyo, ta amfani da kayan aikin Google Docs da Xoom don sauƙaƙe haɗin kai da sadarwa kai tsaye.
Ka sanya mai gudanarwa don sauƙaƙe duk tarurruka, sanya wani don kula da hira don tambayoyi da kuma rubuta jerin masu magana, da kuma wani don karɓar bayanai (ko taimakawa wajen karɓar bayanai).
Aika da imel ɗin tallafi na fasaha idan kuna buƙatar kayan ji na kunne.
Yi amfani da zaɓuɓɓukan tsaro don kayan abinci.
Shiga tashoshin yanar gizo na Stack don tattaunawa da ma'aikatan ku game da rarraba aiki.
Ƙungiyar HR ta yi amfani da tsarin ilimin kimiyya na e-gidan yanar gizo don taimakawa wajen inganta aikin haɗin gwiwa a cikin ma'aikata.
A cikin makon da ya gabata, mun nemi dukkan masu ba da gudummawa su ƙi duk wani tallafi na Wikimedia kamar gyara bayanai, har sai WHO ta sanar da ƙarshen cutar.
Muna gaya musu cewa mun fahimci cewa buƙatarmu don ƙin yarda da sauran ƙayyadaddun abubuwa na iya hana su kammala ayyukan ba da gudummawa, kuma ba wanda zai iya jinkirta ko canza manufofin su.
A cikin mako mai zuwa za mu aiwatar da ƙarin ƙa'idodi don Wikimedia, taron yanki da sauran labarai.
Jinƙai na jama'a game da tsarin duniya yana sa su damu da yanayin da ke ci gaba amma suna jin dadi game da sadarwa da kuma ikon mayar da hankali ga tsarin su da Wikimedia da kuma mataimakinsa.
Ci gaba, CRT yana aiki don sanya shafi a kan Meta-Wiki don samar da sarari ga mai gudanarwa don lura da tasirin da kuma yada alaƙarmu da su.
Rashin aiki saboda matsalolin da suka shafi COVID-19.
Za mu aika maka da gayyatar zuwa ranar asusunka a ranar Alhamis da karfe 14:00 UTC ko 07:00 PT don taron ma'aikata na musamman.
Za mu yi amfani da wannan lokacin don aika sabuntawa, amsa tambayoyinku da kuma ciyar da lokaci tare.
Muna nan tare kuma muna nan don taimakawa duk yadda za mu iya.
A lokacin da ya dace, za mu iya ci gaba da samun bayanai a cikin wannan imel ɗin, da duk bayanan da suka shafi COVID-19, a cikin ofishin Wiki.
CRT yana sabunta waɗannan shafuka da bayanai a wuri guda.
Muna kuma aiki don ci gaba da hulɗa da ma'aikatanmu na shari'a waɗanda ke aiki a ƙasashen da cutar ta kamu.
Idan kuna da wasu tambayoyi game da tafiya, abubuwan da suka faru, nau'in aikin lantarki ko ƙimar ƙalubale ko wani abu da kuke buƙatar taimako, don Allah kada ku yi jinkirin tuntuɓar CRT.
Muna nan don taimakawa wajen samar da tallafi da taimako idan an buƙata.
Idan kana da wata matsala ta sirri ko ta sirri, don Allah aika imel zuwa Brian - Manajan Ayyukan HR na Global Government.
Babu wani daga cikin waɗannan canje-canjen da za a iya ɗauka a matsayin barin aikinmu da kuma tilasta yin aiki.
Amma, sun manta cewa a wannan lokacin, aikinmu da kuma tilasta mu suna da mahimmanci a cikin yanayin da ba a taɓa gani ba.
Waɗannan su ne matakan da muka yi imanin cewa suna da muhimmanci don tallafawa juna, don haka za mu iya ci gaba da aiki, samar da taimakonmu da suke bukata, da kuma sabis ɗin da duniya ke dogara da shi.
Za a yi aikin da aka tsara a kan lokaci.
A yanzu. Lokaci ya yi da za a yi aiki tare da samar da sarari don muhimman ayyukan da za a yi a cikin kwanaki da watanni masu zuwa.
Muna bukatar ku duka don yin wannan aikin, kuma muna bukatar ku kula da kanku da iyalanku don ku kasance cikin mafi kyawun yanayi lokacin da muke buƙatar ku.
Yanzu, don Allah ku wanke hannuwanku kuma kada ku taɓa fuskarku.
Katherine, CRT (Amanda K, Amy V, Bryan J, Doreen D, Gergory V, Jamine V, Lynette L, Ryan M, da Tony S), da sauran manajan ƙungiyar (Grant I, Heather W, Jaime V, Janeen U, Lisa S, Ryan M, da Toby N).
ACE2 wani enzyme ne wanda yake rufewa a cikin ƙwayoyin ƙwayoyin cuta a cikin huhu, jijiyoyi, zuciya, koda da hanji.
ACE2 yana hana ayyukan enzyme na angiotensin-containing enzyme ta hanyar rage yawan hawan jini da kuma kara Ang (((1-7 wanda ake tsammanin magani ne mai kyau don magance cututtukan zuciya. ACE2 kuma yana da amfani a matsayin ƙofar shiga cikin ƙwayoyin cuta ga wasu coronaviruses.
An bayyana kwayar halitta ta mutum a matsayin hACE2.
An sanya enzyme na zinc-metallic zinc-dual angiotensin a kan farfajiyar ciki na tube da sauran kwayoyin.
ACE2 ya ƙunshi mai ɗaukar N na yankin peptidase M2 da mai ɗaukar C wanda ke ɗaure da amino acid mai ɗaukar nauyi.
ACE shine nau'i na nau'i na I na furotin, tare da enzyme mai aiki a kan ƙwayoyin ƙwayoyin ƙwayoyin cuta a kan ƙwayoyin ƙwayoyin cuta da sauran kyallen takarda.
Ana samun ƙwayar halitta daga ACE2 ta hanyar ƙwayar halitta ta hanyar ƙwayar halitta ta hanyar enzyme mai suna shades, wanda ya zama mai yaduwa a cikin jini kuma ya rabu da shi zuwa cikin fitsari.
ACE2 yana cikin yawancin gabobin jiki: ACE2 yana da alaƙa da ƙwayoyin ƙwayoyin cuta musamman ƙwayoyin cuta na cyclocyte type II, ƙwayoyin hanji, ƙwayoyin jini da ƙwayoyin jini da ƙwayoyin tsoka mai laushi a cikin yawancin gabobin jiki.
Ana kuma samun wani mRNA mai suna ACE2 a cikin gaba na kwakwalwa, da kuma tsakiyar kwakwalwa, da kuma cikin kwakwalwa, da kuma cikin kwakwalwa.
Aikin farko na ACE2 shine daidaitawa da ACE.
ACE hormone yana haifar da wani abu mai mahimmanci don yin amfani da kwayoyin halitta a cikin jini.
ACE2 yana haɗuwa da carboxyl-termial amino acid phenylalanine daga anigotensin II (Asp-Arg-Bal-Tyr-IIe-His-Pro-Phe) kuma yana haɓaka cikin angiotensin (1 - 7, (H-Asp-Arg-Val-Tyr-Lle-His-Pro-OH).
ACE2 kuma yana iya ƙuntata wasu ƙwayoyin peptides masu dogara kamar -[des-Arg9] bradykinin, apelin neurotensin, dynorp hin A, ghrelin.
ACE2 kuma yana daidaita yawan ƙwayar amino acid mai sauƙi SLC6A19 kuma an same shi a cikin cututtukan zuciya.
A matsayin furotin mai ɗaukar hoto, ACE2 yana aiki a matsayin babban hanyar shiga cikin ƙwayoyin cuta don wasu ƙwayoyin cuta, kamar HcoV-NL63; SARS-CoV (wanda ke haifar da SARS); da SARS-CoV-2 (wanda ke haifar da COVID-19).
A mafi mahimmanci, haɗuwa da S-CoV da Sars-CoV-2 sun haɗa da S-CoV-1 da kuma Sars-CoV-2 don yin amfani da enzyme mai mahimmanci na ACE2 a kan ƙwayoyin halitta, wanda ya haifar da babban maye gurbin da ke nunawa duka kwayar cutar da enzyme a cikin endosomes a cikin tantanin halitta.
Ana tsammanin cewa rage yawan ACE2, a cikin kwayoyin, na iya taimakawa wajen yaki da cutar.
Koyaya, wasu ƙungiyoyin ƙwararru da masu motsa jiki suna ba da shawarar ci gaba da daidaita matakan rage ACE da maganin ARB.
An gabatar da wani tsari da kuma ci gaban bincike da aka buga a ranar 11 ga Yuli,2020 wanda ya gano "amfani da ACE da aka dasa ya inganta tare da mahimmancin raguwa na 34% na haɗarin abubuwan da ke faruwa tare da sarrafawa".
Bugu da ƙari, "hadarin kamuwa da cutar huhu mai tsanani ya ragu a cikin marasa lafiya da aka yi wa maganin ACE inhibitors fiye da haɗarin kamuwa da cutar huhu, musamman waɗanda ke fama da bugun jini da rashin zuciya".
Yin amfani da ACE inhibitors ya taimaka wajen magance cutar huhu da ke da alaƙa da ACR, kodayake sakamakon ba shi da lafiya a cikin haɗarin cutar huhu gaba ɗaya.
An tsara tsarin mutum na ACE2 (rhACE2) don zama sabon magani don mummunan rauni na huhu, kuma an nuna shi don magance cutar hawan jini na huhu da rashin iskar oxygen a cikin ƙananan aladu tare da lipoisaccharide- yana da nasara a cikin bayyanar cututtuka na matsanancin numfashi.
Rabin rabin rai na ErhACe a cikin ɗan adam kusan awanni 10 ne da aiki guda 30 na minti da ƙari yana da tasiri na awanni 24.
Wasu binciken sun ba da shawarar rhACE2 a matsayin magani mai mahimmanci ga waɗanda ke da ƙwayar cuta ta rigakafi na rigakafi (RAS inhibitor) ko kuma an yi amfani da su don magance cututtukan huhu mai tsanani.
B COVID 19 Apps aikace-aikacen wayar hannu ne da aka tsara don taimakawa wajen bin diddigin mutane dangane da cutar coronavirus ta 2019-20, misali gano mutane (abokan hulɗa) waɗanda zasu iya kasancewa tare da mai cutar.
An samar da shirye-shirye da yawa, tare da tallafin gwamnati a wasu yankuna da wuraren shari'a.
An tsara wasu tushen aiki don gina haɗin haɗin kai na aikace-aikace.
An gabatar da wasu damuwa na musamman, musamman game da tsarin da ke da tushe don gano wurin masu amfani da aikace-aikacen.
Rage kutse cikin bayanan sirri da kuma matakan kamar amfani da siginar Bluetooth don shiga cikin bayanan sirri da kuma sauran wayoyin hannu.
A ranar 10 ga watan Afrilu, 2020, Google da Apple sun sanar da cewa za su yi aiki tare don samar da tallafi ga Bluetooth a cikin aikace-aikacen da ke aiki a kan Android da iOS.
A China, gwamnatin kasar Sin, tare da kamfanin Alipay, sun kirkiro wata manhaja da ke ba wa 'yan kasar damar yin bincike kan ko sun kasance tare da mutanen da ke fama da cutar COVID-19.
Ana amfani da shi a cikin birane sama da 200 na kasar Sin. A Singapore, ana amfani da wata manhaja mai suna Trace Translator.
An tsara wannan shirin ne ta hanyar kungiyar IT kuma nan ba da jimawa ba za a gabatar da shi ga gwamnati. Kamfanin Arewacin Macedonia "Tsaya Coronavirus" shine babban shirin don gano masu kamuwa da cutar da kuma samar da saurin amsawa ga hukumomin kiwon lafiya.
Ma'aikatar sadarwa da fasaha da ma'aikatar lafiya ne suka samar da shirin.
A ranar 14 ga Afrilu 2020, an ƙaddamar da aikace-aikacen don tabbatar da shi daga Google Play Store da Apple App Store.
A ranar 12 ga Afrilu, gwamnati ta sanar da cewa shirin ya kasance mafi kyawun ci gabansa, kuma zai kasance a shirye don masu amfani a cikin mako guda.
Dukkanin Ostiraliya da New Zealand suna ba da shawarar shirin bin sahun Singapore da kuma yarjejeniyar Bluetooth. Rasha na son gabatar da shirin bin sahun marasa lafiya da aka gano da COVID-19 da ke zaune a Moscow, wanda aka tsara don tabbatar da cewa marasa lafiya ba sa barin gida.
Ross Anderson, injiniyan tsaro a Jami'ar Cambridge, ya nuna wasu daga cikin yiwuwar matsalolin da ke tattare da tsarin tsarin, ciki har da, kuskuren kuskure da kuma yiwuwar rashin tasiri idan an iyakance aikin shirin ga ƙananan yawan jama'a.
Dangane da damuwa game da yaduwar ɓarnatar da ko cutar da "coronavirus" apps, Apple ya sanya iyaka kan nau'ikan ƙungiyoyi waɗanda ke ƙarawa da coronavirus-kamar apps a cikin App Store.
Google da Amazon sun kafa irin wannan yarjejeniyar ta hana.
Masu kai hari na musamman sun nuna damuwa game da matsalolin da ke tattare da sanya ido kan amfani da shirye-shiryen coronavirus, musamman game da ko an gina ingantaccen tsarin kulawa don magance cutar coronavirus da za a iya amfani da ita da zarar haɗarin ya ƙare.
Ƙungiyar ta duniya da ƙungiyoyi 100 sun ba da sanarwar abin da ake kira kira kira don ƙuntata wannan nau'in ƙayyadaddun bayanai.
Kungiyoyin sun bayyana sharudda takwas kan ayyukan gwamnati:
Dole ne daidaito ya zama "cikakken doka. Dole ne daidai".
Ƙarin kulawa da hankali dole ne a bi ta hanyar kulawa;
Dole ne a iyakance amfani da bayanai saboda COVID-19;
Dole ne a kiyaye tsaro da kuma mutuncin bayanan kuma a tabbatar da cewa an kiyaye su;
Dole ne mai kula da dijital ya guji ƙara nuna bambanci da nuna bambanci;
Duk wani bayar da bayanai ga ɓangare na uku dole ne a bayyana shi a cikin dokoki;
Dole ne a sami jami'an tsaro don amsawa ga zalunci da kare hakkokin 'yan ƙasa;
Ana buƙatar sa hannu mai ma'ana daga duk "masu karɓar bashi masu dacewa", gami da masana kiwon lafiyar jama'a da kungiyoyi marasa ƙarfi. Kwamitin Kwamitin Kwamitin Kasuwancin Jamus (CCC) da 'Yan Jarida ba tare da Iyaka ba (Reporter Eoin Greenspan) (RSF) sun kuma yi ikirarin yin kuskure.
Shirin da aka gabatar na Google da Apple an yi niyyar magance matsalar ci gaba da saka idanu ta hanyar cire tsarin sa ido daga tsarin sarrafa wayar hannu lokacin da ba a buƙatar ƙarin.
Wasu ƙasashe suna amfani da Intanet bisa tushen saka idanu maimakon aikace-aikace, cire duka biyu yana buƙatar saukar da aikace-aikacen, da ikon dakatar da saka idanu.
A Isra'ila, an yarda da Intanet mai kulawa.
Intanit yana da matsala game da ainihin ɓoyewa na ainihi bisa ga hanyar sadarwa ta hanyar samun damar bayanai a wurare marasa kyau.
Koyaya, ba lallai bane duk tsarin da cibiyoyin uwar garke su sami damar yin amfani da bayanan wurin mutum; an gina wasu tsarin kare sirrin da ke amfani da cibiyoyin uwar garke kawai don sadarwa tare da juna (duba sashin ƙasa).
A Koriya ta Kudu, an yi amfani da tsarin da ba na software ba don aiwatar da kula da sadarwa.
Maimakon amfani da wani takamaiman software, tsarin ya tattara bayanan kulawa daga wasu tushe kamar bayanan kula da na'urar hannu da bayanan katin da aka sarrafa, kuma ya haɗa waɗannan don gano bayanin kula a cikin wasiƙun da aka rubuta ga masu cutar da ba a sani ba.
Baya ga amfani da wannan bayanin don gano hanyoyin sadarwa na ɓoye, gwamnati ta kuma ba da damar samun bayanan jama'a, wasu abubuwa an ba da izinin su saboda ba su da damar yin amfani da canje-canjen da suka faru a dokokin bayanan sirri bayan barkewar MERS a ƙasar.
Ana samun wannan bayanin ga jama'a ta hanyar shirye-shirye da shafukan yanar gizo. Kasashe kamar Jamus sun kafa duka cibiyoyin tattara bayanai da tsarin kare sirri.
Wannan shi ne ranar 6 ga Afrilu, 2020, ba a bayyana cikakken bayani ba tukuna.
Kula da kiyaye alaƙar sirri yana da kyau a kafa, tare da babban jikin bincike na wallafe-wallafen da ke komawa zuwa aƙalla 2013.
Koyaya, PEPP-PT shine damar daidaitawa wanda ke da hanyoyi biyu na cibiyar tattarawa da cibiyar rikici, kuma babu wata yarjejeniya guda ɗaya. Tsarin yarjejeniyar rikici ya haɗa da kula da kusanci da kariya ta musamman (DP-PPT/D-3t), lambar sadarwa ta ɗan lokaci (TCN, lambar tuntuɓar haɗari (fka) (fka, CEN), ladabi da hanyoyin aiki na ƙwarewar ƙwarewar ƙwarewa don kula da haɗin wayar hannu (PACT) da sauransu.
A cikin waɗannan ladabi, bayanan da ke gano mutum ba ya fita daga na'urar, duk daidaitawa yana faruwa a cikin na'urar.
Ƙungiyar sirri a MIT Media Lab tana aiki kan ƙirƙirar "Hanyoyin Tsaro", wani dandamali don amfani da fasahohin tsare sirri yayin tattara da amfani da bayanan wuri ko hanyoyin da aka yanke don lura da yaduwar COVID-19.
Wani bincike da aka samo asali daga wani shiri na White Development mai suna "Rog Walking Program: Protecting Personal Privacy in ......" wanda aka fitar a watan Maris na 2020.
Tsaro na tsaro yana amfani da fasaha na kayan aiki don ba da damar masu amfani don rarraba bayanai masu mahimmanci da kiwon lafiya tare da sauran masu amfani da masu amfani, ba tare da yin watsi da sirrin bayanan ba.
A ranar 5 ga Afrilu 2020, ƙungiyoyin TCN na duniya sun kafa ƙungiyoyi waɗanda ke aiki akan abin da ya zama ainihin tsarin yarjejeniya iri ɗaya, tare da manufar rage ɓarna da barin duniya don amfani da musayar bayanai ta hanyar tsarin software don saka idanu da shirye-shiryen faɗakarwa.
A ranar 9 ga Afrilu, 2020, gwamnatin Singapore ta sanar da cewa ta saki tushen* na yarjejeniyar Blue Trace da aka yi amfani da ita ta hanyar aikace-aikacen gwamnati.
A ranar 10 ga Afrilu, 2020, Google da Apple, kamfanonin da ke sarrafa dandamali na Android da iOS, sun ƙaddamar da shirin kula da saƙo, wanda suka yi imanin yana kare sirri, wanda ya dogara da haɗin Bluetooth Low Energy da kiyaye ɓoyayyen ɓoye.
Sun kuma buga fasali da cikakkun bayanai game da ainihin fasahar da aka yi amfani da ita a cikin tsarin.
A cewar Apple da Google, an saita tsarin don yin aiki a matakai uku:
Ya yi amfani da kayan aiki don taimakawa gwamnati ta samar da tsarin kula da tsaro na musamman don kare lafiyar masu cutar coronavirus.
Wannan aikin yana da alaƙa kai tsaye da ISO da Android kuma shirin Apple shine ɗaukar taken don haɓaka ci gaba da sa ido kan matsalolin ta hanyar fara shigar da tsarin cikin sabon tsarin bincike na tsarin, sannan kuma sake dawo da shi ta hanyar da ta dace lokacin da barazanar ta ƙare.
Magungunan maye gurbin (har ma da sake amfani da shi, sake sakewa, sake amfani ko sake amfani da magani) shine sake amfani da magani da aka yarda da shi don magance cututtuka ko yanayin kiwon lafiya daban, wanda aka tsara shi don.
Wannan shine jerin binciken kimiyya da ake bi yanzu don ƙirƙirar magani mai lafiya da tasiri don COVID-19.
Sauran hanyoyin bincike sun haɗa da haɓaka allurar rigakafi da kuma ƙarin jini daga mutanen da suka warke. SARS-CoV-2 yana da ƙwayoyin cuta 66 na ƙwayoyin cuta, wanda ke da ...
Binciken waɗannan shafukan yanar gizo masu alaƙa ya ba mu damar samar da ƙwayoyin cuta masu tasiri ga ƙwayoyin COVID-19 masu amfani da ƙwayoyin cuta.
Muhimman sunadaran da ke nuna SARS-CoV-2 sune popin-like derivative, RNA mai ɗaure da RNA mai tsaka-tsaki.
Hussain A A, ET duk karatun tare da wasu zaɓaɓɓun abubuwan haɗin za a yi amfani da su sosai kuma a bincika su kusan zuwa kasusuwa tare da mafi ƙarfin magani mai kama da wanda aka yarda da shi saboda saurin motsi na ci gaban maganin SARS-CoV2 a cikin sashin binciken lafiya don ba da shawarar a cikin ƙirar binciken likita.
Chloroquine magani ne na cutar zazzabin cizon sauro wanda ake amfani dashi don magance wasu cututtukan autoimmune.
A ranar 18 ga Maris, WHO ta sanar da cewa chloroquine da hydroxychloroquine suna cikin magunguna huɗu da ake bincike a matsayin ɓangare na tallafin gwaji na asibiti.
Gwamnan New York* Andrew Cosmo ya sanar da cewa jihar New York za ta fara gwajin chloroquine da hydrochloroquine a ranar 24 ga Maris. A ranar 28 ga Maris, FDA ta ba da izinin amfani da sulfur hydrochloroquine da chlorchloroquine phosphate a ƙarƙashin Dokar Amincewa da Amfani da Gaggawa (EUA).
Ba a yarda da maganin ta hanyar tsarin gwajin asibiti na FAD ba, kuma an ba da izinin EUA ne kawai don magance matsalolin da ke tattare da rashin lafiyar marasa lafiya waɗanda ke da rashin lafiya amma ba za su iya karɓar magani a asibiti ba (a cikin gwaji).
CDC ta ce "ba a ba da izinin amfani da shi ba, bayar da magani, ko tsawon lokacin hydroxychloroquine don karewa ko warkewa daga kamuwa da cutar SARS-CoV-2" ba tukuna.
Likitoci sun ce suna amfani da magunguna ne kawai idan "ba su da wani zaɓi".
Wata ƙungiyar bincike ta Turkiyya a Istanbul tana gudanar da ƙaramin bincike kan amfani da chloroquine a hade tare da zinc, bitamin A, bitamin C da ƙananan bincike kan amfani da chloroquine a hade tare da zinc, bitamin A, bitamin C da bitamin D.
Akwai manyan bincike da ake yi a Jami'ar Duke da Jami'ar Oxford.
Makarantar Likita ta NYU Langone tana gudanar da gwaji kan aminci da tasirin kiyayewa daga amfani da hydroxychloroquine.
Gwaje-gwajen da aka yi a dakin gwaje-gwaje na kasar Sin a Wuhan da Shenzhen
Marasa lafiya 35 a Shenzhen sun nuna rashin lafiya a matsakaiciyar kwanaki 4, yayin da tsawon lokacin cutar ya kai kwanaki 11 a cikin marasa lafiya 45 da ba su karɓa ba.
A cikin binciken da aka gudanar a Wuhan, an yi amfani da 240 masu fama da cutar nimoniya, rabin su sun karɓi favipiravir kuma rabin sun karɓi umifenovir.
Ƙungiyar likitocin Italiya ta ba da tabbacin cewa ba a samar da isasshen magani ba kuma har yanzu yana cikin matakai.
A ranar 2 ga Afrilu, Jamus ta sanar da cewa za ta sayi magunguna daga Japan don ma'aikatunta, kuma za ta yi amfani da sojojinta don jigilar magungunan zuwa asibitocin jami'a, inda za a yi amfani da su don kula da marasa lafiya na COVID-19.
A cewar wani labari daga kudancin kasar Sin da safe, Shinzo Abe ya gargadi shugaban kasa Trump game da sayar da magunguna.
Ba zai zama mai lafiya ba don amfani ga mata masu ciki ko waɗanda suke son yin ciki.
Studell a kan Lipnavir/Ritonavir (Kalitra) Bayani game da nau'in: Lipnavir/Ritonavir wani nau'in magani ne da aka sayar a ƙarƙashin New Kalitra wanda aka yi amfani da shi a tsakanin sauran don magance cutar kanjamau da sauran cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut
An tsara magungunan don kawar da nau'in HIV daga ƙwayoyin cuta.
Wata ƙungiyar masu bincike a Jami'ar Colorado suna ƙoƙarin canza magunguna don gano fili wanda ke rubuta enzyme mai lalata furotin na SARS-CoV-2. Akwai wasu zargi a cikin ƙungiyar kimiyya game da tura albarkatu zuwa sabbin magunguna musamman waɗanda aka haɓaka don HIV/AIDS.
WHO ta haɗa da lopinavir/ritonavir a cikin gwajin duniya.
An kirkiro Remdesivir kuma an ci gaba da shi ta hanyar Glide Science don magance cutar Ebola da cutar murar ƙwari. Glide Science ta gano cewa Remdesivir yana da aikin rigakafin kwayar cuta a cikin in vitro akan filato, pennum, paramyxoma, da coronavirus.
Matsalar da ke tattare da maganin kwayar cutar ita ce, haɓakar rigakafi ta hanyar ƙetare ƙwayoyin cuta a kan DNA ya haifar da cututtuka masu tsanani da cututtuka masu saurin kamuwa da cuta.
Wasu nazarin farko sun ba da shawarar cewa Remdesivir yana da ƙarfin rigakafi. Akwai wasu gwaje-gwaje na yau da kullun, biyu da asibitin Cleveland University ya tsara; ɗaya don waɗanda ke da matsakaiciyar cutar kuma ɗayan don waɗanda ke da cutar mai tsanani.
Akwai gwaje-gwaje uku na likita don bitamin C don shiga cikin jini ga mutanen da ke asibiti ko marasa lafiya saboda COVID-19; biyu da aka sarrafa (Sine, Kanada) da kuma wanda ba a sarrafawa (Italiya).
Jihar New York ta fara gwajin maganin azithromycin a ranar 24 ga Maris, 2020.
Cibiyar Kula da Lafiya ta Duniya ta Japan (NCGM) ta shirya gwajin gwaji na asibiti don maganin Alvesco na Tajin cyclesonide, maganin maganin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Hanyar maganin angiotensin-converting enzyme 2, maganin 2 shine hanyar da za a iya gano marasa lafiya 200 a cikin yanayin mai tsanani, a cikin asibitoci a Denmark, Jamus da Austria don tabbatar da ingancin magani.
Masu bincike a Cibiyar Zuciya ta Montreal a Kanada suna nazarin rawar colchicine collagen a rage haushi da cututtukan huhu a cikin marasa lafiya da ke fama da alamun cutar COVID-19.
An kira gwajin COLCORONA, wanda ke kula da mutane 6,000 masu shekaru 40 zuwa sama waɗanda aka gano suna da cutar COVID-19 ko kuma suna da alamun cututtukan da ba sa buƙatar asibiti.
Mata masu ciki ko masu shayarwa ko waɗanda ba su da hanyar hana ɗaukar ciki ba su dace ba.
Ana gano magungunan anticoagulant da yawa a Italiya.
Ana amfani da maganin anticoagulant a cikin maganin marasa lafiya, kuma ci gaba da aikin likita na Italiya don kafa takardar shaidar yadda za a yi amfani da shi.
An ba da rahoton gwajin gwaji na 300 a cikin marasa lafiya game da yadda ake amfani da sodium enoxaparin enoxaparin don hana da amfani da miyagun ƙwayoyi a Italiya a ranar 14 ga Afrilu.
Tun lokacin da aka gano SARS-CoV-2 a matsayin kwayar cuta. Binciken kimiyya ya mai da hankali kan inganta magungunan rigakafin cutar da aka samu a lokacin barkewar cututtuka kamar MERS, SARS, da West Nile virus.
Ribavirin: An ba da shawarar ribavirin don maganin cutar COVID-19 a ƙarƙashin Dokar Sinima ta 7.
Amfenovir: An gabatar da amfenovir don maganin cutar COVID-19 a ƙarƙashin umarnin cutar Sin-Variant 7.
Wasu magungunan rigakafi da aka gano a matsayin magungunan ɓoye na COVID-19:
Tosylisib (mai hana IL-6): China ta amince da shi.
Duba kuma gwaje-gwaje a Italiya da Sin da Tocilizumab #COVID-19.
An yi hasashen rigakafin COVID-19 don cutar coronavirus ta 2019 (COVID-19).
Ko da yake babu wani kwayoyin da ya kammala gwajin gwaji, akwai ƙoƙari da yawa a matakin ci gaba don bunkasa kwayoyin.
A ƙarshen Fabrairun 2020, Hukumar Lafiya ta Duniya (WHO) ta ce ba ta hango cutar SARS-CoV-2 ba, cutar da ke haifar da cutar, a cikin ƙasa da watanni 18.
An zaɓi kwayoyi biyar a cikin binciken farko na aminci a watan Afrilu.
An gano COVID-19 a watan Disamba na 2020.
Yawancin ɓarkewar duniya a cikin 2020, zai haifar da ayyukan saka hannun jari da bincike don haɓaka kwayoyin cuta.
Yawancin hanyoyin da aka kafa na amfani da ilimin halittar halittu don haɓaka maganin rigakafi mai tasiri akan SARS-CoV-2.
A watan Afrilu an sanar da mahimman abubuwan da CEPI ke buƙata don haɓaka Peugeot waɗanda suka haɗa da sauri, iyawa, kayan sarrafawa da haɗin duniya.
A watan Afrilu, masana kimiyya na CEPI sun ba da rahoton cewa akwai fasahohin dandamali daban-daban 10 a ƙarƙashin bincike da ci gaba a farkon 2020 don ƙirƙirar allurar rigakafi mai tasiri akan COVID-19.
Akwai dandamali da yawa na ci gaban manufa a cikin 1st Phase na Nazarin Tsaro wanda ya haɗa da:
Kwayar nucleic acid (DNA da RNA) (mataki na 1 mai haɓaka da kuma mai zaɓin mai zaɓin: moderna, mRNA-1273)
Kwayar cutar da aka yi niyya (mataki na 1 mai haɓaka da kuma mai zaɓin mai amfani: CanSino Biologics, adenovirus mai ɗaukar hoto na 5.
Kamar yadda masana kimiyya na CEPI suka sanar a watan Afrilu, an zaɓi jimlar shafuka 115 a farkon matakan ci gaba, kuma 78 an sanya su a matsayin ayyukan aiki (79 a cewar Cibiyar Milkin), kuma an sanar da 37 a matsayin, amma tare da rashin samun bayanai na jama'a (wanda aka tsara a cikin tsare-tsare ko tsara su).
Mataki na 1-2 na gwaji yana samar da lafiyar farko da gwajin rigakafi, yawanci a kan gwaji, magani mara lahani da kuma riƙewa a duka biyu, yayin da ƙayyade magani a cikin mafi mahimmanci, mafi tasiri.
Gwaje-gwaje na Mataki na 3 yawanci sun haɗa da ƙarin mahalarta, wanda ya haɗa da ƙungiyar sarrafawa da kuma nazarin tasirin maganin don hana cutar yayin lura da mummunan sakamako daga shan magani.
Daga cikin kwayoyin cuta 79 da aka zaɓa a cikin ci gaba mai aiki (wanda aka ƙaddamar a farkon Afrilu 2020), 74 ba su kasance a matakin kimantawa na ɗan adam ba (har yanzu suna cikin bincike).
A ranar 24/1/2020 a Ostiraliya, Jami'ar Queensland ta sanar da cewa tana nazarin kwayoyin cuta na al'ada wanda ke canza kwayoyin halitta na furotin don haifar da amsa mai karewa.
A ranar 24/1/2020 a Kanada, Cibiyar Vaccine ta Duniya (VIDO-InterVac) a Jami'ar Saskatchewan ta sanar da fara aiki a kan maganin, da nufin fara amfani da shi a cikin mutane a 2021.
An sanar da ayyukan ci gaban peyote a Cibiyar Kula da Cututtuka da Cututtuka ta Sin a ranar 26/1/200, da kuma Jami'ar Hong Kong a ranar 28/1/2020.
A ranar 29/1/2020, kamfanonin harhada magunguna Janssen Pharmaceutical, Hanneke Schuitemakr ya sanar da cewa sun fara amfani da shi don haɓaka wani magani.
Jancem ita ce kamfanin da ke haɓaka kwayoyi masu aiki tare da abokin aikinsa na fasaha, Vaxart.
A ranar 18/3/2020, Biotherapeutics ta sanar da sabon haɗin gwiwar masana'antu tare da Vaxart don haɓaka ƙwayoyin cuta.
A ranar 8/2/020, OncoGen Lab a Romania ya kafa wani shafin yanar gizon da aka tsara tare da fasaha mai kama da wanda aka yi amfani da shi don magance cututtukan cututtukan yara.
A ranar 25 ga Maris, manajan binciken ya sanar da cewa sun kammala aikin karshe na samar da peyote kuma suna fara gwaji.
A ranar 27/2/2020, wani kamfani na Generex - NuGenerex Immuno-Oncology ya sanar da cewa sun fara aikin kera peptide mai mahimmanci don magance COVID-19.
Sun so su samar da wani magani wanda za a iya gwadawa a kan mutane "a cikin kwanaki 90".
A ranar 5/3/2020, Jami'ar Washington a St. Louis ta sanar da aikinta na haɓaka peyote.
A ranar 5/3/2020, rundunar likitocin bincike ta Majalisar Dinkin Duniya da rundunar kwamandan a Fort Detrick da rundunar bincike ta Walter Reed a Silver Spring, duka biyu a yammacin Maryland, sun bayyana cewa suna aiki kan wani makami.
A ranar 10/3/2020, sabon maganin halittu ya sanar da cewa yana da alaƙa da kamfanin Novavax.
A cikin ci gaban da kuma samar da wani abun ciki.
Manyan abokan hulɗa sun sanar da shirye-shiryen su don aikin da ba a kammala ba kuma za su fara gwajin gwaji na 1 a ranar 7 ga Mayu, 2020.
A ranar 21/3/2020, Ministan Lafiya na Indiya ya ce suna aiki a kan nau'ikan 11 daban-daban, kuma ko da a cikin saurin gudu zai ɗauki aƙalla shekara ɗaya da rabi zuwa shekaru biyu don haɓaka kwayar cuta.
A ranar 12/3/2020, Medicago, wani kamfanin fasahar kere-kere na Quebec, ya sanar da ci gaban kwayar cutar coronavirus a matsayin karamin sashi a karkashin ba da gudummawa daga Cibiyoyin Nazarin Kiwon Lafiya na Kanada.
An ƙaddamar da kwayar cutar da aka zaɓa a ƙarƙashin binciken dakin gwaje-gwaje, tare da gwajin ɗan adam da aka shirya a watan Yuli da Agusta 2020.
A farkon makon, jaridar Guardian Guardain ta ruwaito cewa Shugaban Majalisar Dinkin Duniya Donald Trump ya ba da CureVac "babban kuɗi" don neman hanyar rigakafin COVID-19, duk da ƙin yarda da Jamus.
A ranar 17/3/2020, kamfanin harhada magunguna na Amurka Pfizer ya sanar da haɗin gwiwa tare da kamfanin BioNTech na Jamus don haɓaka maganin mRNA-based tare.
Wani kwayar cuta mai suna BNT162 mai amfani da mRNA, yanzu yana cikin gwaji kuma ana sa ran fara gwajin asibiti a watan Afrilu na 2020.
A Italiya a ranar 17 ga Maris, 2020, Kamfanin Biotechnology, Takis Biotech ya sanar da cewa sakamakon gwajin da ba a kammala ba zai kasance a watan Afrilu na 2020 kuma za a iya gwada sigar ƙarshe ta Fructose akan mutane da yardar kaina.
A Faransa a ranar 19 ga Maris, 2020, Cibiyar Innovation for Epidemic Preparedness (CEPI) ta sanar da ba da gudummawar dala miliyan 4.9 ga ƙungiyar bincike ta COVID-19 mai haɗuwa da Cibiyar Pasteur da Thames Bioscience (Vienna, Austria) da Jami'ar Pittsburgh.
Sauran haɗin gwiwar CEPI don haɓaka rigakafin COVID-19 sun haɗa da Moderna da Curevac da Inovio da Novavax da Jami'ar Hong Kong da Jami'ar Oxford da Jami'ar Queensland.
A ranar 20/3/2020, hukumomin kiwon lafiya na Rasha sun sanar da cewa masana kimiyya sun fara gwajin kwayoyi shida daban-daban akan dabbobi.
Masu bincike a Kwalejin Sarauta ta Landan sun bayyana a ranar 20 ga Maris, 2020 cewa suna haɓaka maganin rigakafin COVID-19.
An samar da takaddun da aka zaɓa a cikin kwanaki 14 ta hanyar watsi da tsare-tsaren a Sind.
A ƙarshen Maris, Gwamnatin Kanada ta ba da sanarwar ba da tallafin dala miliyan 275 ga ayyukan bincike na maganin rigakafi na COVID-19 96, wanda ya haɗa da wasu ƙwararrun ƙwararrun masana'antu daga kamfanonin Kanada da jami'o'i, kamar su Medicago da Jami'ar Saskatchewan.
A lokaci guda, Gwamnatin Kanada ta sanar da cewa ta ba da dala miliyan 192 musamman don haɓaka COVID-19 PEUCUT, tare da shirye-shiryen kafa "Bankin PEUCUT" na sabbin PEUCUT na duniya waɗanda za a iya amfani da su idan wani sabon cutar coronavirus ya ɓarke.
A ranar 2/4/2020, masu bincike a Jami'ar Pittsburgh Medical School sun sanar da cewa Pittsburgh ta gudanar da gwajin COVID-19 a kan beraye, suna cewa "allurar rigakafin MNA don SARS-CoV-2 S1 ta haifar da amsawar rigakafin rigakafin rigakafi [a cikin beraye] wanda a bayyane ya fara makonni 2 bayan kariya.
A ranar 16/4/2020 a Jami'ar Pharmaceutical ta Waterloo a Kanada ta sanar da zane-zane na DNA da aka zaɓa ta hanyar tsalle.
Ta amfani da kwayoyin cuta, ana tsara DNA don ɗaukar kwayar cutar ɗan adam don samar da ƙwayoyin cuta marasa lahani kamar ƙwayoyin cuta, don ƙarfafa tsarin garkuwar jiki don samar da ƙwayoyin cuta ga SARS-CoV-2.
A watan Maris na 2020, gwamnatin Amurka, masana'antu, da jami'o'i uku sun haɗa kayan aikin su don haɗawa da kwamfutar tafi-da-gidanka mai girma daga IBM, haɗe tare da kayan aikin lissafi daga Hewlett Packard Enterprise, Amazon, Microsoft, da Google.
Wasu ƙwayoyin cuta suna da tasiri daban-daban, wanda ake kira tasirin da ba a bayyana ba.
Wannan yana nufin za su iya amfana bayan an dakatar da cutar.
An yi wani gagarumin aiki a Ostiraliya don neman ma'aikatan kiwon lafiya 4,170.
Abubuwan haɓaka na iya zama marasa lafiya ko tasiri.
Farkon ilimin halittu don ƙayyade tasirin kwayoyin COVID-19 a cikin takamaiman dabbobi, misali, ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta (ACE2), buƙatar matakan aminci na 3 don magance ƙwayoyin cuta masu rai, gudanarwa ta duniya don tabbatar da matakan aminci na gwaji.
An gwada kwayoyin cutar SARS da MERS a kan dabbobi amma ba a gwada su a cikin mutane ba.
A shekarar 2020, babu wani magani ko maganin rigakafi don SARS da aka nuna yana da aminci da tasiri a cikin mutane.
A cewar takardun bincike da aka buga a 2005 da 2006, ganowa da kuma bunkasa sababbin kwayoyi da magunguna don maganin SARS shine babban fifiko ga gwamnatoci da ma'aikatan kiwon lafiya a duniya.
Lokacin da MERS ya zama sanannen cuta, an yi imanin cewa samun binciken SARS na iya ba da wata hanya mai amfani don haɓaka maganin cutar da ke haifar da cutar MERS-CoV.
A watan Maris na 2020, akwai kwayar cuta guda ɗaya ta MERS da ta kammala gwajin gwaji na mutum na 1, kuma akwai wasu uku a cikin ci gaba, dukansu kwayar cuta ce ta kwayar cuta, biyu daga cikin kwayar cutar adenoids (ChAdOx1-MERS da BVRS-GamVac), da kuma MVA-vectored (MVA-MERS-S).
Shafukan watsa labarai na yanar gizo sun bayyana shirin tsabtace kwayar cutar a bayan COVID-19 wanda aka riga aka san cewa akwai wani nau'i.
An gabatar da sababbin abubuwa ne saboda alamun da aka buga game da cutar a kan kafofin watsa labarun tare da abubuwan da suka shafi aikin kwayoyin halitta da kuma bambancin kwayoyin halitta ga sauran nau'in coronavirus kamar SARS.
Cutar kwayar cutar coronavirus b-2019 (COVID-19) cuta ce mai saurin kamuwa da cuta da ke haifar da alamun cututtukan numfashi na SARS-CoV-2.
Alamomin yau da kullum sun haɗa da tari, tari da kuma numfashi.
Sauran alamun cututtuka na iya haɗawa da gajiya, ciwon tsoka, zawo, zazzabi mai zafi, asarar wari, da ciwon ciki.
Lokaci na bayyanar cututtuka na farko shine kullum a cikin kwanaki biyar amma zai iya bambanta daga kwana biyu zuwa goma sha huɗu.
Yayinda yawancin lokuta ke haifar da bayyanar cututtuka, wasu suna ci gaba zuwa ciwon huhu da kamuwa da cututtukan jiki.
A ranar 17/4/2020, an samu sama da mutane miliyan 2.24 da suka kamu da cutar a kasashe da yankuna 210, wanda ya yi sanadiyar mutuwar mutane sama da 153,000.
Fiye da mutane 568,000 sun warke. Ana yada kwayar cutar musamman tsakanin mutane yayin kusanci, galibi ta hanyar ƙananan hawan numfashi ta hanyar shan taba, shan taba, da magana.
Yayin da ƙananan ruwa ke haifar da numfashi, yawancin lokuta suna sauka a ƙasa ko a kan tsire-tsire kuma suna kamuwa da su daga nesa.
Mutane suna kamuwa da cutar ta hanyar taɓa fuskar da ba ta da tsabta sannan su taɓa idanunsu, hanci, da baki.
Kwayar cutar na iya kasancewa a kan tsire-tsire har tsawon sa'o'i 72.
Ana samun mafi yawan yaduwar cutar a cikin kwanaki uku bayan bayyanar cututtuka na farko, kodayake yaduwar na iya faruwa kafin bayyanar cututtuka ko a cikin matakan cutar. Hanyar da aka saba amfani da ita don gano cutar ta hanyar lokacin da za a iya tunawa da shi shine polymerase chain reaction (rRT-PCR) a cikin hanci da makogwaro.
Ana ba da shawarar yin amfani da abin rufe fuska ga waɗanda ake zargi da cutar da masu kula da su.
Shawarwarin likita don amfani da abin rufe fuska ta hanyar mutane daban-daban, wasu gwamnatoci suna ba da shawarar a kan amfani da su, wasu suna ba da shawarar amfani da su, wasu kuma suna ba da shawarar amfani da su.
A halin yanzu, babu takamaiman maganin rigakafi ko maganin rigakafin COVID-19.
An samu yaduwar cutar a cikin yawancin ƙasashe a cikin yankuna shida na WHO.
Wadanda ke dauke da kwayar cutar na iya zama marasa alamun cutar ko kuma suna iya nuna alamun cutar kamar tari, tari, gajiya, da kuma rashin numfashi.
Alamun gaggawa sun haɗa da numfashi mai wuya, ciwon kirji ko ciwon bugun jini, tashin hankali, wahalar farkawa, da hawaye na fuska ko baki: shawarwarin neman kulawar likita nan da nan idan kun sami waɗannan alamun.
A mafi ƙarancin lokaci, ana iya ganin alamun sama na numfashi kamar haushi, sanyi ko ciwon makogwaro.
An lura da alamun numfashi kamar tashin zuciya, tashin zuciya da maƙarƙashiya a cikin ƙididdiga.
Wasu lokuta a cikin Sin suna da ciwon kirji da bugun zuciya.
A wasu lokuta, cutar na iya haifar da ciwon huhu, lalacewar sassan jiki, da mutuwa.
Wannan shi ake kira lokacin bayyanar cututtuka.
Kwana biyar zuwa shida na iya canzawa zuwa kwana biyu zuwa 14.
Don haka a cikin kwanaki 11.5 na kamuwa da cutar. Rahotanni sun nuna cewa ba duk waɗanda ke kamuwa da cutar ba ne ke samun ci gaba.
Ba a san cikakken rawar da masu ɗaukar hoto marasa alamomi ke takawa wajen watsa kwayar cutar ba, kodayake shaidun farko sun nuna cewa suna iya haifar da yaduwar cutar.
Ba a san adadin mutanen da ba su nuna alamun cutar ba a halin yanzu kuma ana binciken su, cibiyar kula da cututtuka ta KCDC ta ce kashi 20 cikin dari na masu kamuwa da cutar ba su nuna alamun cutar ba yayin zaman su a asibiti.
Hukumar Lafiya ta Duniya ta fara da cewa marasa alamun cutar sun kai kashi 1/4 na yawan masu kamuwa da cutar a kowace rana: 166 kamuwa da cutar a ranar, 130 (78) ba su da alamun cutar a lokacin fashewa.
Dukansu leaks da leaks na iya ɗaukar babban kwayar cutar.
Yin magana da ƙarfi yana fitar da ƙananan ɗigon ruwa fiye da magana ta yau da kullun.
Wani bincike a Singapore ya gano cewa cocaine ba tare da murfin ba zai iya sa ƙananan digo su tafi tsawon mita 4.5 (15 ft).
Kodayake ba a yawan watsa kwayar cutar ta iska, masana kimiyya na duniya sun ba da shawarar cewa za a iya samun kwayar cutar ta iska ko kuma masu ɗaukar iska a cikin hanyoyin ɗakunan mutane suna haifar da samfurin RNA mai kyau don kwayar cutar.
Wasu ayyukan likita kamar shigar da bututun iska da CPR na iya haifar da shigar da numfashi zuwa iska mai tsabta kuma hakan yana haifar da yaduwar iska.
Duk da yake akwai ra'ayin cewa ana iya yadawa ta hanyar baki, wannan tsoron ya ragu. Kwayar cutar tana da sauƙin yaduwa lokacin da mutane ke da alamun cutar; yayin da yaduwar na iya faruwa kafin bayyanar cututtuka, tsoro yana da ƙarancin.
Cibiyar Kula da Cututtuka ta Turai (ECDC) ta ce yayin da ba a san yadda cutar ke yaduwa ba. Mutum ɗaya yana kamuwa da mutane biyu zuwa uku. Kwayar cutar tana rayuwa a farfajiyoyi na awanni zuwa kwanaki.
Musamman, an gano kwayar cutar da za ta iya kasancewa a kan kwali na kwana ɗaya, fiye da kwana uku a kan filastik (mai laushi mai zafi) da kuma karfe mai tsabta, da kuma fiye da sa'o'i hudu a kan jan ƙarfe 99%.
Duk da haka, nauyin nauyi yana dogara ne akan zafi da zafin jiki.
Sabulu da kayan shafawa suna da tasiri idan aka yi amfani da su yadda ya kamata, sabulu yana lalata matakan ƙwayoyin cuta, yana hana su aiki, kuma yana sakin su a kan fata da sauran abubuwa.
Sauran magungunan, kamar maganin shafawa da maganin rigakafin cutar (anti-inflammatory). A cikin binciken da aka yi a Hong Kong, an samo samfurori na leaks a cikin zane na kwana biyu bayan fara zaman asibiti.
Daga cikin marasa lafiya shida, biyar sun nuna mafi girman ƙwayar cuta a farkon gwajin, kuma na shida ya nuna mafi girman ƙwayar cuta a gwajin rana ta biyu.
SARS-CoV-2 wani sabon kwayar cuta ne mai saurin kamuwa da cuta, wanda aka fara ganowa daga mutane uku da ke fama da cutar sankarar bargo a birnin Wuhan.
Dukkanin nau'ikan sabon SARS-CoV-2 sun samo asali ne daga wasu ƙwayoyin cuta masu alaƙa da coronavirus a cikin yanayi.
A waje da jikin mutum, sabulu na gida yana kashe kwayar cutar, wanda ke lalata ƙwayoyin cuta. SARS-CoV-2 yana da alaƙa da asalin SARS-CoV.
Cutar huhu ita ce mafi saurin kamuwa da cutar COVID-19 saboda kwayar cutar tana shiga cikin ƙwayoyin cuta ta hanyar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar
Kwayar cutar tana amfani da wani nau'in ƙwayar cuta na ciwon sukari da ake kira "peplomer" don haɗawa da ACE2 da kuma shiga cikin tantanin halitta.
An gano ciwon zuciya mai tsanani a kashi 12% na marasa lafiya da aka kwantar a asibiti a birnin Wan, Sin, kuma yana sake faruwa a cikin cututtuka masu tsanani.
Yawan alamun cututtukan zuciya suna da yawa, wanda ke haifar da ciwon jijiyoyin jiki da rashin lafiyar tsarin rigakafi, amma lalacewar ƙwayar zuciya na iya haɗuwa da masu karɓar ACE2 a cikin zuciya.
Masu karɓar ACE2 suna da ƙayyadaddun ƙayyadaddun ƙwayoyin cuta a cikin zuciya kuma suna aiki a cikin tsarin zuciya.
An gano yawan hawan jini na alveolar (31%) da na jini na jini (25%) a cikin marasa lafiya na ICU da ke fama da kamuwa da cutar COVID-19 kuma ana iya alakanta su da rashin yiwuwar murmurewa.
Kodayake SARS-CoV-2 yana da fifiko ga ƙwayoyin epithelial na ACE2 na ƙwayoyin cuta na numfashi, marasa lafiya da ke fama da cutar COVID-19 suna nuna alamun cututtukan cututtukan jiki.
Musamman, an nuna ƙwayoyin T masu ɓoyewa na GM-CSF marasa lafiya don haɗuwa da masu haɓaka cututtukan cututtukan IL-6 masu ɓoyewa da cututtukan huhu masu tsanani a cikin marasa lafiya na COVID-19.
An kuma bayar da rahoton ƙwayoyin lymphocytes a cikin nazarin.
WHO ta fitar da wasu ka'idojin gwaji don cutar.
Hanyar gwajin da aka saba amfani da ita ita ce anti-inhibition polymerase chain reaction (rRT-PCR).
An yi gwajin ne a kan samfurori na numfashi da aka samu ta hanyar samfurin hanci da na hanci; duk da haka, ana iya amfani da samfurin gishiri ko samfurin ruwa.
Sakamakon zai kasance a cikin sa'o'i biyu zuwa kwana biyu.
Ana iya amfani da gwajin jini, amma suna buƙatar a ɗauki samfuran jini biyu makonni biyu a baya kuma sakamakon yana da ƙima nan take.
Masana kimiyya na kwayar halitta sun iya ware kwayar cutar coronavirus da kuma rarraba tsarin kwayoyin halitta don haka dakunan gwaje-gwaje a duniya zasu iya haɓaka gwajin aikin polymerase chain reaction (PCR) da kansu don lura da kamuwa da cutar.
A ranar 4/4/2020, gwaje-gwaje na antibodies (wanda zai iya lura da cututtuka masu aiki kuma idan wani ya kamu da cutar a baya) wanda ke cikin ci gaba, amma ba a yi amfani da shi ba tukuna.
Kwarewar nono tare da tsutsa ya nuna cewa yana da daidaito kawai 60% zuwa 70%.
FDA a Amurka ta amince da gwajin farko na cibiyar kulawa a ranar 21/3/2020 don amfani a ƙarshen wannan watan. Dokokin gano cutar da asibitin Zhongnan na Jami'ar Wan ya fitar sun ba da shawarar hanyoyin gano cututtuka dangane da dabi'un likita da haɗarin annoba.
Na'urar gilashin gilashi mai ɗorewa tare da ƙirar, rashin daidaituwa da kuma jinkirin ƙididdigar ƙira a farkon lokacin da aka yi amfani da shi.
Kula da numfashi, hoton radiography (ciwon huhu tare da canzawar alveolar) da kuma rigidity na iya bayyana a matsayin ci gaban cutar.
Ba a san komai game da lahani na gani da rashin lafiyar gani daga COVID-19 ba.
Abubuwan da aka fi sani da marasa lafiya a cikin ilimin halayyar mutum sune:
Idanu: cututtukan huhu, cututtukan zuciya, ƙarancin huhu da kuma cutar sankarar huhu.
Akwai nau'ikan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Rashin ƙwayar cuta mai sauƙi: cututtukan ciki, cututtukan huhu, babban ƙwayar cuta mai girma, ƙwayoyin cuta da ƙwayoyin cuta da kuma babban ƙwayoyin cuta.
Cutar cututtuka mai tsanani: DAD tare da zubar da jini mai yawa.
DAD yana haifar da mummunan ciwon numfashi (ARDS) da kuma rashin iskar oxygen a cikin jini.
Cutar cututtuka: Kwayoyin cututtuka daga alveolar capillaries da kuma hanyoyin da ke tsakanin C.
Jini: DIC: Sakamakon rashin ƙwayoyin red.
Matakan rigakafi don rage haɗarin kamuwa da cuta sun haɗa da kasancewa a gida, nisantar wuraren da ake rikici, wanke hannu da sabulu da ruwa na tsawon dakika 20, motsa jiki mai kyau da motsa jiki, da kuma guje wa zubar da ido da hanci da baki da hannayen da ba a wanke ba.
CDC ta ba da shawarar rufe hanci da baki da kayan shafawa yayin tari ko tari, kuma ta ba da shawarar amfani da maganin shafawa idan ba a samu ba.
Ana ba da shawarar tsabtace hannu bayan kowane cocaine ko pijama.
CDC ta ba da shawarar amfani da abin rufe fuska a wuraren jama'a, don iyakance motsi ta hanyar mutanen da ba su da alamun cutar. Manufar shirin nisantar zamantakewa shine rage hulɗa da mutane masu cutar a cikin manyan ƙungiyoyi ta hanyar rufe makarantu da wuraren aiki, dakatar da tafiye-tafiye da kuma hana manyan taron jama'a.
Dokokin nesa sun kuma ce mutane su kasance aƙalla ƙafa 6 (1.8m) nesa da juna.
Babu maganin da aka gano don ya zama mai tasiri wajen hana COVID-19.Kamar yadda ba a yi hasashen cutar ba har zuwa farkon 2021, wani muhimmin ɓangare na gudanar da COVID-19 shine ƙoƙarin rage ƙimar cutar, wanda aka sani da "ƙaddamar da murƙushewa".
CDC ta kuma ba da shawarar cewa mutane su wanke hannayensu da sabulu da ruwa na tsawon dakika 20, musamman bayan sun je bayan gida ko kuma idan hannayensu sun kasance masu datti sosai, kafin cin abinci da kuma bayan shafa hanci, cocaine ko pijamine.
Ya ci gaba da ba da shawarar yin amfani da maganin wanke hannu wanda ya ƙunshi aƙalla kashi 60% na giya, amma kawai lokacin da ruwa da sabulu ba su da yawa. Ga yankunan da ba a samun maganin wanke hannu, WHO ta ba da dokoki biyu don samar da gida.
A cikin waɗannan ka'idoji, aikin antibacterial ya fi girma fiye da ethanol ko isopropanol.
Ana amfani da hydrogen peroxide don taimakawa wajen kawar da ƙwayoyin cuta a cikin barasa; wannan "ba abu ne mai aiki ba don maganin cututtukan hannu".
An ƙara glycerin a matsayin mai laushi.
Ana gudanar da kulawa ta tallafi ga mutane, wanda zai iya haɗawa da maganin magani, tallafin oxygen, da kuma tallafawa wasu kwayoyin cutar.
CDC ta ba da shawarar cewa waɗanda ake zargi da ɗaukar kwayar cutar su sanya abin rufe fuska mai sauƙi.
An yi amfani da ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar
Ana sa ran tsabtace jiki da rayuwa mai kyau da kuma kiyaye abinci don inganta rigakafi.
Magungunan tallafi na iya zama da amfani ga mutanen da ke da alamun bayyanar cututtuka a farkon lokacin kamuwa da cutar. WHO da Hukumar Lafiya ta Duniya sun ba da shawarwarin likita don lura da mutanen da aka kwantar da su a asibiti saboda COVID-19.
Masu lura da lafiya da masana kimiyyar huhu a Majalisar Dinkin Duniya sun tattara shawarwarin maganin cutar daga kwayar cutar a cikin wani abu mai sauki, IBCC.
A watan Afrilu na 2020, babu takamaiman magani don COVID-19.
Don bayyanar cututtuka, wasu likitoci suna ba da shawarar paracetamol a kan ibuprofen don layin farko na amfani.
Ya kamata a ɗauki matakan kariya don rage haɗarin yaduwar kwayar cutar, musamman a wuraren kiwon lafiya inda yin ayyukan da zasu iya haifar da aerosols, kamar sanya bututun iska ko iska mai iska.
Don masu kula da lafiya da ke kula da mutane tare da COVID-19, CDC ta ba da shawarar sanya mutumin da ke da cutar a cikin ɗakin keɓewa (AIIR) da kuma amfani da sanarwa na yau da kullun, mai haɗa kai da sanarwa.
Abubuwan da aka ba da shawarar: PPE shirts, respirators ko masks, masu kare ido, da kuma safofin hannu na likita. Lokacin da aka samu, an yarda da masu amfani da respirators (maimakon masks).
An ba da izinin N95 don wuraren masana'antu amma FDA ta ba da izinin amfani da masks a ƙarƙashin dokar ta ba da izinin amfani da gaggawa (EUA).
An tsara su don karewa daga ƙwayoyin iska kamar ƙura amma tasirin su akan takamaiman tushen halitta ba tabbas bane don amfani da ba a tabbatar da shi ba.
Lokacin da ba a samun abin rufe fuska, CDC ta ba da shawarar amfani da abin rufe fuska, ko abin rufe fuska na gida a matsayin makamancin ƙarshe.
Yawancin lokuta na COVID-19 ba su da ƙarfi sosai don buƙatar iska ko musayar, amma akwai adadin waɗanda suke buƙatar hakan.
Ana gudanar da bincike sosai game da nau'ikan taimakon numfashi ga mutanen da ke da alaƙa da COVID-19 don masu shan iska a asibiti, tare da wasu shaidu cewa ana iya guje wa amfani da inhaler ta hanyar inhaler na baka ko iska mai ƙarfi.
Ba a san ko kowanne daga cikin waɗannan yana da amfani iri ɗaya ga mutanen da ke da cutar mai tsanani ba.
Wasu likitoci sun fi son kasancewa tare da na'urar iska mai saurin motsa jiki idan akwai, saboda wannan yana iyakance yaduwar ƙwayoyin aerosol fiye da na iska mai saurin motsa jiki. Abubuwan da suka faru sun fi yawa a cikin tsofaffi (waɗanda suka wuce shekaru 60, musamman waɗanda suka wuce shekaru 80).
Yawancin ƙasashe masu tasowa ba su da isasshen wuraren kula da marasa lafiya a asibitocin su don kowane mai haƙuri wanda ke iyakance ikon tsarin kiwon lafiya don sarrafa ƙaruwar ƙaruwar cutar coronavirus mai tsanani wanda ke buƙatar zama a asibiti.
Wani gwaji na kimiyya a Sin ya gano cewa kashi 5% an yarda su kasance a cikin dakunan kulawa, kashi 2.3% suna buƙatar taimakon likitancin ventilation, kuma kashi 1.4% sun mutu.
A Sindh, kusan kashi 30% na mutanen da ke asibiti saboda COVID-19 ana kai su ICU.
Kayan aikin iska suna da rikitarwa saboda ci gaban alamun damuwa na numfashi mai tsanani (ARDS) a cikin COVID-19 da kuma aikin oxygenation yana da wahala sosai.
Masu motsa jiki suna da ikon sarrafa matsin lamba kuma ana buƙatar PEEP mai yawa don haɓaka isar da iskar oxygen yayin rage haɗarin motsa jiki da ke tattare da lalacewar iska zuwa cikin huhu.
Ƙarin PEEP bazai samuwa a cikin tsofaffi masu motsa jiki ba.
An fara binciken sababbin magunguna a watan Janairun 2020, kuma akwai magungunan rigakafi da yawa a cikin dakunan gwaje-gwaje.
Magungunan rigakafi na iya zama mafi tasiri.
Kodayake sabbin magunguna suna ɗaukar lokaci har zuwa 2021 don ci gaba, yawancin magungunan da aka ƙaddamar da su an yarda da su don wasu amfani ko kuma a cikin gwaji mai ci gaba.
Za a iya gwada maganin rigakafin cutar a cikin mutane a cikin cututtuka masu tsanani.
WHO ta ba da shawarar cewa masu sa kai su guji gwajin lafiya da inganci. FDA ta ba da izinin ɗan lokaci don warkar da plasma a matsayin magani na gwaji a lokuta da rayuwar mutum ke cikin haɗari.
Ba a buƙatar ƙwarewar binciken likita don nuna tasiri da aminci ga cutar.
A watan Fabrairun 2020, Sin ta kirkiro wata manhajar wayar hannu don rage yaduwar cutar.
Masu zanga-zangar sun nemi a rubuta sunaye da lambobin ID.
Wannan software yana da ikon gano "kusa da" ta amfani da bayanan kula da marasa lafiya da kuma haɗarin kamuwa da cuta.
Kowane mai amfani zai iya bincika matsayin wasu masu amfani uku.
Idan an gano wani babban hadari, ba wai kawai shirin yana ba da shawarar a tsare mutane a gida ba, amma kuma yana sanar da jami'an kiwon lafiya na gida. Ana amfani da bayanan bincike da yawa kan bayanan wayar hannu, fasahar gano fuska, da gano wurin wayar hannu don gano mutanen da ke fama da cutar da kuma abokan hulɗarsu a Koriya ta Kudu, Taiwan da Singapore.
A watan Maris na 2020, gwamnatin Isra'ila ta ba jami'an tsaro damar aiwatar da bayanan wayar hannu kan mutanen da ke da yiwuwar kamuwa da cutar coronavirus.
An yi amfani da hanyar don tilasta keɓewa da kare waɗanda ke iya yin hulɗa da mutanen da ke da cutar.
A watan Maris na 2020, Deutsche Telekom ta ƙaddamar da aikace-aikacen wayar hannu na tattara bayanan wuri tare da Daraktan Gwamnatin Tarayya ta Jamus Robert Koch don gudanar da bincike da hana yaduwar cutar.
Rasha ta samar da fasahar gane fuska don gano waɗanda ke yin keɓewa.
Cibiyar kula da lafiyar yankin Italiya, Giulio Galera, ta sanar da cewa masu haɓaka wayar hannu sun yi gargadin cewa kashi 40 cikin ɗari na 'yan ƙasa za su ci gaba da kasancewa a cikin yanayin da ba su da kyau.
Gwamnatin Jamus ta sanar da hutun karshen mako na Hackathon na awa 48 tare da masu halarta sama da 42,000.
Shugaban Estonia Kristi Kaulalaid ya bayyana wayar salula ta duniya a matsayin wata babbar manufa ta yaki da barkewar cutar coronavirus.
Mutane na iya yin baƙin ciki saboda keɓewa, ƙuntatawa na tafiya, illa mai illa na magani ko tsoron kamuwa da cuta.
BBC ta ruwaito cewa Roy O'Kerner ya ce "fiye da ɗaya rabuwa da zamantakewa, kadaici, damuwa da lafiya, baƙin ciki da koma bayan tattalin arziki sune cikakkiyar hanyar cutar da lafiyar jiki da jin dadi".
Zai iya samun matsakaiciyar hanya tare da wasu alamomi ko babu alamomi, kamar sauran cututtukan numfashi masu tsanani kamar mura.
Matsakaicin yanayin yana warkewa cikin makonni biyu. Wannan yayin da mawuyacin hali ko mawuyacin hali yana ɗaukar makonni uku zuwa shida don murmurewa.
Mata masu juna biyu suna da haɗarin kamuwa da cutar COVID-19 mai tsanani kamar yadda aka samo bayanai daga wasu ƙwayoyin cuta masu kama da su, kamar SARS da MERS, amma akwai karancin bayanai game da COVID-19.
A cikin mawuyacin hali, COVID-19 na iya saurin canzawa zuwa mummunan bayyanar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Matsaloli kamar COVID-19 kamar rashin aiki, zubar da jini da kuma lalacewar zuciya, koda da hanta.
Ana samun hawan jini, musamman ma yana haifar da hawan jini na prosorombin (wani furotin a cikin ƙwayar plasma na ƙwayoyin cuta) a cikin kashi 6% na waɗanda aka kwantar da su a asibiti tare da COVID-19, yayin da ake ganin rashin aikin koda na yau da kullun a cikin kashi 4% na al'ada.
Kimanin kashi 20-30% na mutanen da ke da cutar COVID-19 suna da ƙwayoyin cuta.
A cewar wannan rahoton, matsakaicin lokacin tsakanin bayyanar cututtuka da mutuwa a rana ta goma, tare da biyar da aka ware.
Ko da yake, marasa lafiya da aka tura zuwa ICU suna da matsakaicin lokaci na kwana bakwai tsakanin mutuwa da rayuwa.
A cikin nazarin yanayin da aka yi a baya, matsakaicin lokacin bayyanar alamun farko na mutuwa shine kwanaki 14, tare da matsakaicin kwanaki 6 zuwa 41.
A wani binciken da Hukumar Kiwon Lafiya ta Kasa (NHC) ta yi a kasar Sin, mace-macen maza sun kai kashi 2.8 cikin dari, yayin da mace-macen mata suka kai kashi 1.7 cikin dari.
Gwaje-gwajen nazarin canje-canje ga bayan-samfurin ƙwayar cuta sun nuna cewa yaduwar alveolar (mashin baya na mutum) yana haifar da lalacewar ƙwayoyin fibromycoid (ƙwayoyin dabba) a cikin huhu.
An lura da waƙar ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙ
Cutar sankarar bargo ta nuna alamun ciwon bakin ciki mai tsanani (ARDS).
A cikin kashi 11.8 cikin dari na mutuwar da Hukumar Lafiya ta Kasa ta Sin ta ruwaito, an lura da lalacewar zuciya a cikin babban matakin furotin ko kuma bugun zuciya.
A cewar bayanan watan Mayu daga Majalisar Dinkin Duniya, kashi 89 cikin dari na wadanda aka kwantar da su a asibiti sun kasance wadanda ke da cutar a baya.
Yawan mutuwar yana canzawa bisa ga yanayin saboda bambancin da ke tsakanin yankuna, amma kuma saboda wahalar da ke tattare da su.
Yawan adadin masu kamuwa da cutar zai iya zama dalilin da ya sa ake yawan yawan yawan mutuwar.
Ko da yake, gaskiyar ita ce, mutuwar ta kasance sakamakon cututtuka na baya kuma yawan mutuwar yanzu ba a iya kwatanta su ba.
Masu shan sigari suna da sau 1.4 na kamuwa da cutar fiye da mutane masu fama da cutar COVID-19 kuma kusan sau 2.4 na mutanen da ke buƙatar kulawa ta musamman fiye da waɗanda ba sa shan sigari. An ɗaga damuwa game da yanayin cutar na dogon lokaci.
Asibitin Hong Kong na gwamnati ya gano wani magani wanda ke da ƙarfin numfashi 20 zuwa 30 na wasu mutanen da suka warke daga cutar, da kuma na wasu gabobin da suka lalace.
Wannan zai iya haifar da mahimmancin kula da lafiyar jiki a baya don murmurewa.
Har zuwa watan Mayu na 2020, ba a san ko mutanen da ke fama da cutar sun sami ƙarfin jiki mai ƙarfi da kuma tsawon lokaci ba a cikin mutanen da ke murmurewa daga cutar.
Hakanan, an gano rashin ƙarfi, dangane da halayen wasu ƙwayoyin cuta, amma an gano wasu lokuta da suka warke daga COVID-19 tare da tabbataccen gwajin coronavirus a cikin 'yan kwanaki masu zuwa.
Ana ganin cewa waɗannan cututtukan suna daɗa muni idan an sake kamuwa da cutar a cikin dogon lokaci.
An yi imanin cewa kwayar cutar ta kasance ta halitta kuma ta samo asali ne daga dabbobi, daga cutar Spilover.
Ba a san farkon barkewar cutar ba, amma a watan Disamba na shekarar 2020 cutar ta kamu da cutar ta hanyar mutum zuwa mutum.
Binciken da aka yi kan mutane 41 da suka kamu da cutar COVID-19, an buga su a cikin Lancet a watan Disamba na 2020, tare da farkon bayyanar alamun bayyanar cututtuka a ranar 1 ga Disamba, 2019.
Rahoton hukuma na WHO ya bayyana cewa alamun bayyanar cututtuka sun kasance a ranar 8 ga Disamba, 2019.
Ana amfani da ma'auni da yawa don lissafin mutuwar.
Waɗannan lambobin suna bambanta dangane da yanki da lokacin da aka yi amfani da su kuma suna shafar girman gwajin, ingancin tsarin kiwon lafiya, zaɓuɓɓukan magani, lokacin da barkewar cutar ta fara da halaye na yawan jama'a kamar shekaru, jinsi, kiwon lafiya da sauransu.
A ƙarshen 2019, WHO ta sanya takardar ICD mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar SARS-CoV-2 da kuma cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai dauke da cutar mai suna SARS-COVID-19 (COVID-19).
A cewar masana ilimin lissafi na Jami'ar Johns Hopkins, yawan mace-macen duniya da cutar ya kai kashi 6.9% (153,822/2,240,191) a ranar 17 ga Afrilu, 2020.
Adadin ya bambanta a yankuna, wasu ma'auni kamar yawan mutuwar mutane (CFR), wanda ke nuna yawan mutanen da aka gano sun mutu daga cutar, da kuma yawan mutuwar mutane (IFR), wanda ke nuna yawan mutanen da ke da cutar (wanda aka gano ko ba a gano ba) wanda ya mutu daga cutar.
Wadannan masu ilimin lissafi ba su da tasiri a kan lokaci kuma ba sa neman wani mutum mai kamuwa da cutar yayin yanke hukunci game da yanayin.
Duk da yake ba duk mutanen da ke da cutar ba ne ke da ƙwayoyin cuta, kasancewa da ƙwayoyin cuta na iya ba da bayani game da yawan mutanen da ke da cutar.
A tsakiyar barkewar cutar a Italiya, Castiglione d'Adda, wani ƙaramin ƙauye mai yawan mutane 4,600, mutane 80 (1.7%) sun mutu.
A cikin Gangelt, cutar ta yadu ta hanyar bikin Carnival, ya zama sananne tsakanin matasa, yana haifar da ƙananan mutuwar, kuma ba duk mutuwar COVID-19 ba ne za a iya rarraba su kamar haka.
Bugu da ƙari, tsarin kiwon lafiya na Jamus bai riga ya yi nasara ba.
A cikin Netherlands, kashi 3% na masu cutar suna da rigakafi, wanda aka samo daga masu ba da jini.
An tabbatar da mutuwar mutane 69 (0.004% na yawan) daga COVID-19.
Sakamakon cutar da kuma yawan mace-mace ya bambanta ga maza da mata.
Mutuwar ta fi ta maza yawa a cewar wani bincike da aka gudanar a China da Italiya.
Wannan shine mafi yawan tsoro ga maza a cikin shekaru hamsin.
A China, yawan mace-macen maza ya kai kashi 2.8 cikin dari, yayin da mata suka kai kashi 1.7 cikin dari.
Ba a san ainihin dalilin da ya sa akwai bambancin jinsi ba, amma kwayoyin halitta da kuma yanayin hali na iya zama dalili.
Bisa ga ilimin kimiyya na jinsi, shan taba sigari a cikin mata da kuma karuwar cututtuka na "co-morbid" a cikin maza kamar hawan jini a cikin matasan, a cewar mata, na iya haifar da mutuwar mafi girma a cikin maza.
A Turai, kashi 57% na masu kamuwa da cutar maza ne kuma kashi 72% na waɗanda suka mutu daga COVID-19 maza ne.
Har zuwa watan Afrilu na 2020, gwamnatin Amurka ba ta da bayanan da suka danganci jinsi don kamuwa da COVID-19.
Bincike ya nuna cewa cututtukan ƙwayoyin cuta kamar su Ebola, mura da SARS suna shafar maza da mata daban.
Ma'aikatan kiwon lafiya mata da ma'aikatan jinya sun fi yawa, kuma suna da damar da za su iya kamuwa da cutar.
Hukumar Lafiya ta Duniya ta sanar a ranar 11 ga Fabrairun 2020 cewa sunan cutar "COVID-19" ne.
Shugaban WHO Tedros Adhanom Ghebreyesus ya bayyana cewa CO alama ce ta coronavirus, VI na cutar, da kuma 19 don lokacin da aka fara gano cutar: 31 ga Disamba, 2019.
An zaɓi sunan don kauce wa nuna wani yanki na musamman (misali China) ......
WHO ta fi amfani da kalmar "Covid-19 virus" a matsayin "kwayar cutar da ke da alhakin COVID-19" a cikin tattaunawar jama'a.
Wannan cuta ce da kuma kwayar cuta da ake kira "coronavirus".
A lokacin barkewar cutar a Wuhan, China, an kira kwayar cutar da cutar da "coronavirus" da "Wuhan coronavirus".
A watan Janairun 2020, WHO ta ba da shawarar cewa 2019-nCov da 2019-coronavirus mai saurin yaduwa a matsayin sunaye biyu na dindindin don cututtuka da ƙwayoyin cuta dangane da jagorar 2015 game da amfani da wuri a cikin cututtuka da sunayen cututtuka.
An fitar da sunayen hukuma na COVID-19 da SARS-CoV-2 a ranar 11 ga Fabrairu, 2020.
Saboda girman ƙuntatawa bisa ga ƙa'idodin ƙirar China, wasu injiniyoyin ƙirar dijital suna buga mahimman batutuwan kiwon lafiya kamar su murhun laka da sassan injin iska.
A wani misali, lokacin da asibiti na Italiya ya bukaci gaggawa don samun na'urar numfashi, kuma masu kula da su ba su iya samun na'urar ba a lokacin da aka buƙata, an sake farawa a cikin gida don dawo da wasu daga cikin su kuma an matsa su don buƙatar 100 na numfashi a dare.
Tun farkon farawar COVID-19, an haɗa da tsare-tsaren dabaru, jita-jita da maganganu marasa kyau game da asalin, ma'auni, rigakafi, magani ko wasu fannoni na cutar da kuma saurin yaduwa ta hanyar yanar gizo.
An yi imanin cewa mutane suna iya watsa kwayar cutar ga wasu dabbobi.
Binciken kimiyya ya kasa gano hujja na kwayar cutar a alade, namomin kaza da kaji.
Babu wani magani ko magani da aka amince da shi don magance cutar.
Ana gudanar da bincike na duniya kan maganin COVID-19 da magunguna ta hanyar kungiyoyin gwamnati, kungiyoyin ilimi da masana masana'antu.
A watan Maris, Hukumar Lafiya ta Duniya ta fara gwajin gwaji na 'SOLIDARITY Trial' don daidaita tasirin maganin ga mahaɗan anti-virus huɗu waɗanda ke da alaƙa da alƙawarin tasiri na musamman.
Babu wani mai amfani da shi, amma bangarori daban-daban suna samar da kayan aiki masu dacewa.
Aikin da aka yi a baya akan SAES-CoV ya kasance mai ban sha'awa saboda duka SARS-CoV da SARS-CoV-2 suna amfani da fitowar ACE2 don shiga cikin ƙwayoyin ɗan adam.
An bi sahun hanyoyi uku na kisa.
Na farko, manufar binciken shine samar da wani tsari don kowane kwayar cuta.
Yin amfani da ƙwayoyin cuta waɗanda ba su da ƙarfi ko kuma waɗanda suka mutu don saurin amsawa ga tsarin rigakafin mutum ga sabon kamuwa da COVID-19.
Dabara ta biyu ita ce, kwayar cuta ta biyu don samar da kwayar cuta wanda ke sa tsarin garkuwar jiki ya zama mai saurin kamuwa da wasu sassan kwayar cutar.
A cikin yanayin SARS-CoV-2, waɗannan binciken sun mai da hankali kan furotin S-spike wanda ke taimaka wa kwayar cutar shiga cikin hanyar enzyme ACE2.
Dabara ta uku ita ce ta hanyar amfani da nucleic acid (kwayoyin DNA ko RNA, sabon hanyar samar da cutan).
Gwajin gwaji na kowane ɗayan waɗannan dabarun yana buƙatar gwadawa don aminci da tasiri. A ranar 16 ga Maris, 2020 an fara gwajin asibiti na farko na gwaji akan masu sa kai huɗu a Seattle.
Kwayar cuta tana da kwafin kwayar halitta mara lahani wanda aka samo daga kwayar cutar da ke haifar da cutar.Antibody dependent enhancement an ba da shawarar a matsayin babban abin da zai hana ci gaban kwayar cutar zuwa 2-SARS-CoV, amma wannan yana da matukar jayayya (ba a bayyana ba).
An gudanar da gwaji sama da 300 a cikin Afrilu 2020.
An kimanta gwaji bakwai kuma an amince da maganin su don magance zazzabin cizon sauro, gami da bincike huɗu akan hydrochlorothiazines ko chloroquine.
Yawancin binciken da ake yi a China ana tsammanin za su kasance kan maganin rigakafin cutar, tare da gwaji tara a mataki na uku kan Redisceptor a wasu ƙasashe don samun rahoto a ƙarshen Afrilu.
Ci gaban rukunin likitoci don sake nazarin allurar rigakafin COVID-19 da kuma sunayen sunayen magunguna suna gudana, kamar yadda yake a watan Afrilu 2020. Akwai wasu magungunan rigakafin cutar da aka kimanta don maganin COVID-19, gami da remdesivir da hydrochlorothiazines, lopinavir / ritonavir da lopinavir / ritonavir waɗanda aka haɗa don haɓaka beta a cikin jiki.
Akwai hujjojin farko na tasirin remdesivir, kamar na Mayu 2020.
An lura da ci gaban lafiyar mutum a cikin marasa lafiya waɗanda aka kula da su da remdesivir.
An gudanar da gwaji na sashi na uku a cikin Amurka, China da Italiya. An yi amfani da chloroquine a baya don magance zazzabin cizon sauro, an fara nazarin shi a China a watan Fabrairun 2020 tare da mahimman sakamako na farko.
Koyaya, akwai alaƙa don duba nazarin binciken.
Gwamnatin Koriya da na kasar Sin sun bada shawarar yin amfani da chloroquine.
Koyaya, Cibiyar Nazarin Kwayar cutar Wuhan, yayin da ta ba da shawarar cin abinci na yau da kullun na gram ɗaya, ta lura cewa cin abinci biyu a rana yana da haɗari sosai kuma yana da lahani.
A ranar 28 ga Mayu, 2020, FDA ta ba da sanarwar cewa ta dakatar da amfani da hydrochlorothiazines da chloroquine a cikin yanke shawara game da maganin likita ga mutanen da ke dauke da COVID-19.
Bayanai na farko sun nuna cewa abinci mai yawa a cikin ribavirin yana da mahimmanci ga SARS-CoV-2 a cikin vitro.
An ba da shawarar yin amfani da maganin Nitazoxanide don ƙarin in vivo bayan nuna rashin ƙarfi na SARS-CoV-2.
Gwaje-gwajen chloroquine da hydroxychloroquine tare da maganin rigakafi ko ba tare da maganin rigakafi ba suna da iyakoki da yawa waɗanda ke hana ƙungiyar likitoci amincewa da waɗannan magungunan ba tare da cikakken bincike ba. Oseltamivir ba ya hana SARS-CoV-2 kuma ba shi da wani sanannen aiki a maganin COVID-19.
Cytokine mai yaduwa na iya zama matsala a cikin matakai na gaba na COVID-19 mai tsanani.
Akwai shaidar cewa hydroxychloroquine na iya samun halayen anti-cytokine. An sanya Tocilizumab a cikin umarnin magani ta Hukumar Lafiya ta Duniya bayan an kammala ƙaramin bincike.
Wannan gwaji ne na gwaji na biyu a cikin Italiya bayan sakamakon ya nuna cewa mutane suna da cutar mai tsanani.
Idan aka haɗa shi da samfurin gwajin jini don gano matsalar cytokine, wannan yana nufin amsawa ga haɓakawa, wanda zai iya haifar da mutuwa a wasu mutane masu kamuwa da cutar.
An yarda da maganin karɓar ƙwayar cuta na 6-Cytocin ta FDA bisa ga binciken da aka yi a baya don magance cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
A halin yanzu, babu wata hujja ta bazuwar ko kuma tabbatacciyar shaida cewa tocilizumab magani ne mai tasiri don CRS.
Ana ba da gudummawar tsabtace da kuma samar da ƙwayoyin cuta da tsarin rigakafin waɗanda suka warke daga COVID-19 ga mutanen da ake buƙatar ganowa a matsayin hanyar rashin lafiyar rashin haƙuri.
An gwada wannan aikin don SARS ba tare da cikakken sakamako ba.
Kwayar cutar simintin gyare-gyare ita ce hanyar da aka yi hasashen cewa maganin rigakafi mai rauni zai iya sarrafa rigakafin SARS-CoV-2.
Sauran hanyoyin, duk da haka, kamar ƙwayoyin cuta masu dogara da ƙwayoyin cuta ko aikin hana ƙwayoyin cuta na iya yiwuwa.
Sauran nau'ikan maganin maganin rashin ƙarfi, alal misali, amfani da maganin maganin ƙwayoyin cuta na monolonal yana ci gaba.
Samfuran ƙwayar jini na jini, wanda ya ƙunshi ƙwayar jini na masu haƙuri da suka warke da kuma ƙwayoyin cuta na musamman wanda za a iya ƙarawa don saurin yaduwa.
Cutar kwayar cutar coronavirus rukuni ne na cututtuka masu alamomi.
Li Wenliang, wani likita a asibitin Wuhan, wanda daga baya ya kamu da COVID-19 kuma ya mutu bayan an kara wayar da kan jama'a game da yaduwar cutar.
